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ABSTRACT 
 
Although the regenerative capacity of the dentine-pulp complex, induced by pulp capping 
agents, is well established, the molecular processes by which this occurs, are poorly 
understood. Calcium silicate cements are powerful stimulators of wound healing in the pulp. 
This project aimed to investigate the potential of calcium silicate cements to liberate dentine 
extracellular matrix (dECM) components, characterise growth factors present and determine if 
these dECM components, or any specific growth factor characterised, had bioactive effects on 
pulp wound healing. dECM was solubilised from human dentine using solutions of EDTA, 
calcium hydroxide, white MTA, grey MTA and Biodentine®. Proteomic analysis using 
cytokine arrays and multiplex ELISA demonstrated the presence of a broad range of growth 
factors, which were differentially released, suggesting that each agent had differing capacities 
to liberate such molecules. In vitro analysis of pulp cells exposed to dECM components 
released by calcium silicate cements, demonstrated increased capacity for cell proliferation 
and chemotaxis. A previously unidentified growth factor in dECM, hepatocyte growth factor, 
was shown to induce pulp cell proliferation, migration, differentiation and mineralisation in 
vitro. Growth factors liberated from dentine by the soluble components of pulp capping 
agents may regulate reparative events leading to pulp wound healing in vivo.  
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1.0 INTRODUCTION 
 
1.1 Dentine-pulp complex 
 
The dentine-pulp complex (Figure 1.1) is a unique mineralised connective tissue that is 
composed of two integrated constituents: the pulp - an underlying gelatinous soft 
connective tissue which has a rich vasculature and is well innervated, and the dentine - an 
outer casing of mineralised tissue. Although these tissues have chemical compositions and 
structures which differ (Linde and Goldberg, 1993), it is not possible to consider them as 
separate entities since their physiological processes during development, homeostasis, 
pathology and repair are intertwined and reliant upon one another. The major component of 
any connective tissue is extracellular matrix; this consists mainly of fibrillar proteins, which 
are predominantly collagen in the case of dentine, and this provides its structural integrity. 
Ground substance in the dentine extracellular matrix (dECM) provides viscoelasticity, 
amongst many other functions, and is principally comprised of proteoglycans, 
glycosaminoglycans (GAGs) and (glyco-)proteins. 
 
Dentine is a permeable structure that is perforated by tubules, which traverse from the 
amelodentinal junction (ADJ) or cementoenamel junction (CEJ) to the pulp chamber. The 
pulp and dentine thus form a complex or continuum via the communication provided by the 
dentinal tubule and the odontoblast process, which projects into the tubule. In health, 
odontoblasts line the entirety of the pulp chamber. The extent to which the odontoblast 
process occupies the tubule has been debated within the literature; some authors suggest 
that it occupies the entire length of the tubule (Maniatopoulos and Smith, 1983, Sigal et al., 
1985, Sigal et al., 1984), whilst others claim that it is confined to the pulpal third 
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circumpulpal dentine
150 µm
predentine
pulp tissue
pulp horn
(Garberoglio and Brannstrom, 1976, Thomas and Carella, 1983, Thomas and Carella, 
1984). This controversy results from the relatively aggressive chemical treatments required 
for tissue preparation, which can result in process contraction. Enamel, the covering to 
coronal dentine, appears macroscopically to be impervious, but it actually behaves like a 
semi-permeable membrane (Bergman, 1963). This structural arrangement results in the 
dentinal tubules being fluid filled throughout their entire length as they are in 
communication with the extracellular fluids of the pulp, periradicular tissues and the whole 
of the oral cavity. Amongst a number of functions, dentinal fluid act as a conduit for 
communication. For example, external thermal stimulation of the tooth results in 
hydrodynamic activation of nerve fibres within the dentine-pulp complex; this arises from 
expansion or contraction of the dentinal fluid, brought about by temperature changes 
(Anderson et al., 1970). For the purpose of description only, dentine and the pulp will now 
be considered separately. 
 
 
 
 
 
 
 
 
 
 
Figure 1.1 Histological section showing the structure of the dentine-pulp complex in a 
human third molar with haematoxylin and eosin staining (H&E). (Histological processing 
was performed by Sue Finney and image captured by the author at x10 magnification) 
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1.2 Dentine and its bioactive niches 
 
Dentine is a porous biological composite comprised of hydroxyapatite crystal filler 
particles in a collagenous matrix (Pashley and Tay, 2012). By weight, it consists of 70% 
mineral phase, 20% organic matrix and 10% water; its mineral content is therefore less than 
enamel (96%), but more than bone and cementum (65%) (Goldberg et al., 2011). The 
mineral phase of dentine comprises of calcium-deficient and carbonate-rich hydroxyapatite 
plate-like crystals, which are considerably smaller than those found in enamel. The organic 
matrix is predominantly made up of type I collagen (90%) with the remainder including 
non-collagenous proteins (NCPs), GAGs and proteoglycans (Veis, 1993, Butler, 1998, 
Santos et al., 2009). This unique combination of constituents enables dentine to function as 
a bulk supportive structure for the tooth and to play an important active biological role 
during homeostasis and repair.  
 
The dECM is secreted by the odontoblast, a specialised post-mitotic cell. Due to the 
varying secretory behaviour of this cell during its life, it will deposit different types of 
dentine, which are categorised into primary, secondary and tertiary dentine (Kuttler, 1959) 
(Figure 1.2). The dentine that is formed prior to eruption, up until the point at which the 
root end is complete, is termed primary dentine. The initial layer of primary dentine, 
deposited by newly differentiated odontoblasts adjacent to enamel, is referred to as mantle 
dentine; it is approximately 150 μm wide, contains loosely packed collagen fibrils and is 
less well mineralised. The remaining primary dentine is considerably more ordered with 
consistent tubular structure and is laid down at a rate of approximately 4 μm per day until 
crown and root formation is complete (Schour and Hoffman, 1939). Once the tooth is 
formed, odontoblast secretory activity significantly decreases and secondary dentine, 
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sometimes known as physiological dentine, begins to form at a much slower rate of around 
0.4 μm per day. During the life of an unaffected tooth, the volume of the coronal pulp 
chamber decreases at a more rapid rate than that of the radicular pulp chamber indicating 
that secondary dentine is not deposited at an even rate throughout the entire pulp chamber. 
The boundary between primary and secondary dentine is demarcated by a subtle 
calciotraumatic line but the tubules traversing this maintain continuity. The only 
morphological difference between primary and secondary dentine is that the ‘S-shaped’ 
curvature of the dentinal tubules is more accentuated in secondary dentine, perhaps 
reflecting crowding of the odontoblasts as they move inwards towards the pulp core. 
Tertiary dentine refers to the dentine formed focally in response to noxious stimuli such as 
tooth wear, caries, trauma or iatrogenic intervention (Smith, 2012). Two types of tertiary 
dentine are formed and are termed reactionary and reparative dentine; both of these types of 
dentine are described below in more detail (section 1.5). 
 
Circumpulpal dentine is deposited after the mantle dentine has been formed and makes up 
the remainder of the dentine structure. It exists in two forms; the majority of circumpulpal 
dentine is intertubular dentine whilst the minor component in humans is peritubular 
dentine. Peritubular dentine is secreted from the odontoblast process; it is more highly 
mineralised, rich in NCPs, but contains relatively few collagen fibrils compared with 
intertubular dentine. Intertubular dentine is secreted from the terminal web of the 
odontoblast and is predominantly composed of densely packed type I collagen fibrils (20-
75 nm in diameter) that are interlaced with plate-like crystallites. These structures run 
parallel to the fibril long axis and are approximately 2-5 nm in thickness and are 60 nm in 
length (Goldberg et al., 2011). Collagen fibrils are coated with NCPs and overlap with each  
  
  
B
CA
primary dentine
secondary dentine
tertiary dentine
(reactionary)
root canal
 
  
Figure 1.2 A case of a 24 year old female patient who had suffered trauma to her maxillary incisor 7 years earlier. A) Pre-operative 
periapical radiograph of maxillary central incisors following GDP’s attempt to find the root canal. B) Access cavity in left maxillary 
incisor and C) higher resolution image of (B). This shows primary dentine to be a “creamy” colour. Secondary dentine is a darker 
colour compared with the primary dentine. Tertiary dentine is clearly demarcated by peripheral secondary dentine and has an “icy” 
mottled appearance interspersed with a more grey coloured dentine. The canal can be seen located in the centre of the tertiary dentine 
suggesting that the tertiary dentine was deposited at an equal rate by the odontoblasts lining the pulp chamber (clinical case by author). 
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other, creating gaps between them where GAGs are localised; the interaction of these with 
other bioactive molecules is considered in section 1.2.2.  
 
1.2.1 Dentine extracellular matrix 
 
As previously discussed, the majority of the dECM is comprised of collagenous proteins. 
Numerous other molecules, largely NCPs, make up the remainder of the dECM and these 
molecules may be considered the most bioactive in terms of being regulators of 
homeostasis and repair within the dentine-pulp complex. The broad range of NCPs are 
summarised in Table 1.1. The well characterised small integrin-binding ligand N-linked 
glycoproteins (SIBLINGs) present within dECM are known to act as nucleation factors as 
they regulate hydroxyapatite crystal formation (Hunter and Goldberg, 1993, Goldberg et al., 
1996, Fisher et al., 2001, He et al., 2003). Although most of these molecules have been 
detected in both bone as well as dentine, some are considered more characteristic of 
dentine. Indeed, dentine sialophosphoprotein (DSPP) is highly expressed by odontoblasts 
(Sreenath et al., 2003) whilst its cleaved products, dentine sialoprotein (DSP) and dentine 
phosphoprotein (DPP), are more abundant in the dECM compared with the bone matrix. 
The SIBLING, dentine matrix protein-1 (DMP-1), is also expressed by differentiating 
odontoblasts (Toyosawa et al., 2004) and is thought to be essential for maturation of 
predentine (Feng et al., 2003, Ye et al., 2004), however, despite its name, it is also 
implicated in mineralisation of bone and cementum (MacDougall et al., 1998). Depending 
on its degree of phosphorylation, DMP-1 has been shown to be a signalling molecule for 
promoting mineralisation but under certain conditions it can also act as an inhibitor (Tartaix 
et al., 2004). Bone sialoprotein (BSP), which is present in tertiary dentine, has been shown 
to play important roles in both initiating and inhibiting hydroxyapatite crystal growth 
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during mineralisation (Qin et al., 2004, Boskey et al., 2008). Osteopontin (OPN) and matrix 
extracellular phosphorylated protein (MEPE) are both present in dECM and are expressed 
by odontoblasts. Both of these molecules have also been reported to play a regulatory role 
during hydroxyapatite crystal growth and mineralisation (Boskey et al., 1993, Boskey et al., 
2002, Gowen et al., 2003). The SIBLING molecules play a crucial role in the regulation of 
dECM secretion and mineralisation, particularly during initial dentine formation, 
homeostasis and repair, by acting not only as promoters but also as inhibitors of 
hydroxyapatite crystal formation. Other non-phosphorylated matrix proteins, such as 
osteocalcin, are expressed by odontoblasts and are thought to aid maturation of enamel 
early in primary dentinogenesis (Papagerakis et al., 2002), however, their role in dentine 
maturation is unclear. The small leucine-rich proteoglycans (SLRPs), decorin and biglycan, 
are thought to facilitate mineralisation in predentine through their ability to bind to calcium 
(Embery et al., 2001, Goldberg et al., 2003a). 
Table 1.1 Summary of non-collagenous proteins present in dECM. Adapted from Goldberg 
and Smith 2004. Key to abbreviations is provided on page xii. 
 
Phosphorylated 
matrix proteins 
(SIBLINGs) 
Non-phosphorylated 
matrix proteins 
Proteoglycans 
(SLRPs) 
Matrix 
metalloproteinases 
(MMPs) 
DSPP, DSP, DPP, 
DMP-1, BSP, OPN, 
MEPE 
Matrix GLA protein, 
osteocalcin, 
osteonectin 
Decorin, biglycan, 
lumican, fibromodulin, 
osteoadherin 
Collagenase (MMP-1), 
gelatinases (MMP-2 
and -9), stromelysin-1 
(MMP-3), enamelysin 
(MMP-20) 
 
Growth factors and 
cytokines 
Serum derived 
proteins 
Others 
TGF-β1 
IGF-I, IGF-II 
PDGF-AB, VEGF, 
PlGF, FGF-2, EGF 
BMP 
IL-1α, IL-1β, IL-4,   
IL-6, IL-8, IL-12 
 
Albumin, lipoproteins, 
αHS2-glycoprotein 
Membrane phospholipids, extracellular-mineral-
associated phopholipids 
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Other NCPs found in dECM include matrix metalloproteinases (MMPs), which are a class 
of zinc- and calcium-dependent hydrolases with twenty-three family members in total. 
These enzymes play an important role in matrix remodelling, angiogenesis and wound 
healing (Hannas et al., 2007) and have been shown to be released during cariogenic attack 
and during treatment of dentine with ethylenediaminetetraacetic acid (EDTA), citric acid 
and dentine bonding agents (Pashley et al., 2004, Tay et al., 2006, Mazzoni et al., 2007). 
Odontoblasts secrete MMP enzymes (Llano et al., 1997, Caron et al., 1998), which catalyse 
the degradation of matrix macromolecules, such as collagens and proteoglycans. MMPs 
have been shown to be involved in the initiation and regulation of mineralisation (Fanchon 
et al., 2004, Beniash et al., 2006) and the processing of DSPP (Yamakoshi et al., 2006). In 
vitro, MMP-2 has been shown to cleave DMP-1 which leads to the formation of a bioactive 
molecule capable of enhancing differentiation of progenitor pulp cells (Chaussain et al., 
2009). Release of MMPs also appears to be important in activating other biological 
molecules, as adrenomedullin (ADM), insulin-like growth factors (IGFs) and transforming 
growth factor–β1 (TGF-β1) have all been shown to have their activity modified by such 
proteolytic enzymes (Dallas et al., 2002, Martinez et al., 2004, Miyamoto et al., 2004). 
These data suggest that MMPs, released along with the other molecules from the dECM, 
have the potential to orchestrate reparative events by promotion and attenuation of key 
cellular events (Smith et al., 2012a).  
 
1.2.2 Growth factors and cytokines in dECM 
 
Growth factors and cytokines are key signalling molecules that control and regulate cellular 
events involved in tissue development, homeostasis and repair. They are known to play a 
central role in initiating and regulating events in wound repair in the dental pulp (Smith et 
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al., 2012a). Indeed, their roles and activities are being explored to identify new biological 
repair and tissue engineering approaches for treatment of pulpal and periradicular disease 
(Kim et al., 2010). Growth factors are potent peptide signalling molecules, which can elicit 
autocrine, paracrine and endocrine effects at very low concentrations (picogram range) 
(Lazar-Molnar et al., 2000, Smith et al., 2012a). Some growth factors are highly specific in 
their activity, while others have broader effects. These molecules act by binding to specific 
cell surface receptors and initiating a cascade of intracellular events, which lead to 
transduction of the signal to the cell nucleus; this, in turn, may lead to gene expression 
changes which ultimately influence cell behaviour and activity.    
 
During tooth development, epithelial-mesenchymal interactions are responsible for 
initiating the differentiation of ameloblasts and odontoblasts, which then begin to secrete 
enamel and dentine respectively. In particular, TGF-β family members have been shown to 
be important in facilitating signalling leading to odontoblast differentiation (Begue-Kirn et 
al., 1992, Begue-Kirn et al., 1994, Ruch et al., 1995). During mineralisation of dECM, 
growth factors secreted by odontoblasts (Smith and Lesot, 2001) interact with extracellular 
matrix or mineral components and become ‘fossilised’ or sequestered within it (Smith et 
al., 1998, Sloan et al., 2002). These interactions with other matrix components are 
important in protecting these signalling molecules from degradation as their half-lives are 
often of the order of only a few minutes if not protein bound (Wakefield et al., 1990). The 
precise nature of the association of these molecules with the dECM is not yet fully 
understood (Tziafas et al., 2000, Smith et al., 2001, Cassidy et al., 1997, Roberts-Clark and 
Smith, 2000), however, a group of heparan sulphate proteoglycans present within the 
dECM are thought to be involved. Decorin and biglycan are two such proteoglycans / 
GAGs, which have been shown to bind TGF-β1 in dentine (Smith et al., 1998, Baker et al., 
 10 
 
2009). The heparan sulphate binding proteoglycans have also been shown to interact with 
numerous other proteins in dECM which, importantly, include the growth factors: 
fibroblast growth factors (FGF), vascular endothelial growth factor (VEGF), placental 
growth factor (PlGF), platelet-derived growth factor (PDGF) and hepatocyte growth factor 
(HGF) (Dreyfuss et al., 2009). Some growth factors, such as the IGFs, are bound to specific 
binding proteins (BPs), which support and attenuate the bioactivity of their signalling 
activity (Arai et al., 1996, Kuang et al., 2006). Some growth factors, such as HGF, are 
known to bind to glycoproteins including fibronectin and vitronectin and these molecular 
complexes have been shown to enhance biological activity to promote neovascularisation 
during health and disease (Rahman et al., 2005). In other tissues, signalling molecules such 
as the bone morphogenetic proteins (BMPs) and interleukin-2 (IL-2) are able to bind to 
collagen type I and III directly (Paralkar et al., 1990, Paralkar et al., 1991, Somasundaram 
et al., 2000), whereas collagen type II and IV have been shown to have binding domains for 
both BMP and TGF-β family members (Zhu et al., 1999, Larrain et al., 2000). Brain-
derived neurotrophic factor (BDNF) has been shown to bind to a number of different GAGs 
in tissues of the central nervous system (Kanato et al., 2009). Although relatively little is 
directly known about how growth factors and cytokines are bound to dECM, there is 
enough evidence to suggest that the mechanism of binding is similar to how these 
molecules bind to the ECM of other tissues (Smith et al., 2012a). 
 
To date, several different growth factors have been identified in dECM including TGF-β1 
(Finkelman et al., 1990, Cassidy et al., 1997, Smith et al., 1998), IGF-I, IGF-II (Finkelman 
et al., 1990), BMP (Bessho et al., 1991) PDGF-AB, VEGF, PlGF, FGF-2 and epidermal 
growth factor (EGF) (Roberts-Clark and Smith, 2000). Pro- and anti-inflammatory 
cytokines including IL-1α, IL-1β, IL-4, IL-6, IL-8, IL-12 and granulocyte macrophage 
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colony stimulating factor (GM-CSF) have also been reported as being present in dECM 
(Cooper et al., 2010, Graham et al., 2007). Although this rich cocktail of growth factors and 
cytokines present in dECM has been identified, it is likely that there are many more key 
signalling molecules sequestered in dentine that are yet to be identified. The role of the 
TGF-β1 growth factor is, however, well documented in tooth development and repair and it 
is thought to play a key role in initiating the differentiation of odontoblasts at the periphery 
of the dental papilla (Ruch et al., 1995). In addition, TGF-β1 has been shown to be a 
chemoattractant for dental papilla-derived cells (Kwon et al., 2010) and other less well 
differentiated cells (Macdonald et al., 2007, Brenmoehl et al., 2009). The application of 
TGF-β1 and its other isoforms has been shown to induce odontoblast-like cell 
differentiation and dentinogenesis in vitro (Sloan and Smith, 1999, Melin et al., 2000) and 
in vivo (Hu et al., 1998). While TGF-β1 has demonstrable key biological activities, it is 
likely that the effects of dECM components when released are not due to one bioactive 
molecule alone. Indeed, extracts of whole dECM components have been shown to induce 
increased proliferation of stem / progenitor cells in vitro at relatively low concentrations, 
however, it appeared that relatively high concentrations inhibit proliferation (Musson et al., 
2010, Zhang et al., 2011).  
 
While the dECM is known to be a rich source of bioactive molecules, research thus far has 
concentrated on characterisation of specific growth factors, which have been identified 
using more conventional enzyme-linked immunosorbent assays (ELISAs). The principle 
underpinning this technique is based on the formation of an antigen (target protein) / 
antibody complex which has a direct or indirect reporting system which indicates the 
concentration of the target protein compared with a standard (Engvall and Perlmann, 1971, 
Van Weemen and Schuurs, 1971). During the 1990s, antibody array technology was 
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developed to enable high-throughput analysis of multiple targets simultaneously using 
small sample volumes (Ekins and Chu, 1991, Ekins, 1998). This technology allows a more 
rapid and in-depth approach to protein analysis and it has previously been applied to 
characterise dECM components for inflammatory cytokine content (Graham et al., 2007, 
Cooper et al., 2011), but it has yet to be used for growth factor analysis in dECM.  
 
Application of such a high-throughput approach has the potential to better characterise 
growth factor presence within the dECM and identify new molecules, which could 
contribute to dentine-pulp complex development and repair. Indeed, one particular 
candidate is the multifunctional growth factor, HGF, which has previously been 
demonstrated to act as a powerful mitogen, morphogen, motogen and chemotactic agent in 
multiple tissue types; it is involved in a variety of physiological processes, including tissue 
development and regeneration (Trusolino et al., 2010). HGF signalling is mediated by 
binding to its transmembranous tyrosine kinase receptor encoded by the proto-oncogene c-
Met (Bottaro et al., 1991). Expression of c-Met in various developing and mature organs 
indicates that HGF is a mesenchymal-derived factor that acts on neighbouring developing 
epithelia which express c-Met, thus playing a key role in tissue development where 
epithelial-mesenchymal interactions occur (Birchmeier and Gherardi, 1998). Interestingly, 
expression of HGF and c-Met has been localised in developing tooth germs, implicating 
potential signalling roles in dental tissue development (Sonnenberg et al., 1993, Kajihara et 
al., 1999). Studies conducted using an ex vivo mouse tooth germ model have demonstrated 
that HGF translation arrest results in abnormal tooth development, with the enamel organs 
being surrounded by a thin layer of dentine and dental papilla thus appearing “inside-out” 
compared with that of the normal tooth germ (Tabata et al., 1996). 
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1.2.3 Mobilisation of dECM components 
 
The hypothesis that mobilisation of bioactive molecules from dECM initiates a sequence of 
events leading to pulp repair and regeneration is well established (Smith et al., 2012a), 
however, the mechanism(s) by which dECM components are released is far less well 
understood. Different solutions have been used to release soluble dECM components, 
including EDTA (Smith and Leaver, 1979), lactic acid (Dung et al., 1995), citric acid 
(Mazzoni et al., 2007), phosphoric acid (Smith and Smith, 1998, Ferracane et al., 2010) and 
calcium hydroxide (Graham et al., 2006). Interestingly, although the pH of these solutions 
ranges from acidic through to alkaline, they are all still capable of extracting ECM 
molecules from dentine, so it therefore appears that the process is not entirely pH dependent 
(Goldberg and Smith, 2004). In terms of yield, EDTA has been shown to be the most 
effective and is therefore considered to be a valuable control agent for in vitro studies in 
this area. Understanding the mechanisms by which dECM components are released by such 
agents would open new avenues for research into the development of novel biologically-
based treatment modalities for dental tissue regeneration.  
 
1.3 Dental pulp 
 
The dental pulp lies at the core of the tooth encased by the dentine. The loose connective 
tissue of the dental pulp is surrounded at its periphery by a highly specialised single layer of 
cells called odontoblasts. A network of capillaries, known as the terminal capillaries, exists 
in close proximity to this layer of odontoblasts, providing nutrients and performing 
homeostatic functions. In addition, free nerve endings pass between odontoblasts to form 
the terminal axons of the plexus of Raschkow, which provides the nervous supply (Okiji, 
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2012). Also within this layer, dendritic cells can be found which detect transdentinal 
antigenic stimuli (Jontell et al., 1998) and perform an immune defensive role. Beneath the 
odontoblasts is a relatively sparse area, which contains few cells and is known as the cell 
free zone or zone of Weil (Nanci, 2013). This zone is not always possible to distinguish 
when the odontoblasts are highly active, but it is generally rich in unmyelinated nerve 
fibres, capillaries and processes of fibroblasts. More centrally to the cell free zone is the cell 
rich zone of Höhl, which is densely populated with fibroblasts, undifferentiated 
mesenchymal stem cells and immune defence cells (macrophages and lymphocytes). More 
central to this zone is the pulp core, which has similar content to the cell rich zone, 
however, the cells here are less densely packed and there is a higher density of larger blood 
vessels and collagen bundles (Nanci, 2013) (Figure 1.3).  
 
 
 
 
 
 
 
 
 
 
Figure 1.3 Histological section showing the structure of the dentine-pulp complex in a 
human third molar with H&E staining. (Histological processing was performed by Sue 
Finney and image captured by the author at x20 magnification) 
 
 
To enable the study of the homeostatic and reparative events of the dental pulp in vitro, 
numerous different pulp-derived cell lines have been utilised. Immortalised cell lines such 
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as murine odontoblast-like cells (MDPC-23) (Hanks et al., 1998a) and undifferentiated 
murine dental pulp cells (OD-21) (Hanks et al., 1998b) have been used extensively. MDPC-
23 cells are derived from mouse dental papilla and express odontoblast phenotypic markers 
such as DPP, DSP, type I collagen, alkaline phosphatase, osteopontin and osteocalcin 
(Hanks et al., 1998a). Although experiments with these cells have been published widely, 
cultures tend to comprise of a homogeneous cell type and thus may not provide a true 
representation of pulp tissue. More recently, heterogeneous populations of primary rat 
dental pulp cells have been characterised in detail (Patel et al., 2009) and maintenance at a 
low passage enables the potential for cells to differentiate into those with a phenotypic 
profile similar to that of odontoblasts.  
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1.3.1 Cells of the dental pulp 
 
This section reviews the individual specialised cells found within the pulp and which have 
functions related to tertiary dentine formation.  
 
1.3.1.1 Odontoblasts 
 
Odontoblasts are highly differentiated, post-mitotic cells developmentally derived from the 
neural crest and whose functions include secretion of dECM during tooth development, 
tissue homeostasis and responsiveness to noxious stimuli. They have a life-span the same as 
the viable tooth. Coronal odontoblasts differ from those found in the root canal in terms of 
their morphology; those lining the crown are elongated and more columnar with a polarised 
nucleus, whereas those found in the root canal exhibit a more pyramidal morphology. This 
difference in cell shape may, however, be artefactual due to the density with which 
odontoblasts are packed into the coronal aspect of the pulp chamber compared with the root 
(Smith, 2008). The morphology of the odontoblast very much reflects the stage within its 
life cycle and thus its functional activity (Couve, 1986). In general, odontoblasts 
characteristically are elongated with a nucleus polarised towards the basal compartment of 
the cell and a high nuclear to cytoplasmic ratio, especially during cell development. The 
organelles in an actively secreting odontoblast are prominent; as is typical of a secretory 
cell, there are extensive rough endoplasmic reticula, numerous golgi apparatus and 
mitochondria scattered throughout the main cell body. The quiescent odontoblast is shorter 
and described as being “stubby” with a less polarised nucleus. The numbers of organelles, 
including rough endoplasmic reticulum, golgi apparatus and mitochondria, are significantly 
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reduced in quiescent cells and they are located in a more perinuclear arrangement (Smith, 
2008).  
 
The odontoblast process is a direct extension of the main cell body beyond the junctional 
complex. It is sparsely filled with organelles compared with the cell body, which reflects its 
decreased secretory activity. The process is not a single isolated smooth projection from the 
cell body as it has numerous lateral branches which may contact other branches from 
neighbouring processes. The odontoblast process is comprised predominantly of a well-
developed cytoskeleton with microfilaments running along its long axis (Holland, 1985, 
Frank and Steuer, 1988). The extent to which the process extends into the tubule has 
generated some debate over the years, however, with the use of more sophisticated 
techniques, it now seems probable that the process only extends to peripheral dentine 
during development (Byers and Sugaya, 1995, Yoshiba et al., 2002). 
 
The cell bodies of odontoblasts are joined together laterally by desmosomes, which form 
gap junctions and occluding zones (tight junctions) (Sasaki et al., 1982, Calle, 1985). The 
inter-odontoblast space allows transfer of intracellular ions and water soluble metabolites 
and this may act as a communication system leading to changes in secretory activity of the 
odontoblast (Okiji, 2012). As yet, however, the degree of permeability and the mechanisms, 
which control flow within this space are not fully understood. Tight junctions around the 
neck of odontoblasts have been shown to be impenetrable (Turner et al., 1989, Bishop and 
Yoshida, 1992), however, following cavity preparation a tracer was shown to permeate into 
predentine and dentine (Turner et al., 1989, Izumi et al., 2001). This suggests that the 
change in permeability may be a defensive action and increasing fluid outflow towards 
dentine may prevent inward diffusion of any noxious or infecting agent.   
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1.3.1.1.1 Odontoblast differentiation 
 
In the early stages of odontogenesis, cells that originate from the neural crest migrate 
towards the first branchial arch. Differential growth between epithelial cells of the dental 
lamina and the underlying mesenchyme initiates the formation of a tooth bud. As the dental 
organ becomes more developed, the most peripheral cells of the dental papilla start to 
differentiate and become odontoblasts (Smith, 2008). All cells within the dental papilla of 
the developing enamel organ have the potential to become odontoblasts, however, it is only 
those that contact the basement membrane of the internal dental epithelium which receive 
the relevant signals to initiate this process (Ruch et al., 1995). These cells undergo several 
cycles of cell division and during the last cycle of mitosis, the cells contacting the basement 
membrane become pre-secretory, pre-polarised odontoblasts. Those dental papilla cells 
which do not receive this signal form the cells in the subodontoblastic Höhl’s layer. During 
this cycle, the cells move from a position, which is roughly parallel to the basement 
membrane, to a new orientation, lying perpendicular to it. The pre-odontoblast undergoes 
major cellular changes and restructuring to develop into a functional cell (Goldberg et al., 
2011). 
 
1.3.1.1.2 Secretory activity of odontoblasts 
 
Radiolabelled 
3
H-proline has been used to demonstrate a pathway of collagen synthesis and 
secretion in odontoblasts which follows a course typical of cells present in connective 
tissues. In vivo animal experiments have shown that, once taken up into the odontoblast cell 
bodies, the radiolabelled isotope followed a course from the rough endoplasmic reticulum 
to the golgi apparatus and was finally exocytosed into the predentine via pre-secretory and 
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secretory granules (Weinstock and Leblond, 1974, Frank, 1979). Notably, while other 
matrix components, such as phosphoproteins, glycoproteins and proteoglycans, are secreted 
along a similar pathway (Weinstock et al., 1972, Weinstock and Leblond, 1973), their route 
is more rapid and occurs in minutes rather than days. It has been suggested (Linde, 1984) 
that odontoblasts secrete different components from different surface sites on the cell. 
Collagen and proteoglycans are secreted from the proximal end of the odontoblasts, 
whereas specific NCPs are secreted at the distal level close to the mineralisation front. 
Although this is hypothetical, it may explain why peritubular dentine is collagen poor but 
rich in NCPs (section 1.2). Indeed, it has also been suggested that NCPs act as nucleators 
for hydroxyapatite formation (Linde, 1989) at the mineralisation front. It is likely that this 
is where growth factors, secreted from the active odontoblast, become sequestered in the 
dentine, however, this is currently only a suggesion and their precise location in dentine is 
unclear (Smith et al., 1998).  
 
Dentinogenesis does not simply relate to matrix deposition, but rather entails a process of 
complex remodelling from the transition of predentine to dentine (section 1.2.1). One of the 
major differences between bone and dentine is the difference in turnover rate and 
remodelling of the extracellular matrix. It had traditionally been thought that dentine was 
inert and was not modified once it had matured, however, there is now some evidence of 
limited endocytosis by odontoblasts (Linde and Goldberg, 1993). Indeed, the odontoblast 
communicates intimately with its extracellular matrix via its processes and their lateral 
branches, which form a canalicular network; exchange and remodelling may occur at a 
level that is undetected, however, this is currently hypothetical.  
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In order for dentine to be mineralised, significant quantities of mineral ions have to be 
transferred from the vasculature to the mineralisation front. Although the capillary plexus 
penetrates the odontoblastic layer, there are still only two routes for this transfer to take 
place; it can occur either through the inter-odontoblast space or via direct transfer through 
the odontoblast itself. As previously discussed (section 1.3.1.1), tight junctions exist at the 
proximal end of the odontoblast and this results in it being a relatively impervious layer, 
however, it has been demonstrated that calcium ions can pass through this space (Nagai and 
Frank, 1974). It has also been shown that a transmembranous phosphate and calcium ion 
transport mechanism exists through the odontoblast (Linde and Lundgren, 1995, Lundquist, 
2002). Mineralisation is achieved via the production of matrix vesicles during the formation 
of mantle dentine; these are rich in adenosine triphosphatase and phosphohydrolytic 
enzymes and contain a high concentration of mineral ions (Eisenmann and Glick, 1972). It 
has been suggested that once the mature odontoblast is formed, circumpulpal dentine is 
mineralised by a process in which extracellular matrix components, secreted by 
odontoblasts, act as nucleation factors. Recently, it has been shown that hydroxyapatite 
crystal formation is directed by such secreted components (Qin et al., 2007). 
 
1.3.1.2 Fibroblasts and multipotent cells 
 
Fibroblasts constitute the largest proportion of cells within the pulp and are most densely 
located in the cell-rich zone, although they can be found throughout the pulp. Their 
function is to secrete extracellular matrix; when they are active, this secretory function is 
reflected in their cellular morphology, with numerous rough endoplasmic reticulum and 
golgi apparatus. When they are quiescent, they appear considerably smaller, spindle shaped 
and contain far fewer of those organelles involved in the synthesis and secretion of collagen 
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type I and III, and NCPs. Fibroblasts have been shown to express osteonectin, BSP (Garcia 
et al., 2003, Martinez and Araujo, 2004) and OPN (Yokota et al., 1992), which are 
functionally involved in hard tissue formation, as well as growth factors such as isoforms 
from the TGF-β superfamilies (Sloan et al., 2000, Nakashima et al., 1994, Gu et al., 1996).  
 
A number of different populations of mesenchymally derived stem cells have been 
identified within the pulp and associated tissues. Any true stem cell is undifferentiated and 
has the ability to differentiate into several different phenotypes, for instance, into 
osteoblasts, chondrocytes or adipocytes (Augello et al., 2010). Amongst fibroblasts, within 
the cell-rich zone and central core of the pulp, undifferentiated mesenchymal cells have 
been identified and are reported as being multipotent. When isolated by enzymatic 
digestion in vitro from human dental pulps and implanted into immunocompromised mice 
in vivo, these cells were shown to develop into a tissue with a dentine-like structure lined 
with odontoblast-like cells. The isolated cells were termed ‘dental pulp stem cells’ (DPSCs) 
(Gronthos et al., 2000). It has recently been proposed that these cells within pulp tissue act 
as progenitors and contribute to reparative dentinogenesis (Tecles et al., 2005) (section 
1.5.2). Other isolated dental stem cell populations from the pulp include those from human 
exfoliated deciduous teeth, termed ‘stem cells from human exfoliated deciduous teeth’ 
(SHED) (Miura et al., 2003) and those identified in the apical papilla, called ‘stem cells 
from apical papilla’ (SCAP) (Sonoyama et al., 2006). It has been proposed that SCAP cells 
may lead to continued root formation following a treatment procedure called pulp 
revascularisation, which is performed on an immature tooth that has undergone pulp 
necrosis (Iwaya et al., 2001, Banchs and Trope, 2004, Thibodeau and Trope, 2007). A more 
recent study has suggested there is another source of progenitor cells that may originate as 
pericytes from perivascular tissue (Feng et al., 2011). Although it is established that 
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progenitor cells are required to participate in reparative dentinogenesis, many questions still 
remain unanswered with regard to the origin of these cells and whether they are even 
derived from a pulpal source (section 1.5.2). 
 
1.3.1.3 Immunocompetent cells 
 
For any tissue with a blood supply, the defence system to protect that tissue is supported by 
immunocompetent cells, recruited from the bloodstream, which become transient 
inhabitants of the tissue. These cells will respond to foreign antigens and infectious agents, 
initiating and modulating immune and inflammatory reactions, whilst supporting other 
cellular processes. Dendritic cells are resident in the pulp and they rapidly accumulate at the 
odontoblast layer if stimulated by an antigen (Jontell et al., 1988, Yoshiba et al., 1996). It 
has been proposed that TGF-β1, released from dentine during its degradation by bacteria or 
iatrogenic agents, may act as a chemotactic factor for dendritic cells and initiate the 
immune response (Farges et al., 2003). T-lymphocytes would be considered normal 
residents of the healthy dental pulp, however, B-lymphocytes are rarely found and a 
specific role in the dental pulp’s response during disease has not been identified. T-
lymphocytes require specific antigen presentation to activate a response and this is likely to 
be undertaken by dendritic cells. Once the antigen has been recognised, T-helper cells will 
orchestrate the immune response, whilst cytotoxic T-cells act directly and attempt to 
destroy the antigen. Macrophages are found in the dental pulp during health and they 
reportedly accumulate around the blood vessels, especially in the pulp core. Their primary 
function is immuno-surveillance and phagocytosis, especially of invading bacteria (Okiji et 
al., 1992), and they act opportunistically. The inflammatory and immune response 
associated with the dentine-pulp complex is considered in more detail in section 1.6.2. 
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1.3.2 Pulp extracellular matrix 
 
Collagen is the major organic constituent of pulp tissue, as it is for dentine. It contributes, 
by dry weight, 26% in human premolars and 32% in third molars; most of this is collagen 
type I and III (van Amerongen et al., 1983). The proportion of type III collagen is greater in 
the pulp than it is in dentine; odontoblasts almost exclusively secrete type I collagen, 
however, pulp fibroblasts have the ability to secrete both types. Throughout the pulp tissue, 
there are intensely hydrophilic proteoglycans which create the gel-like consistency of the 
pulp tissue. Proteoglycans are three dimensional structures, which can be schematically 
represented as an interdental brush (Okiji, 2012); the proteoglycan core forms the central 
spine with GAG chains sprouting off the core, represented by the bristles. Many 
extracellular proteins, including growth factors such as TGF-β1, have binding sites for 
GAGs, which may regulate the activity of these bioactive molecules. NCPs, such as 
fibronectin, are distributed throughout the pulp and have been shown by 
immunolocalisation to form corkscrew fibres that run parallel to odontoblasts, passing from 
the pulp into predentine (van Amerongen et al., 1984, Yoshiba et al., 1994). Notably, 
fibronectin has been implicated in the terminal differentiation of odontoblasts during 
primary dentinogenesis (Lesot et al., 2001). In vitro, isolated pulp extracellular matrix and 
its breakdown products have been shown to act as a chemoattractant for primary pulp cells, 
suggesting that, during disease, degradation of the pulp extracellular matrix may play an 
important role in stimulating pulp repair (Smith et al., 2012c). 
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1.4 General processes in wound healing 
 
The stages of pulpal repair follow a very similar pattern to the wound healing processes 
described for other tissues within the human body. For a tissue to repair itself following 
injury, a complex cascade of precisely timed and co-ordinated physiological processes must 
be initiated; this ultimately leads to tissue regeneration or scar formation if ideal 
environmental conditions predominate. These overlapping stages are classically divided 
into four phases: haemostasis, inflammation, cell proliferation and tissue remodelling 
(Gurtner et al., 2008, Velnar et al., 2009).  
 
1.4.1 Haemostatic phase 
 
When a tissue is punctured in some form and the integrity of the blood supply is breached, 
a complex clotting cascade is initiated to prevent exsanguination and ensure continuity of 
the body’s vascular supply. Initially, platelets aggregate and form a plug, whilst the affected 
blood vessels immediately constrict to reduce blood flow to the site of injury. EGF, IGFs, 
PDGF and TGF-β1 are immediately released from the cytoplasm of platelets at the site of 
injury (Pool, 1977) and act as chemotactic factors for other cellular process involved in 
wound healing. The formation of fibronectin amongst the platelet plug provides a 
provisional matrix, which allows adhesion of leukocytes, fibroblasts and endothelial cells 
(Laurens et al., 2006); this creates a dynamic environment for subsequent modification and 
maturation. 
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1.4.2 Inflammatory phase 
 
Following formation of the initial wound, the surrounding tissue may start to necrose and is 
at risk of bacterial invasion and infection. To prevent this, early in the healing process 
(within 24 – 36 hours), neutrophils are recruited through the activation of complement, the 
exocytosis of platelets and the release of products through the degradation of bacteria 
(Grose and Werner, 2004). Neutrophils are necessary for the removal and destruction of 
bacteria and damaged tissue by the process of phagocytosis. Macrophages appear later 
(approximately 48 – 72 hours) and are formed by the differentiation of monocytes at the 
wound site. Apart from playing a role in phagocytosis, macrophages provide a pool of 
growth factors, especially TGF-β family members and others including EGF, FGF and 
TGF-α, which activate fibroblasts and endothelial cells to initiate tissue repair (Velnar et 
al., 2009).  
 
1.4.3 Proliferative phase 
 
This subsequent phase occurs between 2 – 10 days post-injury and is characterised by cell 
proliferation and migration where the fibrin matrix is replaced by granulation tissue. In 
order for the tissue to mature it needs a nutrient supply, so the development of blood 
vessels (angiogenesis) in the new tissue is one of the initial steps. Key regulators of 
angiogenesis include PDGF, VEGF and FGF-2, which are secreted into the wound during 
the haemostatic phase (Takeshita et al., 1994, Baum and Arpey, 2005).   
 
In vitro, numerous different techniques have been used to mimic these wound healing 
events and to determine the rate at which mesenchymal cell numbers (e.g. fibroblasts and 
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stem cells) increase. Traditionally, in monolayer cultures, cell numbers are determined 
using a counting chamber such as a haemocytometer. However, for large experiments, this 
can be time consuming so colorimetric assays are commonly used; these utilise a surrogate 
marker, such as metabolic activity, to calculate cell number from a standard curve produced 
in a parallel experiment. Examples of these techniques include the MTT assay [3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] and the WST-1 assay (water 
soluble tetrazolium salts). Assays to test the ability of agents to act as chemotactic factors 
include transwell assays, scratch wound assays and 3D matrix invasion assays, amongst 
others (Eccles et al., 2005). 
 
1.4.4 Remodelling phase 
 
The final phase of wound healing may last for several years and frequently will involve 
specialised cells, depending on the complexity of the tissue being reformed. For this phase 
to take place, appropriate signals are required for intracellular signalling to initiate 
differentiation of progenitor cells. It is not fully understood if these cells originate from 
local tissue or are recruited from other sources. More recently, circulating mesenchymal 
stem cells (MSCs) have been shown to enhance reparative mechanisms in a variety of 
tissue types including the lung (Wong et al., 2009), skin (Sasaki et al., 2008) and gut 
(Okamoto et al., 2006). The remodelling phase relies on establishing a fine balance between 
controlling degradation of provisional matrix and synthesising a new, more developed 
matrix to replace it. Maturation of extracellular matrix includes removing fibronectin and 
hyaluronic acid, which are replaced with new collagen fibrils, and increasing the diameter 
of those collagen fibrils initially secreted (Baum and Arpey, 2005). MMPs, produced by 
neutrophils, macrophages and fibroblasts, are responsible for the breakdown of unwanted 
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extracellular matrix; this process is regulated by inhibitory factors (Mulder and Vande 
Berg, 2002, Toy, 2005). As the old matrix is replaced with new, the drivers for controlling 
these processes are removed and the metabolic activity of this healing / healed tissue 
decreases until the wound has completely matured. 
 
1.5 Response of the dental pulp to injury 
 
The oral cavity is a hostile environment and the dental pulp comes under attack from a 
number of different challenges, such as caries, periodontal disease, trauma, iatrogenic 
damage and anachoresis. In response to some of these noxious agents, the pulp will lay 
down tertiary dentine in an attempt to protect itself. Tertiary dentine has been sub-
classified, based on the mechanism by which it is deposited, into reactionary dentine and 
reparative dentine (Lesot H. et al., 1993, Smith et al., 1995). Reactionary dentine is defined 
as, “tertiary dECM secreted by surviving post-mitotic odontoblasts in response to an 
appropriate stimulus” (Smith, 2012). This stimulus tends to be mild and slowly progressing, 
such as wear, erosion or slowly developing caries. This response consists of an up-
regulation in odontoblastic activity compared with what is normally expected for secretion 
during secondary dentinogenesis (Figure 1.4). Reparative dentine is defined as, “tertiary 
dentine secretion by a new generation of odontoblast-like cells in response to an appropriate 
stimulus, after the death of the original post-mitotic cells responsible for primary and 
secondary dentine secretion” (Smith, 2012). If favourable environmental conditions prevail, 
reparative dentinogenesis may occur after a stimulus, such as rapidly progressing caries, 
trauma or an iatrogenic intervention. Both reactionary and reparative pulpal responses 
represent repair of a wound and thus will follow the basic outline of events associated with 
repair of any other connective tissue (section 1.4). 
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1.5.1 Reactionary dentinogenesis 
 
Although it cannot be accurately determined, the amount of reactionary dentine laid down 
by the pulp is likely to correlate with the severity and duration of the stimulus. The 
molecular basis by which this increased odontoblast secretory activity is initiated, or indeed 
halted, is not fully understood. It has been shown that, in ferrets, lining unexposed cavities 
with solubilised dECM following very careful cavity preparation resulted in increased 
reactionary dentine formation (Smith, 1994). The processes leading to upregulation of this 
odontoblast activity are not known, however, it is proposed that in the case of caries, 
bacterial acids may cause release of growth factors that initiate intracellular pathways 
leading to increased secretory activity of odontoblasts (Dung et al., 1995, Cooper et al., 
2010). 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4 A diagram representing a cross-section of the tooth illustrating reactionary 
dentinogenesis. A) A slowly progressing carious lesion presents a relatively mild challenge 
to the dentine-pulp complex. B) The pulp responds by odontoblast up-regulation of their 
synthetic and secretory activity resulting in a focal deposition of dECM beneath the lesion.  
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Iatrogenic invention causes tertiary dentine to be laid down; this can be clearly 
demonstrated in patients through routine sequential radiographs which are taken over a 
time-course of years. The remaining dentine thickness (RDT) is defined as the thickness of 
dentine between the base of a cavity and the underlying pulp and is frequently used when 
describing pulpal responses to iatrogenic interventions. An in vivo study of young patients 
(217 teeth) (Murray et al., 2000) who experienced standardised buccal class V cavities, on 
teeth that were due to be extracted for orthodontic reasons, showed that the amount of 
reactionary dentine secretion was greater in younger patients and in those who had deeper 
and wider cavities. In addition, it was found that the greatest secretion of reactionary 
dentine occurred when the deepest part of the cavity was between 0.25 - 0.5 mm away from 
the pulp. If RDT was less than 0.25 mm, no reactionary dentine was secreted suggesting 
that not all the odontoblasts in this region had survived the iatrogenic intervention. In these 
cases odontoblast survival was approximately 50% (Murray et al., 2002). 
 
1.5.2 Reparative dentinogenesis 
 
When odontoblasts are injured and subsequently die, it is not possible for odontoblasts 
adjacent to the wound to migrate, divide and replace the lost functional activity as these 
cells are fully differentiated and are post-mitotic. Reparative dentinogenesis relies on a 
much more complex series of events compared with that of reactionary dentinogenesis. 
This process requires recruitment and proliferation of stem / progenitor cells, their 
migration, signalling of odontoblast-like cell differentiation and initiation of dentine 
secretion at the site of tissue injury (Figure 1.5). It is thought that these events are closely 
aligned with those which occur during embryonic development of teeth (Smith and Lesot, 
2001), however, these reparative events remain incompletely understood.  
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Figure 1.5 A diagram illustrating the process of reparative dentinogenesis. A) A rapidly 
progressing carious lesion presents a more severe challenge to the dentine-pulp complex, 
and B) this results in odontoblast death. However, if the disease process is arrested, a 
wound repair reaction can occur if favourable environmental conditions prevail. This 
process will include cell proliferation and migration of progenitor cells. C) Progenitor cells 
differentiate into odontoblast-like cells. D) Odontoblast-like cells secrete dECM beneath 
the lesion which increases the distance between the pulp and the source of assault.  
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If the odontoblast layer loses its integrity, there may be an initial non-specific response 
paralleling that seen in normal connective tissue wound healing (section 1.4). The earliest 
specific response that can be seen is the secretion of a fibrodentine matrix by far less well 
developed cuboidal cells (Baume, 1980). It is thought that this fibrodentine matrix may 
contain the relevant signalling molecules for odontoblast differentiation, mirroring the role 
of the dental basement membrane in primary dentinogenesis (Ruch et al., 1995). However, 
it is possible that exposure of such molecules on the surface of the existing dECM may 
provide the necessary stimulus for odontoblast-like cell differentiation. For some time, it 
was thought that the progenitor cells, which ultimately differentiate into odontoblast-like 
cells, were recruited from the pulp itself (Fitzgerald, 1979, Fitzgerald et al., 1990) and most 
likely from the cell rich zone of Höhl (Ruch et al., 1995). More recently, that hypothesis 
has been questioned and it has been suggested that these cells may originate from pericytes 
(Feng et al., 2011) or from circulating mesenchymal stem cells / haematopoietic cells 
(Frozoni et al., 2012). In order for the progenitor cells to localise to the site of injury, there 
must be appropriate signalling to attract these cells; the molecules responsible for this 
signalling process are termed chemokines. Recently, both pulp and dentine extracellular 
matrix have been shown to contain chemotactic factors capable of inducing pulp cell 
migration in vitro (Smith et al., 2012c). Notably, TGF-β1, which has been shown to be 
present in the dECM, has been shown to be a chemoattractant for inflammatory and repair 
cells (Pierce et al., 1992) and mitogenic for cells in the subodontoblastic layer (Melin et al., 
2000).  
 
Following chemotaxis and recruitment of progenitor cells to the site of injury, appropriate 
signals are required to initiate differentiation. In vitro culture of embryonic dental papillae 
cells with solubilised dECM components induced a physiological gradient of odontoblast 
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differentiation, which was inhibited by neutralising antibodies for TGF-β1 (Begue-Kirn et 
al., 1992). Similarly, in ferrets, treatment of exposed pulps with similar solubilised dECM 
components led to reparative dentine formation with regular tubular structure (Smith et al., 
1990). Combined, these observations suggest that signalling molecules involved with 
initiating developmental differentiation of odontoblasts are also involved in similar events 
during reparative dentinogenesis in postnatal teeth. Interestingly, microarray analysis of 
odontoblasts in early stage (primary dentinogenesis) and late stage (secondary 
dentinogenesis) has shown that genes involved in the p38 mitogen-activated protein (MAP) 
kinase pathway were down-regulated in secondary dentinogenesis suggesting that this 
pathway is critical for regulation of odontoblast secretory activity (Simon et al., 2009). 
Indeed, during tertiary dentinogenesis when odontoblasts are more active, the p38 MAP 
kinase pathway was reactivated (Simon et al., 2010) and interestingly, this signalling has 
been shown to be regulated by TGF-β1 (Ning et al., 2002, Zhao et al., 2004). Clearly, a 
precise understanding of these events will help to inform dental pulp regenerative strategies 
in the future. 
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1.6 Managing the injured pulp 
 
The vitality of the dental pulp can be challenged in many ways, including carious tissue 
loss, non-carious tooth surface loss, trauma and iatrogenic damage; this can lead to 
reversible or irreversible changes (Burke and Samarawickrama, 1995). The extent of injury 
to the pulp is very difficult to determine and clinicians rely on weak empirical evidence, 
since there is a poor correlation between clinical signs and symptoms and the true 
histological state of the pulp (Dummer et al., 1980). Ironically, in 1922, not long after the 
pioneering thesis of Herman (1920), the exposed pulp was described as a “doomed organ” 
(Rebel, 1922). Unfortunately, that dogma still blights our approach and anecdotally appears 
to be followed in many undergraduate teaching programmes even though our understanding 
of the reparative mechanisms of the dentine–pulp complex is now so much greater and 
maintaining vitality of the dental pulp is known to be advantageous to the patient in many 
ways. Following pulpal injury, the vitality of the pulp can be maintained therapeutically in 
one of three ways: indirect pulp cap, direct pulp cap and pulp amputation / pulpotomy. 
Classically, a definition of indirect pulp capping would include “the stepwise excavation of 
caries”, however, more pragmatically, it would be defined simply as a procedure during 
which a lining material is placed in a deep cavity close to the pulp in order to encourage a 
favourable response. A direct pulp cap is defined as a procedure in which the pulp is 
covered with a protective dressing or base placed directly over the pulp at the site of 
exposure [European Society of Endodontology (2006)]. Pulp amputation or pulpotomy is 
when part of the exposed pulp is removed, leaving some intact undisturbed tissue in which 
a therapeutic agent is placed in order to maintain its vitality. Pulpectomy, included here for 
completeness only, is total removal of the pulp when it is considered irreversibly inflamed 
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and root canal treatment is subsequently required [European Society of Endodontology 
(2006)].  
 
Successful maintenance of pulp vitality following injury has numerous benefits. It 
preserves the tooth’s defence system, avoids pulpectomy and subsequent root canal 
treatment (costly and likely to weaken the tooth), avoids extraction of the tooth with its 
subsequent disadvantages, and ensures continued development of the dento-alveolar 
complex particularly in younger patients. With an increasing understanding of pulp 
biology, the precision of operative techniques improving (Stanley, 1989, Simon et al., 
2013) and patients’ expectations growing, it is likely that procedures to maintain pulp 
vitality will become increasingly commonplace; this, in turn, should lead to more 
predictable results. 
 
As already discussed, vital pulp treatment has sometimes been viewed with scepticism 
(Rebel, 1922); this has probably been compounded by the lack of evidence that exists due 
to the paucity of good quality clinical research (Miyashita et al., 2007, Olsson et al., 2006). 
Numerous different techniques and procedures have been investigated during the last ninety 
years (Miyashita et al., 2007), however, inconsistencies in the study conditions and the 
techniques used means that robust comparisons cannot readily be drawn. From a biological 
standpoint, there are three key issues to consider when undertaking pulp treatment - the 
microbial challenge, the inflammatory challenge and the choice of pulp capping agent. 
These three factors are explored in more detail below. 
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1.6.1 The microbial challenge 
 
It was not until 1965, when the classic study by Kakehashi et al. was performed on germ-
free rats, that microorganisms were shown unequivocally to play a role in the aetiology of 
pulpal and periradicular disease. Prior to this, there had, however, been suggestions that this 
might be the case and that the microbial challenge could be the primary cause of pulpal and 
periradicular disease (Miller, 1894). Kakehashi et al. (1965) exposed the pulps of a group of 
germ-free rats, which were maintained in sterile conditions, and a group of conventional 
rats, which were maintained in standard laboratory conditions for the test period of up to 42 
days. Histological analysis, performed on the exposed teeth of both groups, showed that the 
exposed teeth of normal rats had signs of gross inflammation, pulp necrosis and 
periradicular disease. However, in the germ-free rats there was little inflammation and in 
those sacrificed later in the study, there was evidence of pulp healing and dentine bridge 
formation. Under normal conditions, the dentine-pulp complex is sterile and it is only 
subject to microbial challenge if breached by trauma, periodontal disease, an operative 
intervention or, most commonly, carious disease. The vital pulp is often able to resist this 
microbial challenge by laying down peritubular dentine and reactionary dentine, whilst also 
increasing the release of host defence molecules, such as antibodies and complement, in 
dentinal fluid (Ackermans et al., 1981, Okamura et al., 1980, Okamura et al., 1979, 
Pashley, 1996); however, even if the carious process only reaches the peripheral dentine, 
pulpal inflammation may still be present (Brannstrom and Lind, 1965). Furthermore, 
increasing the duration of the microbial contamination of the pulp is known to decrease the 
chance of successful pulpal healing (Masterton, 1966, Torneck et al., 1983, Kakehashi et 
al., 1969, Cox et al., 1982). It is very difficult to determine the degree of microbial load and 
the duration of the microbial challenge, and there are few clinical studies which attempt to 
 36 
 
address this issue (Olsson et al., 2006). It is clear, however, that minimising the microbial 
challenge, posed by caries or due to microleakage around restorations, remains the most 
important determinant of success in preventing pulpal disease progression and indeed, in 
achieving a predictable treatment outcome once the pulp is injured (Kakehashi et al., 1965, 
Brannstrom and Nyborg, 1973, Bergenholtz, 1977, Bergenholtz et al., 1982).   
 
1.6.2 The inflammatory and immune challenge 
 
The odontoblast process acts like an outpost to the cellular defence system of the dental 
pulp; from its strategic position, it can identify early bacterial invasion and initiate 
mediation of various host defence mechanisms (Fouad, 2012). Although the odontoblast is 
a terminally differentiated cell, it plays an important role in mediating the interplay between 
immune and reparative responses of the dental pulp when exposed to an injurious challenge 
(Cooper et al., 2011, Cooper et al., 2010). Odontoblast cell surface receptors, including 
members of the Toll-like family (TLR 1-6 and 9), have been shown to sense bacterial 
components, such as lipoteichoic acid (LTA) and lipopolysaccharide (LPS), which are 
present in the cell wall of gram positive and negative bacteria. The odontoblasts then 
release chemokines that recruit immune cells such as dendritic cells and T-lymphocytes, 
which subsequently propagate the immune response (Durand et al., 2006, Farges et al., 
2003, Nomiyama et al., 2007, Veerayutthwilai et al., 2007). Dendritic cells have been 
shown to establish a close spatial relationship with odontoblasts which are under carious 
attack; they can induce odontoblast differentiation and increased activity in terms of 
secretion of dECM (Ohshima et al., 1995). Notably, pro-inflammatory cytokines are 
involved in this process and include interleukin-1α (IL-1α), interleukin-2α (IL-2α) and 
tumor necrosis factor (TNF-α) and these regulate the inflammatory reaction in response to 
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bacterial components (Hosoya et al., 1996, Matsuo et al., 1994, McLachlan et al., 2004, 
Pezelj-Ribaric et al., 2002). Interestingly, amongst other pro-inflammatory cytokines, IL-1α 
has been shown to be solubilised in vitro from dECM by lactic acid and calcium hydroxide 
(Cooper et al., 2010).  
 
Bacterial infection of the dental pulp leads to the activation of complex inflammatory 
processes. This response is originally initiated, as discussed earlier, by odontoblasts and 
subsequently by pulp fibroblasts (Staquet et al., 2008) via signalling through TLRs; this 
leads to the further release of pro-inflammatory cytokines and chemokines. This complex 
cocktail is supplemented by other pro-inflammatory cytokines from the dECM, which may 
initiate wound healing events driving either reactionary or reparative dentinogenesis, 
depending on the severity of the assault (Cooper et al., 2010). Longstanding chronic 
inflammation, however, will tend to lead to pulpal death. There is therefore a fine balance 
between the positive drivers from the inflammatory and immune response, which lead to 
pulp regeneration, and the negative ones, which are detrimental to the pulp’s vitality 
(Goldberg et al., 2008, Smith et al., 2012b). 
 
1.7 Pulp capping – material selection 
 
Numerous different materials have been used as direct pulp capping agents; these have 
included gold foil (Pfaf, 1756, Dammaschke, 2008), aqueous calcium hydroxide (Heys et 
al., 1981), commercial preparations of calcium hydroxide (Stanley and Lundy, 1972), 
glycyrrhetinic acid / antibiotic mixture (Shovelton et al., 1971), resin bonding agents 
(Horsted-Bindslev et al., 2003), corticosteroid / antibiotic mixture (Cowan, 1966), isobutyl 
cyanoacrylate (Bhaskar et al., 1972), resin modified glass ionomer (do Nascimento et al., 
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2000) and more recently, calcium silicate cements such as mineral trioxide aggregate 
(MTA) (Aeinehchi et al., 2003, Nair et al., 2008). The aim of using these materials in pulp 
capping is to induce a hard tissue barrier between the injured pulp and the restoration being 
placed in the tooth, thus maintaining the tooth’s vitality. The properties of a direct pulp 
capping agent should ideally include [adapted from (Cohen and Combe, 1994)]: 
 
 Antibacterial activity 
 Creation of a bacterial tight seal and prevention of microleakage 
 Promotion of tertiary dentinogenesis and controlled hard tissue barrier formation 
 Biocompatibility – prevention of ‘over’ irritation and avoidance of induction of a 
severe inflammatory response 
 Radiopacity 
 Ease of clinical handling 
 Resistance to forces of displacement of any subsequent material placed over the 
pulp capping agent 
 
No material is known to demonstrate all of these properties, however, there is clinical and 
laboratory evidence to show that calcium hydroxide and the calcium silicate cement, MTA, 
satisfactorily meet these requirements, at least in part. Evidence is increasingly emerging 
that MTA induces a more predictable pulp healing response than calcium hydroxide 
(Aeinehchi et al., 2003, Nair et al., 2008); this is clearly illustrated in Figure 1.6. 
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Figure 1.6 Pulpal response 3 months after inducing an iatrogenic pulp exposure in aseptic 
conditions in human third molars and capping with calcium hydroxide or white MTA. A) 
Macrophotographic view of mesial half of third molar showing calcium hydroxide (CP) 
placed into pulp with hard tissue response. B, C and D) Histological section of (A) 
showing incomplete dentine bridge (BR) (tunnel defect) with chronic inflammatory cell 
infiltrate (IC). E) Macrophotographic view of mesial half of third molar showing white 
MTA (CP) placed into pulp with hard tissue response. F, G and H) Histological section of 
(E) showing complete hard tissue barrier (BR) organisation of pulp tissue and no evidence 
of inflammatory cell infiltrate. (Histological sections embedded in epoxy resin and stained 
with periodic acid-Schiff and methylene blue-azur II). Images reproduced from Nair et al., 
2008, with permission (John Wiley and Sons) and thanks to H.F.Duncan.) 
  
 40 
 
1.7.1 Calcium hydroxide 
 
Numerous different materials have been used as pulp capping agents over the years with 
varying degrees of success, however, generations of clinicians have returned to using 
calcium hydroxide, which is considered the ‘gold standard’ (Goldberg et al., 2008). This 
agent has been in use for over ninety years (Hermann, 1920) and has been intensively 
researched during this time (Glass and Zander, 1949, Schroder, 1972, Stanley and Lundy, 
1972, Schroder, 1973, Tronstad, 1974, Pitt Ford, 1979, Schroder, 1985, Pitt Ford and 
Roberts, 1991). Indeed, direct pulp capping studies using calcium hydroxide on non-
experimental pulp exposures that were carious or induced by trauma have demonstrated 
clinical success rates of 80–90% (Baume and Holz, 1981, Ravn, 1982, Matsuo et al., 1996). 
 
There is still considerable debate about the mode of action of calcium hydroxide; numerous 
animal studies have shown histological dentine bridge formation in 50-87% of teeth treated 
(Brannstrom et al., 1979, Heys et al., 1981, Cox et al., 1982, Cox et al., 1985, Pitt Ford, 
1985) but this is, however, less predictable in humans (Aeinehchi et al., 2003, Chacko and 
Kurikose, 2006, Nair et al., 2008). It has been suggested that its action is related to its 
caustic nature; it has a high pH of 11-12, which initially induces tissue irritation and 
superficial necrosis, known as a zone of coagulation necrosis (Glass and Zander, 1949). For 
clinical application, calcium hydroxide is either mixed as a pure powder with an aqueous 
solution (water or saline) or is more commonly used as a commercially available hard 
setting wound dressing / lining material, such as Life® (Kerr, Boggio, Switzerland) or 
Dycal® (Denstply Caulk, Milford, DE, USA), with a number of different types of vehicles 
(Fava and Saunders, 1999). Aqueous suspensions have been shown to induce wider zones 
of necrosis compared with commercial preparations (Heys et al., 1981). In a histological 
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study using rhesus monkeys by Heys et al. (1981), wound healing occurred at the material 
interface when commercial preparations were used, however, for calcium hydroxide paste 
formed with saline, the reparative tissue formation was some distance from the material 
itself, leaving a persistent vacant zone. The hard setting materials resulted in less evidence 
of caustic damage and it appears that the necrotic zone was removed by phagocytosis and 
replaced with granulation tissue (Stanley and Lundy, 1972). In a more recent study in 
humans (Lu et al., 2008), one week of pulp capping with calcium hydroxide resulted in a 
moderate inflammatory infiltrate, disorganised tissue with hyperaemia and no evidence of a 
hard tissue barrier. At one month, the majority of samples showed a reduced inflammatory 
response with evidence of dECM secretion and partial hard tissue repair. This is consistent 
with earlier reports, which suggested that hard tissue healing next to calcium hydroxide was 
unpredictable and not complete across the wound, with numerous tunnel defects being 
present (Cox et al., 1996). 
 
The mechanisms by which calcium hydroxide induces hard tissue repair are not entirely 
understood (Smith, 2002). However, it has been suggested that the superficial necrotic layer 
acts to separate the vital tissue from the wound so that the pulp can repair itself (Schroder, 
1985). Others have postulated that it is the creation of a supersaturated environment of 
calcium ions adjacent to the pulp that induces hard tissue healing. This latter hypothesis 
was, however, subsequently disproved when it was demonstrated that the calcium ions, 
which were incorporated into the mineralised dentine bridge, originated from the 
underlying tissues rather than the pulp capping material itself (Pisanti and Sciaky, 1964, 
Sciaky and Pisanti, 1960). It has also been proposed that the tissue may respond favourably 
to the high pH environment, which is created by the release of hydroxyl ions (Kardos et al., 
1998). Without doubt, the bactericidal nature of calcium hydroxide brought about by its 
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high pH, provides an environment which is conducive to pulp survival (Kakehashi et al., 
1969, Kakehashi et al., 1965). In studies in which exposed pulps were purposely infected 
with bacteria prior to pulp capping with calcium hydroxide, dentine bridges were still 
formed in a high percentage of cases (Pitt Ford, 1985, Cox et al., 1985). These findings 
suggest that the bactericidal nature of calcium hydroxide is an important property of the 
material. More recently, it has been shown that calcium hydroxide can solubilise growth 
factors sequestered in dentine; this is thought to initiate the sequence of reparative events 
which leads to tertiary dentine formation (Graham et al., 2006). 
 
Although numerous studies have demonstrated successful pulp healing with calcium 
hydroxide, many clinicians view its use in pulp capping with scepticism. A 5 and 10 year 
retrospective analysis of 123 calcium hydroxide pulp capping procedures performed on 
carious exposures showed that 45% had failed in the 5 year group and 80% had failed in the 
10 year group (Barthel et al., 2000). In another retrospective analysis of 248 teeth, with 
follow up of 0.4-16.6 years (mean 6.1 ±4.4 years), overall survival rate was found to be 
76.3% after 13.3 years (Dammaschke et al., 2010). Pulp capping in patients that were over 
60 years showed a considerably less favourable outcome than in patients younger than 40 
years old. All forms of calcium hydroxide, including the hard setting variants, are easily 
solubilised; this poses a challenge for long term restorative success when it is used as a 
lining material or pulp capping agent, because even the best restorative materials available 
will inevitably undergo some form of microleakage. Under amalgam restorations, Dycal 
has been shown to be relatively soft in 70% of cases (Pereira et al., 1990) and furthermore, 
it undergoes significant wash out (Novickas et al., 1989) so although it is bactericidal, it 
does not maintain a durable seal against bacterial microleakage (Cox and Suzuki, 1994).  
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1.7.2 Mineral trioxide aggregate 
 
MTA was developed in the 1990s by Mahmoud Torabinejad (Lee et al., 1993) and is now 
widely thought of as the first choice material for managing endodontic problems which 
require a material to interface with the pulp (Nair et al., 2008) or periradicular tissues 
(Saunders, 2008). It was approved by the U.S. Food and Drugs Administration (FDA) in 
1998 as ProRoot MTA Original (Dentsply Tulsa Dental, Oklahoma, USA). The original 
grey version was ostensibly developed as an agent to seal the root canal from the 
periradicular tissues, however, it was also found to be biocompatible when interfacing with 
pulpal tissue and showed promise as a therapeutic pulp capping agent. The original grey 
variety caused issues in terms of aesthetics when it was used for pulp treatment in anterior 
teeth; a white variety was therefore developed and subsequently, in 2001, FDA approval 
was granted for this version, ProRoot MTA (Dentsply Tulsa Dental, Oklahoma, USA). It 
has since become apparent that both varieties of MTA cause discolouration and it is 
recommended that neither should be used in the aesthetic zone (Lenherr et al., 2012, 
Ioannidis et al., 2013). MTA is presented as a fine hydrophilic powder, which is mixed with 
water, at a specific powder to water ratio, to obtain a workable “sandy” consistency. The 
composition is complex and predominantly based on ordinary Portland cement (OPC). The 
original patent (Torabinejad and White, 1995) says that “Portland cement should remain as 
its principle embodiment” and even suggests the preferred brand (Figure 1.7). Comparisons 
of OPC and ProRoot MTA using sophisticated methodologies, such as energy dispersive X-
ray analysis (EDXA) (Dammaschke et al., 2005, Camilleri et al., 2005, Asgary et al., 2009), 
X-ray diffraction (XRD) (Camilleri et al., 2005) and X-ray photoelectron spectroscopy 
(XPS) (Dammaschke et al., 2005), demonstrate the basic similarities between the materials, 
however, the absence of bismuth oxide, the radiopaque agent in ProRoot MTA, is noted. 
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Broadly, MTA contains calcium oxide (50-75 mass%), silicone dioxide (15-25 mass%) and 
aluminium oxide (2-5 mass%) (Darvell and Wu, 2011). The original grey form of MTA 
contains ferric oxide, however, this is absent in the white version. Calcium sulphate is also 
added to modify handling and setting characteristics.  
 
 
Figure 1.7 A copy of the original patent for MTA. Highlighted in the abstract is the 
suggestion that the preferred embodiment of the cement is Portland cement. Later in the 
patent a preferred brand of Portland cement is suggested, “Colton Fast-Set brand 
(California Portland Cement Company, USA)”. 
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1.7.2.1 Other calcium silicate cements 
 
As MTA gained in popularity, it was inevitable that other manufacturers would begin to 
develop similar materials, particularly because the commercial patent was relatively weak. 
MTA Angelus (Angelus Soluções Odontológicas, Londrina, Brazil) was recently developed 
and is available in grey and white forms; it does not contain calcium sulphate (Oliveira et 
al., 2007, Camilleri et al., 2012), which may explain its shorter setting time of 10-15 
minutes (Song et al., 2006, Santos et al., 2008). As ProRoot MTA and MTA Angelus are 
based on OPC and thus manufactured from naturally occurring raw materials, it is 
conceivable that they contain traces of heavy metals such as arsenic, lead and chromium 
(Duarte et al., 2005, De-Deus et al., 2009, Camilleri et al., 2012). In an attempt to prevent 
this contamination, other manufacturers use pure laboratory grade materials. More recently, 
the dental materials Bioaggregate (Innovative Bioceramix Inc. Vancouver, Canada) and 
Biodentine® (Septodont, Saint Maur des Fosses, France) have been manufactured using 
this approach. Bioaggregate is composed predominantly of calcium silicate oxide and 
calcium silicate. Hydroxyapatite, calcium phosphate silicate and calcite are also present, 
with tantalum oxide used as the radiopacifier (Park et al., 2010). Biodentine® powder 
predominantly consists of tri-calcium silicate as the core material with di-calcium silicate, 
calcium carbonate (filler), iron oxide (shade) and zirconium oxide (radiopacifier). It differs 
from other materials in this restorative category because its liquid phase has active 
components, for example, calcium chloride (accelerator) and a hydrosoluble polymer 
(reducing agent) (Richard, 2010). As a result, the powder to liquid ratio is more precise 
than other brands of MTA and it is mixed in an encapsulated form.  
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Given that there are now a number of dental materials, which are chemically related to 
MTA, it would seem pertinent to introduce a generic name to describe this group, 
particularly because MTA is not an accurate description of the material itself and has 
developed more into a brand / trade name. For standardisation purposes and to prevent 
confusion for teaching and research, a generic class name should be used. All of these 
materials primarily consist of calcium silicates and therefore, it would appear prudent to 
call them calcium silicate cements, however, this does not accurately distinguish them from 
acid-base calcium silicates that were used in dentistry previously (Johnson, 1908, Voelker, 
1916). Darvell and Wu (2011) recently proposed the generic term hydraulic silicate 
cements (HSC) for this new group of materials. Although this term more accurately reflects 
the chemical composition of these materials, it appears from recent scientific literature that 
the term calcium silicate cements is preferred and therefore, this term will be used 
henceforth in this text.   
 
1.7.2.2 Manufacture and setting reaction 
 
Patented in 1824 (Aspdin, 1824), Portland cement has been used consistently in civil 
engineering since 1850 (Blezard, 1998); surprisingly, despite its considerable role in 
construction, its precise setting reaction still remains unclear.  
 
Both OPC and MTA are produced via a basic manufacturing process, which generates a 
fine powder that, when hydrated, sets to form solid cement. The manufacturing process 
includes blending the various constituents and heating them to 1400-1500 °C; this is known 
as ‘clinkering’ and the resultant product as the ‘clinker’. Darvell and Wu (2011) have 
recently outlined the chemical reactions that occur both during the manufacture of calcium 
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silicate cements (Figure 1.8) and during their subsequent hydration when used clinically 
(Figure 1.9). During the manufacture of MTA, the sintering of the raw materials 
predominantly forms tri- and di- calcium silicates (Figure 1.8 ①). Limestone (calcium 
carbonate), which is found in OPC, will produce calcium oxide and carbon dioxide gas 
(Figure 1.8 ②). Depending on the purity of the initial materials used, oxides of their related 
metal may be formed, for example sodium, potassium and magnesium oxide, as in the case 
of ProRoot MTA Original. Those materials containing aluminium will also form tri-
calcium aluminate (Figure 1.8 ③) Subject to the blend of initial materials used, it is likely 
that unreacted calcium oxide will remain. The clinker, which will be fused as blocks or 
large particles, is ground into fine particles. With some forms of calcium silicate cements, a 
modifier such as calcium sulphate (gypsum) is added; this is the case for ProRoot MTA. 
 
 
 
 
Figure 1.8 Outline of chemical reactions and resultant products formed during the 
clinkering process in the manufacture of calcium silicate cements [adapted from Darvell 
and Wu (2011)]. 
 
 
The hydration reaction is complex and dependent upon the proportions of each reactant, the 
presence of impurities and the temperature (varies as the reaction is exothermic). This 
chemical reaction is summarised in Figure 1.9. In brief, the presence of water will cause 
calcium oxide to react immediately and produce calcium hydroxide (Figure 1.9 ④). If tri-
calcium aluminate is present, this also reacts rapidly to form a succession of hydrates 
(Figure 1.9 ⑤). The resultant products can produce a diffusion barrier which may inhibit 
further downstream reactions. If a sulphate is present (e.g. modifier - calcium sulphate), 
opposing reactions will dictate (Figure 1.9 ⑥). This will prevent further reactions until all 
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of the sulphates are consumed, acting somewhat like a retardant. The core reaction is the 
formation of calcium silicate hydrate from the hydration of tri- and di- calcium silicates 
(Figure 1.9 ⑦). In summary, once set, calcium silicate cements form a hydrated calcium 
silicate matrix interspersed with calcium hydroxide crystals. If other reactants are present, 
such as aluminium oxide or calcium sulphate, crystalline products of hydrated calcium 
aluminate and sulphate aluminates will also be present. 
 
 
 
 
 
 
 
Figure 1.9 Outline of chemical reactions and resultant products formed during hydration of 
calcium silicate cements for clinical use [adapted from Darvell and Wu (2011)]. 
 
The setting time for ProRoot MTA and other similar materials is considered to be between 
2-4 hours according to manufacturers’ instructions, however, like OPC, these materials 
mature over a long period of time depending on their environment. Hardened OPC and 
calcium silicate cements have a continuous pore system with hydraulic radii (defined as the 
ratio of the volume to the surface area of a pore faction), between <1 – 1000 nm (Odler, 
1993). The initial water to powder ratio affects total pore space. Generally, the total pore 
space is equivalent to the initial water to powder ratio; therefore, increasing the water to 
powder ratio increases pore space (Odler, 1993, Fridland and Rosado, 2003). As a result, 
this means that if the set cement is in a moist or aqueous environment, the fluid is likely to 
penetrate the surface of the cement and there will be ionic exchange between the cement 
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surface and the fluid surrounding it. Reports regarding the degree of solubility of MTA 
have not been consistent, with most indicating low or no solubility (Poggio et al., 2007, 
Shie et al., 2009) whilst others have suggested that the material is soluble over a longer 
period of time (Fridland and Rosado, 2005). Inconsistencies are likely to be due to the 
different methodologies used and the variable interpretations of the term solubility 
(Parirokh and Torabinejad, 2010). Due to the complex chemical composition of calcium 
silicate cements, it is not surprising that a number of different leachable ions are liberated 
from the cement surface in an aqueous environment (Table 1.2). 
 
Table 1.2 Summary of ions leached from white and grey ProRoot MTA. * Presence 
confirmed but concentration not reported. 
 
Type of calcium 
silicate cement 
Chemical 
component 
determined as 
present 
Concentration Reference 
Grey MTA (ProRoot - 
Tulsa Dental, Dentsply, 
USA) 
Calcium (Ca
2+
) 482.00 (mg/L) (Fridland and 
Rosado, 2003) Potassium (K
+
) 45.20 (mg/L) 
Sodium (Na
+
) 21.40 (mg/L) 
Iron (Fe
3+
) 4.96 (mg/L) 
Sulphate (SO4
2-
) 
 
5.20 (mg/L) 
White MTA (ProRoot - 
Tulsa Dental, Dentsply, 
USA) 
 
Chromium(Cr) 0.84 (mg/Kg) (Schembri et al., 
2010) Arsenic (As) 0.39 (mg/Kg) 
Lead (Pb) 0.02 (mg/Kg) 
White MTA (ProRoot - 
Tulsa Dental, Dentsply, 
USA) 
Calcium  12368 (µg/g) (Camilleri, 2010) 
Potassium  * 
Sodium  * 
Magnesium  * 
Silicone * 
Bismuth 3.62 (µg/g) 
Phosphorous  * 
Aluminium * 
Iron * 
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1.7.2.3 Biological properties of calcium silicate cements 
 
In order for a material to be regarded as clinically successful as a pulp capping agent, it 
should demonstrate a number of important properties (section 1.7). Since its introduction, 
MTA has undergone extensive in vitro and in vivo analysis as a clinical material that 
interfaces with the pulpal and periradicular tissues and subsequently, it has been described 
as “one of the least cytotoxic dental materials commercially available” (Torabinejad and 
Parirokh, 2010).  
 
The antimicrobial and antifungal effects of MTA have been extensively analysed, with 
conflicting results reported. MTA was shown to have an antibacterial effect on some 
facultative bacteria, but no effect on any strict anaerobes, while in contrast, this study 
showed that zinc oxide-eugenol based materials that were tested in parallel showed 
inhibition of growth amongst both types of bacteria (Torabinejad et al., 1995c). An 
assessment using unimicrobial and polymicrobial broths of bacteria and fungi showed that 
MTA inhibited fungal and microbial growth in both types of culture (Estrela et al., 2000). 
Interestingly, grey MTA was shown to inhibit similar amounts of growth of S. sanguis and 
E. faecalis at lower concentrations than white MTA suggesting that it may have greater 
antibacterial activity (Al-Hezaimi et al., 2006). Attempts have been made to enhance the 
antibacterial properties of MTA by combining it with chlorhexidine instead of water, at 
concentrations of 0.12% (Stowe et al., 2004) and 2% (Holt et al., 2007), both of which 
proved successful, however, other authors have expressed doubts about its utility in terms 
of biocompatibility (Hernandez et al., 2005) and deterioration of physical characteristics 
(Holt et al., 2007). Although in vitro micro-leakage studies are frequently viewed with 
scepticism (Rechenberg et al., 2011, Wu and Wesselink, 1993, De-Deus, 2008), they are 
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the main means of determining the ability of a material to create a barrier to prevent 
bacterial penetration in a given clinical scenario. Numerous different in vitro techniques 
have been used to compare the sealing ability of MTA to other materials used in the same 
clinical situation. MTA has been shown to be superior to amalgam, super EBA (ethoxy 
benzoic acid) and intermediate restorative material (IRM) using different techniques 
including dye leakage (Torabinejad et al., 1994, Martell and Chandler, 2002), fluid 
filtration (Wu et al., 1998, Karlovic et al., 2005) and bacterial penetration studies 
(Torabinejad et al., 1995d, Fischer et al., 1998, Tang et al., 2002). Notably, MTA is 
recognised as providing a good seal when used for a number of different clinical 
applications. 
 
The biocompatibility of MTA has been tested rigorously in vitro and in vivo. Early studies 
in dogs showed that the histological response of the periradicular tissues was more 
favourable when MTA, rather than amalgam, was used as a root end filling material 
(Torabinejad et al., 1995a); similarly, the histological response was better when MTA 
rather than a calcium hydroxide based sealer (Sealapex, SybronEndo, California, USA) was 
used to repair root perforations (Holland et al., 2001). Numerous studies have used 
monolayer cell culture experiments with different cell types, including primary pulp cells 
(Yasuda et al., 2008), cementoblasts (Hakki et al., 2009), periodontal ligament fibroblasts 
(Keiser et al., 2000), osteoblasts (Camilleri et al., 2004) and gingival fibroblasts (Pistorius 
et al., 2003), to assess the cytotoxicity of MTA. The consensus view expressed in these 
papers is that MTA demonstrates minimal cytotoxicity to these cell types in monolayer 
culture (Torabinejad and Parirokh, 2010).  
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MTA has been shown to exhibit excellent biocompatibility when it is in contact with pulp 
wounds in animals (Ford et al., 1996, Keiser et al., 2000, Faraco and Holland, 2001, Asgary 
et al., 2008, Kuratate et al., 2008) and in humans (Aeinehchi et al., 2003, Accorinte Mde et 
al., 2008, Min et al., 2008, Nair et al., 2008). Histological studies of iatrogenic exposures in 
human teeth, managed in aseptic conditions, compared teeth that were capped with MTA 
with those capped with calcium hydroxide. Notably, the teeth capped with MTA 
demonstrated greater reparative dentine formation in terms of thickness and quality, less 
inflammation and more predictable healing (Aeinehchi et al., 2003, Min et al., 2008, Nair et 
al., 2008). The precise mechanism by which MTA works, however, is not well understood. 
It has been shown to induce key stages in pulp repair, namely pulp cell proliferation 
(Moghaddame-Jafari et al., 2005), migration (Kuratate et al., 2008) and differentiation 
(Masuda-Murakami et al., 2010). Immunohistochemical analysis of pulp wounds, which 
had been capped with MTA for up to 11 weeks, showed expression of DSPP and collagen 
type I in those odontoblasts in direct contact with the MTA. There was also evidence of 
dentine secretion by these cells (Simon et al., 2008). The surface of MTA has been reported 
to form hydroxyapatite when it is in contact with synthetic body fluids (Sarkar et al., 2005, 
Reyes-Carmona et al., 2009). It is suggested that this biologically accepted surface layer 
allows for excellent cell / material adhesion and enables superior sealing characteristics 
when compared with other materials.   
 
MTA displays many of the properties expected of an ideal pulp capping agent (section 1.7). 
It has been clearly demonstrated that MTA is biocompatible and there is an indication that 
it may also be bioinductive, however, a clear biological mechanism of action is yet to be 
determined. MTA is now widely accepted to be the material of choice for pulpotomy and 
vital pulp capping; gaining a better understanding of its biological mechanism of action is 
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essential in order to improve our understanding of pulp tissue repair so that novel dental 
tissue regenerative strategies can be developed. 
  
1.8 Regenerative endodontics 
 
The ultimate goal for pulp biologists would be to regenerate the dental pulp following 
injury, or to engineer a whole tooth. The dental pulp has a natural ability to protect itself 
and does so by secreting tertiary dentine in response to noxious attack. Herman (1920) 
demonstrated that it was possible to use a simple iatrogenic intervention to manipulate the 
pulp tissue into secreting dECM, thus showing that pulp regeneration was possible. Since 
that time, our knowledge of the biological mechanisms underpinning these events has 
developed to such an extent that the principles of pulp tissue engineering can now be 
demonstrated (Cordeiro et al., 2008).  
 
The basis of regenerative tissue therapy follows the basic principles of tissue engineering; 
there are three core components, as outlined below: 
 
i) a scaffold to act as an initial matrix for tissue development  
ii) stem or progenitor cells that have the ability to differentiate into other 
specialised cells with functional activity 
iii) the correct extra- and intra-cellular signalling induction necessary to 
orchestrate the complex events required for tissue development 
 
The regenerative capacity of other oral tissues has already been demonstrated; for example, 
the use of enamel matrix protein from porcine fetal teeth (Emdogain®, Strauman) has been 
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used for periodontal tissue regeneration (Heijl et al., 1997) and recombinant BMPs have 
been used for bone augmentation (Fujimura et al., 1995). The dentine-pulp complex is an 
elaborate tissue, which is highly developed; therefore, unravelling the signalling cues that 
lead to its regeneration following injury, or even necrosis, presents enormous challenges. In 
terms of cell signalling, the key events that lead to reparative dentine formation are: 
proliferation, migration, differentiation and mineral secretion. There have been huge 
advances in biological research methods to analyse such processes, some of which have 
already been discussed (section 1.2.2). An exciting recent development utilises adenoviral 
vector transfection. This technique, initially conceived by Goff and Berg (1976), enables 
the incorporation of specific genetic instructions into the target cells, leading to over-
expression of selected proteins. In this way, it is possible to test the specific effect of 
signalling molecules in key reparative events such as those described above. 
 
The exploitation of chemotaxis and cell homing, in developing novel treatment modalities 
to harness the natural reparative mechanism of the pulp, shows exciting potential (Laird et 
al., 2008, Mao et al., 2010). Successful engineering of dental pulp tissue using chemotaxis-
induced cell homing has recently been reported (Kim et al., 2010) and in this analysis, 
several cytokines were studied including FGF, VEGF and PDGF alone or in combination 
with nerve growth factor (NGF) and BMP-7. While the optimum combination of cytokines 
required to induce the necessary cellular organisation remains to be determined, these data 
clearly indicated that synergistic signalling interactions are likely to occur during wound 
repair. 
 
Recently, the debate about undertakng more conservative pulp treatments, such as 
pulpotomy rather than pulpectomy, has been reintroduced (Simon et al., 2013). Greater 
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understanding of the various biological events associated with pulp wound healing will 
facilitate the development of novel therapeutic strategies. As MTA is known to promote 
profound tissue regenerative responses, an understanding of the mechanisms by which it 
does so, will help to ensure that regenerative endodontics ultimately becomes a clinical 
reality. 
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Figure 1.10 Ionic interactions at the surface of calcium silicate cements. In vivo the surface 
of calcium silicate cement will be infiltrated by tissue fluid and extracellular exudate which 
will liberate soluble ions from the cement. The fluid immediately surrounding the cement 
will have a unique ionic composition. 
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1.9 Project aims 
 
This project aimed to examine the interaction of calcium silicate cements with dECM and 
assess their role in the events leading to tertiary dentinogenesis. The following hypotheses 
were investigated:  
 
1) The interaction of calcium silicate cements, in both their set and setting phases, with 
tissue fluid (substituted with water in vitro) results in the formation of a unique 
ionic solution (Figure 1.10 opposite) which causes disruption of dECM, leading to 
the release of bioactive molecules. 
 
2) The soluble constituents of therapeutic pulp capping agents liberate dECM 
components, which contain a rich cocktail of growth factors, some of which have 
not previously been identified in dECM (Figure 1.11 A-D overleaf). 
 
3) The components of dECM released by therapeutic pulp capping agents, including 
those released by calcium silicate cements, promote regenerative events such as 
proliferation and chemotaxis in dental pulp cells. 
 
4) HGF is solubilised from dECM by the soluble products of calcium silicate cements 
and plays an important role in the repair-associated processes of chemotaxis, 
differentiation and mineralisation during dental pulp repair.  
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Figure 1.11 A) Diagrammatic representation of dentine, including inorganic and organic components, at a nanometre scale. B) Dentine 
represented in A) immersed in tissue fluid or extracellular exudate that has interacted locally with calcium silicate cement and has a 
unique ionic composition (components in diagram are not to scale). 
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Figure 1.11 C) Ionic exchange between dentine and soluble components of calcium silicate cements has resulted in disruption of 
hydroxyapatite crystals leading to D) solubilisation and release of bioactive molecules from dECM including non-collagenous proteins, 
glycosaminoglycans and growth factors (components in diagram are not to scale). 
C D 
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2.0 MATERIALS AND METHODS 
 
2.1 Isolation of dentine extracellular matrix components 
 
2.1.1 Preparation of dentine extracellular matrix extractant solutions 
Solutions of 10% EDTA (control) (pH 7.2) (Sigma-Aldrich, UK), 0.02M calcium hydroxide 
(pH 11.9) (Sigma-Aldrich, UK), the solubilised components of white MTA (pH 11.7) 
(Dentsply Tulsa Dental, USA), grey MTA (pH 11.7) (Dentsply Tulsa Dental, USA) and 
Biodentine® (pH 11.2) (Septodont, France) were prepared by dissolving solids in distilled 
water. The solutions of MTA were prepared by mixing 1.72 g of white or grey MTA with 1 
litre of distilled water with constant agitation at 37 °C for 72 hours. The solution of 
Biodentine® was prepared by mixing the encapsulated material as per the manufacturer’s 
instructions in an amalgamator (Kerr Optimix, CA, USA) at 4000 rpm for 30 seconds and 
allowing it to set in a plastic weigh boat at 37 °C for 24 hours with a thickness no greater than 
2 mm. The set material was crushed to a fine powder in a ceramic mortar and pestle and 
graded using a 44 mesh sieve (≤0.354 mm2). 1.72 g of Biodentine® powder was subsequently 
suspended in 1 litre of distilled water with constant agitation at 37 °C for 72 hours. Insoluble 
particles were subsequently removed by filtration from all solutions. 
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2.1.2 Atomic absorption spectroscopic analysis of extraction solutions 
 
To determine the concentration of calcium, aluminium, magnesium, sodium, potassium and 
iron in control and experimental extraction solutions
1
, flame atomic absorption spectroscopy 
was employed. Standard solutions were prepared for calcium, aluminium, magnesium, 
sodium and potassium from the following salts: calcium chloride dehydrate (Sigma-Aldrich, 
UK), aluminium nitrate (Sigma-Aldrich, UK), magnesium chloride hexahydrate (Sigma-
Aldrich, UK), sodium phosphate tribasic hexahydrate (Sigma-Aldrich, UK) and potassium 
phosphate monobasic (Sigma-Aldrich, UK), at a concentration of 1000 ppm. For iron, a 
proprietary standard solution (1000 ppm) was used (Fisher Scientific, UK). Each standard 
solution was diluted to concentrations of 40, 20, 10, 5 and 1 ppm. These standards, a control 
(EDTA) and the experimental solutions (calcium hydroxide, white MTA and grey MTA) as 
described above (section 2.1.1), were analysed using an atomic absorption spectrophotometer 
(AAS; Model 751, Instrumentation Laboratory, USA). Solutions were aspirated, mixed with 
acetylene and air and atomised in a flame. A light beam from a hollow cathode lamp with a 
filament specific to the element of interest was passed across the atomised sample to a 
monochronometer and intensity was determined with a detector. As each element absorbs at a 
specific wavelength of light, the decrease in intensity of the light determines the concentration 
of the sample. The experimental set up is illustrated in Figure 2.1. Concentrations of each 
element in control and experimental solutions were calculated from standard curves generated 
from the solutions, as described above (Figure 2.2). 
  
                                                          
1
 Analyses were not performed for Biodentine® as it was not commercially available when this experiment was 
undertaken. 
 62 
 
y = 0.0531x
R² = 1.0
0
0.2
0.4
0.6
0.8
1
1.2
0 5 10 15 20
In
te
n
si
ty
 (
A
U
)
Mg2+ concentration (ppm)
 
Figure 2.1 A schematic diagram of flame atomic absorption spectroscopy. (A) Sample is 
aspirated and mixed with acetylene and air; (B) it is atomised in a flame in gas phase, (C) a 
beam of light from a hollow cathode lamp (filament specific to element of interest) is passed 
through the atomised sample into (D) a monochronometer, then intensity was determined with 
a detector (E). (Reproduced with permission from 
http://lawrencekok.blogspot.co.uk/2012/10/ib-chemistry-on-atomic-absorption.html).  
 
 
 
 
 
 
 
Figure 2.2 A representative example of a standard curve generated using atomic absorption 
spectroscopy, showing flame intensity (absorbance units) plotted against solutions containing 
a range of concentrations of magnesium ions as described in section 2.1.2. The R
2 
coefficient 
(>0.9) and linear regression equation are displayed next to the line of best fit.  
A 
B C
F 
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2.1.3 Isolation of dentine extracellular matrix components 
 
To assess the ability of therapeutic pulp capping agents to release dentine extracellular matrix 
components (dECM), the solutions produced in section 2.1.1, containing the soluble 
components of EDTA, calcium hydroxide, white MTA, grey MTA and Biodentine®, were 
applied in a well-established and recognised extraction technique (Smith and Leaver, 1979). 
The root surfaces of a total of 572 non-carious intact human extracted molars and premolars 
(predominantly third molars and premolars) obtained from Birmingham Dental Hospital’s 
Tooth Bank
2
, were prepared; remaining attached soft tissue and cementum were removed 
using both a scalpel blade and a rotating brush with dental prophylactic paste (Nupro®, 
Dentsply, UK). Cleaned teeth were dissected into 1 mm longitudinal sections using a diamond 
edged rotary disc saw (TAAB, UK) cooled with distilled water. Pulp tissue was subsequently 
extirpated and the pulp chamber surface scraped clean with a large excavator (Ash, Dentsply, 
UK). Enamel was removed using bone clippers and the remaining dentine was crushed into a 
fine powder using a percussion mill (Spex 6700 Freezer/Mill, Glen Creston Ltd, UK) cooled 
with liquid nitrogen to prevent protein denaturation. The powdered dentine was graded using 
a 60 mesh sieve (≤0.251 mm2). 
 
dECM components were extracted from the powdered dentine using the solutions previously 
described (section 2.1.1) (EDTA, calcium hydroxide, white MTA, grey MTA and 
Biodentine®) with the addition of the protease inhibitors, 10 mM n-ethylmaleamide (Sigma, 
UK) and 5 mM phenyl-methyl-sulphonyl fluoride (Sigma, UK) to prevent protein 
denaturation. Extractions were performed with constant agitation at 4 °C for 14 days.   
                                                          
2
 Approval for the use of human tooth tissue was obtained from the UK National Research Ethics Service 
(09/H0405/33). 
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Figure 2.3 Photographic images of processing stages applied in the isolation of dentine 
extracellular matrix components. A-B) Removal of soft tissue and cementum from tooth 
roots, C) sectioning teeth into 1 mm sections, D) careful removal of pulp tissue, E) removal 
of enamel, F) pulverisation of dentine into powder using a percussion mill cooled with liquid 
nitrogen, G) graded dentine powder, H) extraction of dECM components in 30 mL 
polystyrene universals (Appleton Woods, UK) from dentine powder (5 g), using different 
extraction solutions (20 mL) constantly agitated at 4 °C, I) following dialysis, extraction 
supernatants were freeze dried, and J) close up of freeze dried dECM components in round 
bottom flask.  
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Each day, the solution was centrifuged (Jouan B4i, Thermo scientific, UK) at 3000 rpm for 10 
minutes and supernatants were decanted prior to measurements being obtained for pH and 
absorbance. These absorbance values were obtained at 280 nm using a spectrophotometer 
(UV/VIS spectrophotometer, Philips UK), to monitor protein dissolution. The pooled 
supernatants were exhaustively dialysed for 14 days at 4 °C with repeated changes of distilled 
water, at least once daily, to remove salts and impurities. The resultant dialysates were shell 
frozen in round bottom flasks using liquid nitrogen and lyophilised using a freeze dryer 
(Modulyo, Edwards, UK). The lyophilised dECM component preparations were stored at -20 
°C prior to use. The extraction process is illustrated in Figure 2.3. 
 
2.2 Characterisation of dECM preparations 
 
2.2.1 One dimensional sodium dodecyl sulphate polyacrylamide gel electrophoresis (1D 
SDS PAGE) 
 
Prior to loading, 0.5 mg of extracted lyophilised dECM components were dissolved in 10 µL 
of LDS buffer (Invitrogen, UK), 26 µL of deionised water and 4 µL of reducing agent 
(Invitrogen, UK). Following denaturation at 105 °C for 10 minutes, loading volume was 
optimised by repeated attempts and it was determined that 2 µL of the solution was loaded 
onto either a 3-8% Tri-Acetate (NuPAGE, Invitrogen, UK) or a 10% Bis-Tris (NuPAGE, 
Invitrogen, UK) pre-cast polyacrylamide gel to separate higher and lower molecular weight 
proteins, respectively. 2 µL of molecular weight marker (Mark12, Invitrogen, USA) was 
included within the gel. Gels were electrophoresed at 150 V and 45 mA for 1 hour using SDS 
running buffer (Invitrogen, UK). Protein banding was visualised using Coomassie blue or 
silver staining techniques as described below. Throughout both staining procedures, glassware 
was ultra-clean, high quality water was used and gels were handled with care.  
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2.2.1.1 Coomassie blue staining 
 
Gels were fixed in a solution of 50% methanol (BDH laboratory supplies, Poole, England) 
10% acetic acid (BDH laboratory supplies, Poole, England) and 40% deionised water 
overnight. Gels were then rinsed with copious volumes of deionised water twice and 
immersed in a staining solution containing 0.5% Coomassie blue R-250 (BDH laboratory 
supplies, Poole, England) for 2 hours. Each gel was transferred to a destaining solution 
containing 5% methanol, 7.5% acetic acid and 87.5% deionised water for approximately 1-2 
hours until the background appeared clear. Images of the stained gels were captured using a 
Nikon Coolpix 950 (Nikon, Japan) under illumination from a white light box (Hancocks, 
England). 
  
2.2.1.2  Silver staining 
 
Tri-Acetate and Bis-Tris gels were stained with SilverXpress silver staining kit (Invitrogen, 
UK) as per the manufacturer’s instructions. Protein gels were fixed using a solution 
containing 50% methanol, 10% acetic acid and 40% deionised water for 10 minutes. Gels 
were immersed in a solution of 50% methanol and 2.5% of the propriety sensitising agent; 
Tris-Acetate for 10 minutes and Bis-Tris for 30 minutes. Each gel was washed twice with 
ultrapure water for 5 - 10 minutes and stained for 15 minutes with the silver solution. Each gel 
was washed a further two times in ultrapure water. Gels were immersed in developer and 
gently agitated until bands reached an appropriate visible intensity at which point 5 mL of 
stop solution was added. Finally, the gels were washed a further three times in ultrapure water 
to remove background stain and images were captured under illumination from a light box 
using a Nikon Coolpix 950 (Nikon, Japan). The molecular weight of each migrated protein 
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band was determined by comparison with the known weight of the molecular weight markers 
(Mark12, Invitrogen, USA). The number of bands separated and their respective molecular 
weight for each extract was determined using GeneTools image acquisition software 
(Syngene, Cambridge, UK). 
 
2.2.2 Dye binding assays for total NCPs and glycosaminoglycan quantification 
 
To determine the total amount of non-collagenous protein (NCPs) recovered from dECM 
preparations extracted by the different solutions, two dye binding assays sensitive to 
microgram levels were employed: the Bradford assay (Bradford, 1976) and Bicinchoninic 
acid (BCA) protein assay (Smith et al., 1985). 
 
2.2.2.1 Dye binding assay for NCPs - Bradford assay 
 
The Bradford assay is based on an absorbance shift of the dye Coomassie Brilliant Blue G-
250 from its unbound form (cationic – green/red) to its bound form (anionic – blue), which 
can be detected spectrophotometrically at a wavelength of 595 nm. Bovine serum albumin 
(BSA) (Sigma-Aldrich, UK) was dissolved in dH20 to give a stock concentration of 1 mg/mL. 
From this, a serial dilution was generated to produce 5 samples with the following 
concentrations: 2, 4, 6, 8, 10 μg/mL, to provide a standard curve. Lyophilised dECM 
components were dissolved in dH20 at a concentration of 2 mg/mL. 50 μL of standard, 
experimental sample or blank were aliquoted into a cuvette; to this, 1.5 mL of Bradford 
reagent (Sigma-Aldrich, UK) was added, gently vortexed and incubated for 5 minutes at room 
temperature. Absorbance was measured using a spectrophotometer (UV/VIS 
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spectrophotometer, Philips UK) at 595 nm for three replicates of sample and standard; sample 
concentration of NCP content was calculated from the standard curve (Figure 2.4). 
 
 
 
 
 
 
 
 
Figure 2.4 Representative example of standard curve used to determine concentration of non-
collagenous proteins, generated using BSA as a standard in the Bradford assay, as described 
in section 2.2.2.1. The R
2 
coefficient (>0.9) and linear regression equation are displayed next 
to the line of best fit. 
 
2.2.2.2 Dye binding assay for NCPs - Bicinchoninic acid protein assay 
 
The principle of the Bicinchoninic acid assay (BCA) is the formation of a Cu
2+
/protein 
complex in alkaline conditions, which causes a reduction of Cu
2+ 
to Cu
+
. BCA forms a blue / 
purple complex with Cu
+
, and the reduction of Cu
2+
 ions can be determined by absorbance 
changes detected at a wavelength of 562 nm (Smith et al., 1985). This assay was performed in 
parallel with the Bradford assay (section 2.2.2.1) using the same concentrations of BSA to 
create a standard curve and the same experimental samples were analysed. 2 mL of BCA 
 69 
 
y = 0.0974x
R² = 0.98
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
0 2 4 6 8 10
A
b
so
rb
a
n
ce
 (
5
6
2
 n
m
)
Non-collagenous protein concentration (μg)
working reagent (Sigma-Aldrich, UK) was added to 100 μL of standard, experimental sample 
or blank in a plastic cuvette and vortexed gently. The resulting solution was incubated at 37 
°C for 2 hours and absorbance measured at a wavelength of 562 nm using a 
spectrophotometer (UV/VIS spectrophotometer, Philips UK). Three replicates were generated 
for each standard and experimental sample and measured within 5 minutes of each other. 
Concentration of NCP was calculated from the standard curve generated (Figure 2.5). 
 
 
 
 
 
 
 
Figure 2.5 Representative example of a standard curve used to determine concentration of non-
collagenous protein using BSA as a standard in the Bicinchoninic acid assay as described in 
section 2.2.2.2. The R
2 
coefficient (>0.9) and linear regression equation are displayed next to 
the line of best fit. 
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2.2.2.3 Dye binding assay for GAGs – Farndale assay 
 
Quantification of glycosaminoglycans (GAGs) in dECM preparations extracted by different 
reagents was determined using the Farndale assay (Farndale et al., 1986). The assay utilises 
the ability of GAGs to bind to dimethylmethylene blue (DMMB) which will result in a 
change in absorbance of of the GAG/DMMB complex at 525 nm. 
 
The Farndale reagent was prepared with 46 μM of 1, 9 dimethylmethylene blue (Sigma, UK), 
40 mM glycine (Sigma, UK) and 40 mM sodium chloride (Sigma, UK), and stored at room 
temperature and protected from light prior to use. To produce a standard curve, 2 mg of 
chondroitin-4-sulphate (Type A, whale cartilage, Fluka Biochemika, Germany) was dissolved 
in 20 mL of 0.5 M acetic acid; from this stock solution, serial dilutions of 2, 4, 6, 8, and 10 
μg/mL were generated. Lyophilised dECM preparations were dissolved in 0.5 M acetic acid at 
a concentration of 2 mg/mL. 1 mL of prepared Farndale reagent was added to 100 μL of the 
standard, experimental sample or blank in a cuvette and gently mixed. Absorbance was 
measured at a wavelength of 525 nm using a spectrophotometer (UV/VIS spectrophotometer, 
Philips UK). All samples and standards were analysed in triplicate. Concentrations of GAGs 
were calculated by extrapolation from the standard curve produced (Figure 2.6). 
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Figure 2.6 Representative example of a standard curve used to determine concentration of 
glycosaminoglycans using chondroitin-4-sulfate as a standard in the Farndale assay as 
described in section 2.2.2.3. The R
2 
coefficient (>0.9) and linear regression equation are 
displayed next to the line of best fit. 
 
2.2.3 Immunoassays 
 
To determine the presence and the concentrations of specific growth factors in dECM 
preparations extracted by control and test reagents, a sandwich-type immunoassay for 
transforming growth factor-β1 (TGF-β1) and adrenomedullin (ADM) was employed. 
 
2.2.3.1 Preparation of phosphate buffered saline 
 
Phosphate buffered saline (PBS) was prepared by dissolving 7.8 g sodium chloride (Sigma-
Aldrich, UK), 1.5 g dipotassium phosphate (Sigma-Aldrich, UK) and 0.2 g monopotassium 
phosphate (Sigma-Aldrich, UK) in 1 L of distilled water and it was adjusted to pH 7.4. 
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2.2.3.2 TGF-β1 Enzyme-linked immunosorbent assays (ELISA) 
 
The TGF-β1 ELISA applied here was a modification of that previously described 
(Danielpour, 1993). In total, 2 mg of each sample of lyophilised dECM components were 
dissolved in 150 μL of PBS prior to addition of 30 μL of 1 M hydrochloric acid (Sigma-
Aldrich, UK); this was then incubated at room temperature for 10 minutes to activate the 
TGF-β1. The reaction was neutralised with 30 μL of 1.2 M sodium hydroxide (Sigma, UK) 
and 0.5 M HEPES (Sigma-Aldrich, UK); 50 μL of the resultant solution was assayed in 
triplicate using the Quantikine Human TGF-β1 ELISA kit (R & D Systems, UK) according to 
the manufacturer’s instructions. A serial dilution of TGF-β1 was created from a stock solution 
of 2000 pg/mL with the following concentrations: 1000, 500, 250, 125, 62.5, 31.25 pg/mL, to 
create a standard curve. 200 μL of standard, sample or blank was added to a well of the 
prepared 96-well plate, which was then sealed and incubated at room temperature for 3 hours. 
After incubation, wells were washed with wash buffer in an automated plate washer (Bio-Tek 
Instruments, USA). Visual inspection was used to ensure that the wash buffer was completely 
removed prior to advancing to the next step. 100 μL of TGF-β1 conjugate was added to each 
well, sealed and incubated for 2 hours at room temperature. The washing procedure was 
repeated and then 100 μL of substrate solution was added to each well and incubated for 30 
minutes at room temperature in the dark. To terminate the reaction, 100 μL of the stop 
solution (R & D Systems, UK) was added and the absorbance was read using an ELX800 
Universal Microplate Reader (Bio-Tek Instruments, USA) at 450 nm with correction set at 
540 nm to reduce optical interference. Concentrations of TGF-β1 in dECM preparations 
extracted using different reagents were calculated from the standard curve produced (Figure 
2.7). 
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Figure 2.7 Representative example of a standard curve used to determine concentration of 
TGF-β1 using ELISA analysis as described in section 2.2.3.2. The R2 coefficient (>0.9) and 
linear regression equation are displayed next to the line of best fit. 
 
2.2.3.3 Adrenomedullin enzyme immunoassay (EIA) 
Quantification of ADM in each dECM preparation was determined using an adrenomedullin 
EIA Kit (Phoenix Pharmaceuticals, Inc. California, USA) according to the manufacturer’s 
instructions. A solution with a concentration of 10 mg/mL was made for each lyophilised 
sample of dECM preparation with assay buffer (Phoenix Pharmaceuticals, Inc. California, 
USA). A serial dilution with assay buffer of rehydrated ADM was generated from a stock to 
produce the following concentrations of standard: 0.01, 0.1, 1.0, 10, 100 and 1000 ng/mL. 50 
μL of sample, standard or blank were added to wells of the prepared 96-well plate with 
internal controls. 25 μL of rehydrated primary antiserum and 25 μL of rehydrated biotinylated 
peptide were added to each well apart from the internal controls; the plate was then sealed and 
incubated at room temperature for 2 hours with gentle agitation on an orbital shaker (Denley 
orbital mixer, ThermoFisher Scientific, UK). After incubation, the plate was washed, as 
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described above, using assay buffer. 100 μL of streptavidin-horseradish peroxidase was added 
to each well apart from internal controls; the plate was sealed and incubated for 1 hour. The 
plate was then washed and 100 μL of substrate solution was added to each well and incubated 
for 1 hour in the dark. Following incubation, 100 μL of 2N HCl was added to each well to 
terminate the reaction. Absorbance readings at 450 nm were measured using an ELX800 
Universal Microplate Reader (Bio-Tek Instruments, USA). Concentrations of ADM in each 
sample were calculated using XLFit4 statistical software (IDBS, UK) by comparison with the 
standard curve produced (Figure 2.8). 
 
 
 
 
 
 
 
 
Figure 2.8 A graph generated on XLFit4 statistical software to determine the concentration of 
ADM in samples of dECM preparations using a standard curve. In this example, calculation 
of the concentration of ADM in three samples of EDTA (EDTA 1-3) extracted dECM 
components is made on the x-axis illustrated with red dotted lines determined from 
absorbance on the y-axis. 
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2.2.4 Human cytokine antibody array 
 
To analyse the range of growth factors sequestered within dECM and solubilised by control 
and test reagents, a human cytokine antibody array AAH-GF-1 (RayBiotech, Norcross, GA, 
USA) was utilised. This approach enabled relative expression levels of multiple proteins 
(Table 2.1) to be determined at high throughput using a sandwich ELISA technique. 
 
Table 2.1 Proteins analysed in dECM components extracted by EDTA, calcium hydroxide, 
white and grey MTA using the human cytokine antibody array AAH-GF-1 (RayBiotech, 
Norcross, GA, USA). Key to abbreviations is provided on page xii. 
 
AR FGF-6  HGF  IGF-I NT-4  PlGF  TGF-β3  
FGF-2 FGF-7  IGFBP-1  IGF-I SR PDGF R a SCF VEGF 
NGF G-CSF IGFBP-2  IGF-II PDGF R b SCF R  VEGF R2  
EGF GDNF  IGFBP-3  M-CSF PDGF-AA  TGF-α VEGF R3  
EGF R GM-CSF IGFBP-4  M-CSF R  PDGF-AB TGF-β1 VEGF-D 
FGF-4  HB-EGF IGFBP-6 NT-3  PDGF-BB TGF-β2   
 
 
Lyophilised dECM preparations extracted by EDTA, calcium hydroxide, white and grey 
MTA were dissolved in PBS to a concentration of 200 µg/mL of total protein as determined 
by the Bradford assay using BSA as a standard (section 2.2.2.1). Nitrocellulose membranes 
labelled with specific antibodies (Table 2.1) were prepared according to the manufacturer’s 
instructions. Membranes were placed in the well tray provided and immersed in 2 mL 1X 
blocking buffer to block any nonspecific binding sites, then incubated at room temperature for 
30 minutes. The blocking buffer was decanted and 1 mL of dECM dissolved in PBS was 
placed on the surface of the membrane and incubated at room temperature for 2 hours. Any 
antigen targets would bind to specific capture antibodies at this point. The sample was 
removed and each membrane was immersed in 1X wash buffer I and agitated for 5 minutes 
using an orbital shaker; this washing procedure was repeated three times. Each membrane was 
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then washed a further two times using 1X wash buffer II using the same technique. The wash 
solution was removed and 1 mL of diluted biotin-conjugated antibody was added to each 
membrane to bind to the target antigen-antibody complexes and incubated further at room 
temperature for 2 hours. The membranes were washed again with wash buffer I and II as 
previously described above to remove any unbound antibody-enzyme conjugates. 2 mL of 
diluted HRP-conjugated streptavidin was added to each membrane to label antigen-antibody 
complexes and incubated at room temperature for 2 hours. The wash procedure using wash 
buffer I and II was repeated. 
 
To detect immunosorbed antigen-antibody complexes, the membrane was removed from its 
carrier, drained of wash buffer and placed face up on a clean plastic sheet. A total of 500 μL 
of a solution of 50% 1X detection buffer C and 50% 1X detection buffer D was added to the 
membrane surface and incubated at room temperature for 2 minutes. Excess detection agent 
was removed, and the membrane was sandwiched between two plastic sheets and air bubbles 
were carefully removed. Under dark room safe light conditions, the membrane was exposed to 
X-ray film (Carestream Kodak X-OMAT, Sigma-Aldrich, UK) for 3 minutes, which was then 
manually processed. Each film was immersed in GBX developer / replenisher (Carestream, 
Kodak, Sigma-Aldrich, UK) for approximately 5 minutes with moderate agitation. It was then 
transferred to a stop bath (Carestream Kodak, Sigma-Aldrich, UK) for 30 seconds and fixed 
in GBX fixer / replenisher (Carestream Kodak, Sigma-Aldrich, UK) for 60 seconds. Finally, 
the film was washed in running water for 5 minutes. An image of each membrane was 
captured using the G:BOX gel imaging system (Syngene, Cambridge, UK) and transferred to 
GeneSnap image acquisition software (Syngene, Cambridge, UK) for volume density 
quantification. RayBio® Analysis Tool (RayBiotech, Norcross, GA, USA) was used to 
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A B 
calculate relative expression levels of each protein for dECM preparations extracted by 
EDTA, calcium hydroxide, white and grey MTA. 
 
2.2.5 Multiplex sandwich ELISA analysis 
 
To determine the concentration and confirm the presence of specific growth factors, surface 
receptors and a binding protein in dECM, extracted by control and experimental reagents, a 
quantitative multiplex sandwich ELISA service (Quantibody® RayBiotech, Norcross, GA, 
USA) was utilised. Using parallel internal standard controls, this system allowed quantitative 
measurement of the concentration of multiple proteins in an array format. The technique is 
performed on a glass slide with multiple spots of specific antibodies related to the proteins of 
interest (Figure 2.9). 
 
 
 
 
 
 
Figure 2.9 A schematic diagram showing the glass slide layout for detection of multiple 
proteins simultaneously using a sandwich ELISA technique. A) Glass slide spotted with 16 
wells of identical antibody arrays B) Close-up of a well shows that each capture antibody, 
together with the positive and negative control is arrayed in quadruplicate.  
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Lyophilised dECM preparations were dissolved in PBS at a concentration of 190 µg/mL total 
protein as determined from the Bradford assay using BSA as a standard (section 2.2.2.1). 100 
μL of sample diluent was added to each well and incubated at room temperature for 30 
minutes whilst agitated gently on an orbital shaker to block the slides. The buffer was then 
decanted from each well. 100 μL of sample or serial dilutions of standard were added to each 
well of the activated prepared glass slide containing spots of antibody for the targets listed in 
Table 2.2. Samples and standard were incubated for 2 hours at room temperature and then 
washed five times with the 1X wash buffer I under gentle agitation. The same process was 
repeated twice with wash buffer II. 80 μL of the detection antibody was added to each well 
and incubated at room temperature for 2 hours. Following five sequential washes with the 
appropriate wash buffer I, 80 μL of cyanine 3 dye-conjugated streptavidin was added to each 
well and incubated for a further 1 hour at room temperature without light, to bind to any 
cytokine-antibody-biotin complexes. The slide was washed and the fluorescence was 
measured at a wavelength of 532 nm using a microarray scanner (Agilent G2505B, Cheshire, 
UK) at a resolution of 2 μm. Three biological replicates were assessed for each sample of 
dECM preparation. Concentrations of each growth factor, binding protein or surface receptor 
were calculated from standard curves (Figure 2.10). 
Table 2.2 A list of the proteins analysed in dECM components extracted by EDTA, calcium 
hydroxide, white MTA, grey MTA and Biodentine® using the customised Quantibody human 
cytokine array QAH-CUST service. Key to abbreviations is provided on page xii. 
 
 
  
TGF-β1 EGF PDGF-AA SCF 
IGF-I SR IGF-I HGF NGF 
BMP-4 IGF-II G-CSF NT-3 
BMP-7 IGFBP-1 GM-CSF NT-4 
FGF-2 VEGF M-CSF GDNF 
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Figure 2.10 Representative example of a standard curve used to determine concentration of 
HGF in samples of dECM using multiplex ELISA analysis as described in section 2.2.5. The 
R
2 
coefficient (>0.9) and linear regression equation are displayed next to the line of best fit. 
 
2.3 Tissue isolation 
 
2.3.1 Human pulp tissue 
 
Human pulps were obtained from freshly extracted healthy premolar teeth which were 
removed for orthodontic reasons
3
. The teeth were immersed in RNA Later (Qiagen, West 
Sussex, UK) immediately after extraction. Within one hour of removal, the crown was 
sectioned with a needle diamond bur (166-017M, MDT, Israel) in a dental turbine (Synea, 
W&H, UK) at the cementoenamel junction to expose the most coronal point of the pulp 
chamber. The pulp tissue was carefully extirpated from the root canal system using a size 40 
                                                          
3
 Approval for the use of human tooth tissue was obtained from the UK National Research Ethics Service 
(09/H0405/33). 
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K Flexofile (Dentsply, Maillefer, Switzerland) and re-immersed in RNA Later prior to RNA 
isolation (section 2.6.2). 
 
2.3.2 Rat pulp tissue 
 
For rat dental pulp cell (RDPC) cultures and rat pulp tissue isolation, maxillary and 
mandibular incisor teeth were dissected from 100-120 g body weight freshly sacrificed male 
Wistar Hannover rats (Charles River Laboratories, Aston University, Pharmaceutical Sciences 
Animal House, UK) using a scapel. Teeth were washed in sterile PBS (pH 7.5) and placed in 
sterile αMEM medium (Biosera, UK), containing 2 mM L-glutamine (Sigma-Aldrich, UK) 
supplemented with 1% penicillin / streptomycin (10 000 units/mL of penicillin with 10 
mg/mL streptomycin) (Sigma-Aldrich, UK). In a laminar flow hood, teeth were carefully 
sectioned along their long axis; pulp tissue was carefully removed using fine forceps and 
placed in sterile αMEM medium. Pulps were washed three times in sterile αMEM medium 
prior to isolation of RDPCs (section 2.4.2). 
 
2.3.3 Rat non-dental tissue isolation 
 
RNA was isolated from different rat tissues, including tongue, palatal mucosa, bone marrow 
and lung from a freshly sacrificed 100-120 g male Wistar Hannover rat. The tongue was 
detached from its base and approximately 20-30 mg removed from the tip. Palatal mucosa 
was dissected from the hard palate and a representative section approximately 20-30 mg in 
weight detached. Bone marrow was removed whole and pooled from the central core of four 
femoral bones after longitudinal sectioning with a scalpel. Lung tissue was dissected from the 
thoracic cavity and approximately 20-30 mg separated from the inferior lobe. Upon removal, 
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each tissue was finely minced with a scalpel and placed in a 1.5 mL microcentrifuge tube 
containing 600 μL of Buffer RLT (Qiagen, West Sussex, UK) and 0.01% β-Mercaptoethanol 
(Promega, Madison, WI, USA). The resulting suspension was disrupted with a Turrax 
Homogenizer (IKA, Staufen, Germany) for 30 seconds. RNA isolation was subsequently 
performed as outlined in section 2.6.2. 
 
2.4 Cell culture 
 
To study pulp cell responses in vitro, an immortalised cell line, murine MDPC-23 isolated 
from foetal mouse dental papillae (Hanks et al., 1998a) and primary RDPCs isolated from 
male freshly sacrificed 100-120 g male Wistar Hannover rat were used (section 2.3.2). The 
MDPC-23 cell line was kindly donated by Professor Jacques Nör, University of Michigan 
School of Dentistry, USA. 
 
2.4.1 Culture media and processes 
 
2.4.1.1 MDPC-23 culture medium 
 
Dulbecco’s modified Eagle’s medium (DMEM) (Biowest, Nuaillé, France), containing 2 mM 
L-glutamine (Sigma-Aldrich, UK) supplemented with 1% penicillin / streptomycin (10 000 
units/mL of penicillin with 10 mg/mL streptomycin) (Sigma-Aldrich, UK) and 10% foetal 
bovine serum (FBS) (Biowest, Nuaillé, France), was used as standard medium for MDPC-23 
cell culture. 
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2.4.1.2 Primary pulp cell culture medium 
 
Alpha minimum essential medium (αMEM) (Biosera, UK), containing 2 mM L-glutamine 
(Sigma-Aldrich, UK) supplemented with 1% penicillin / streptomycin (10 000 units/mL of 
penicillin with 10 mg/mL streptomycin) (Sigma-Aldrich, UK) and 10% FBS (Biosera, UK), 
was used for the culture of RDPCs (maintenance medium).  
 
2.4.1.3 Optimisation of mineralising medium 
 
To determine the ability of growth factors to induce mineralisation in RDPC cultures, an 
optimal medium supplementation regime was determined to enable sensitive detection of 
differences in in vitro mineralisation induction (Gronthos et al., 1994, Maniatopoulos et al., 
1988). Each well of a 6-well plate (Corning, Tewksbury, MA, USA) was seeded with 5 x 10
4
 
RDPCs (passage 2) and grown to 60-80% confluence. Medium described in section 2.4.1.2 
containing 5% FBS (instead of 10% FBS) was used to decrease growth rates for the extended 
culture periods with further inclusion of one of the following combination of supplements: 1) 
PBS (control) 2) 50 μg/mL ascorbic acid (Sigma-Aldrich, UK) + 10 mM beta-
glycerophosphate disodium salt hydrate (BGP) (Sigma-Aldrich, UK), 3) 10 mM BGP, 4) 5 
mM BGP, 5) 10 mM BGP + dexamethasone 10
-8
 (Dex) (Sigma-Aldrich, UK) and 6) 5 mM 
BGP + Dex 10
-8
. This culture medium was replaced every 48 hours. Three replicates for each 
group were assayed for mineral content using the alizarin red assay (section 2.5.3) at days 5, 
12 and 16. The optimum mineralisation medium identified for future experimental analysis 
was determined to be maintenance medium supplemented with 5% FBS instead of 10% FBS 
with 5 mM BGP.  
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2.4.1.4 Cell counting 
 
To ensure correct seeding densities, viable cells were counted using a Neubauer 
haemocytometer. 50 μL of cell suspension was mixed with 50 μL of 0.4% Trypan blue 
solution (Sigma-Aldrich, UK). 10 μL of the resultant mixture was pipetted into the Neubauer 
chamber and Trypan blue negative cells were counted under a variable relief contrast 
(VAREL) microscope (Zeiss Axiovert 25, Germany). A minimum of three counts were 
performed per sample and mean values were used to calculate the number of cells in the 
solution per mL. Cell suspensions were diluted accordingly and seeded at the required 
densities. 
 
2.4.2 Primary pulp cell preparation 
 
RDPCs were isolated using the Trypsin / EDTA enzyme digestion method (Patel et al., 2009). 
Pulp tissue obtained from one rat (four incisors) (section 2.3.2) was combined and 
mechanically minced using a scalpel on a sterile glass slide to give fine pieces no greater than 
1 mm
3
. The pulp tissue was placed in a 15 mL Falcon® tube with 2 mL of 0.25% (w/v) 
Trypsin 1 mM EDTA.4Na (Gibco, Paisley, UK) and constantly agitated at 37 °C in 5% CO2 
for 30 minutes. To terminate enzymatic activity, two volumes of supplemented α-MEM 
containing 10% FBS were added. The resultant tissue suspension was passed through a cell 
strainer of pore size 70 μm (Becton Dickenson, Oxford, UK) into a 50 mL Falcon® tube to 
obtain a single cell suspension and centrifuged (Jouan B4i, Thermo scientific, UK) at 900 g 
for 3 minutes. The supernatant was removed, the cell pellet was re-suspended in 1 mL of 
medium and cells were seeded in a 25 cm
2
 flask (Corning, Tewksbury, MA, USA). Medium 
was refreshed every 48 hours and cells were passaged once they had reached 80% confluence 
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by detachment using 0.25% (w/v) Trypsin 1 mM EDTA.4Na (Gibco, Paisley, UK). 1 x 10
5
 
cells were seeded in a 75 cm
2
 flask (Corning, Tewksbury, MA, USA) for expansion. All 
subsequent experiments were performed at culture passage two. 
 
2.4.3 MDPC-23 cell preparation 
 
MDPC-23 cells were revived from cryogenic storage. Cryovials were heated to 40 °C for 1-2 
minutes until thawed and the cell suspension was transferred to 1 mL of fresh medium and 
centrifuged (Jouan B4i, Thermo scientific, UK) at 900 g for 2 minutes. The supernatant was 
removed and cells were resuspended in 1 mL of fresh medium and plated in 25 cm
2
 flasks. 
The cells were cultured for 2 hours at 37 °C in 5% CO2 to enable cell attachment to the culture 
plasticware prior to addition of 4 mL of medium. Medium was refreshed every 24 hours and 
cells were passaged once they had reached 80-90% confluence by detachment using 0.25% 
(w/v) Trypsin 1 mM EDTA.4Na (Gibco, Paisley, UK). 1 x 10
5
 cells were seeded in a 25 cm
2
 
flask for expansion. All subsequent experiments were performed at passage two. 
 
2.4.4 Adenoviral transfection of rat dental pulp cells 
 
Adenoviral vectors (Ad) are commonly used as a means for delivering gene supplementation 
into cells. This technique (Goff and Berg, 1976) was used to induce expression of hepatocyte 
growth factor (HGF) and its antagonist NK4 in RDPCs.  
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2.4.4.1 Optimisation of adenoviral transfection rate 
 
RDPCs were seeded at a density of 2 x 10
3
 cells in a 25 cm
2
 flask and grown to 80% 
confluence. Medium was removed and cells were washed with 1 mL of PBS. Cells were then 
infected with EGFP (enhanced green fluorescent protein) AdNK4 (provided by Dr M. Y. 
Alexander, University of Manchester and manufactured by the Vector Core, Gene Therapy 
Program, Department of Medicine, University of Pennsylvania, USA) at a multiplicity of 
infection (MOI) of 0 – 400 particles / cell in 1 mL of PBS and incubated for 40 minutes. 
Medium was then added to a volume of 5 mL. A MOI of zero was used as control. Infection 
rates were determined on days 1, 3 and 5 by analysis of images observed under a Nikon 
Eclipse TE300 microscope using phase contrast and fluorescent light (Super high pressurised 
mercury lamp, Nikon, Japan). In five representative areas of the culture, cells were counted 
within the field of view at a magnification of x400 under phase contrast and fluorescent light. 
The mean percentage of EGFP positive cells was determined for each flask.  
 
2.5 Functional response assays 
 
2.5.1 WST-1 Cell proliferation assay 
 
The WST-1 assay utilises the reduction of tetrazolium salt WST-1 [2-(4-iodophenyl)-3-(4-
nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium] to a coloured formazan compound, which 
occurs when it is exposed to a cell surface of metabolically active cells (Mosmann, 1983). 
When WST-1 reagent is added to cell cultures, it is metabolised and a colorimetric 
measurement can be obtained to determine the amount of formazan produced; subsequently, 
an estimated cell number can be determined from a standard curve. The number of cells can 
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be extrapolated from the standard curve based on the resultant change in absorbance 
providing an estimate of number of viable cells present in the culture. 
 
To determine cell number, 20 μL of WST-1 (Roche Applied Biosciences, Mannheim, 
Germany) was added to 180 μL of medium in each well. Plates were kept in the dark for 
precisely 1 hour and incubated in standard culture conditions. The absorbance of the reduced 
compound was measured at a wavelength of 450 nm with a reference filter at 630 nm using an 
ELx800 Absorbance Microplate Reader (Biotek, Winooski, VT, USA). Cell number was 
calculated from a standard curve (Figure 2.11 and 2.12). 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.11 Representative example of standard curve used to estimate cell number with 
WST-1 cell proliferation assay in a 48-well plate using RDPCs as described in section 2.5.1. 
The R
2 
coefficient (>0.9) and linear regression equation are displayed next to the line of best 
fit. 
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Figure 2.12 Photographic representation of a 48-well plate seeded with RDPCs of different 
seeding densities (0-100 000 cells) with four replicates of each following 1 hour incubation 
with WST-1 reagent. The image shows visibly the difference in colours for each seeding 
density. The plate was read using an optical plate reader at a wavelength of 450 nm with a 
reference filter at 630 nm in order to generate a standard curve and subsequently extrapolate 
cell number for each well.  
 
2.5.1.1 Analysis of RDPC cell growth following supplementation with dECM 
preparations  
 
To determine the optimal seeding density of RDPCs and MDPC-23 cells in a 48-well plate, 
different initial seeding densities were used and growth was monitored over a 7 day time 
period. Data indicated that the optimal seeding density for RDPCs was 1.0 x 10
4 
per well and 
for MDPC-23 cells it was 7.5 x 10
3 
per well in a 48-well plate (IWAKI, Chiba, Japan). Cells 
were seeded in 30 μL of medium in the centre of the well and allowed to attach for 2 hours 
prior to addition of 170 μL of the appropriate medium without FBS. Twenty-four hours later, 
medium was replaced with a dECM preparation supplemented medium. Preparations of 
dECM were previously extracted using EDTA, calcium hydroxide, white MTA and grey 
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MTA (section 2.1.3) and supplemented in medium at concentrations of zero (control), 0.1, 
1.0, 10.0 and 100.0 μg/mL. To generate a standard curve of absorbance against cell number 
(Figure 2.11), 48-well plates were seeded at the following densities: 3125, 6250, 12500, 
25000, 50000 and 100000 for RDPCs and 1250, 2500, 5000, 10000 and 20000 for MDPC-23 
cells. Cultures were maintained for up to 7 days and 4 replicates for each control and 
experimental condition were analysed. At each time point (1, 3, 5, and 7 days for RDPCs and 
1, 2, 3, 4, and 5 days for MDPC-23 cells), an assay of cell number was performed using the 
WST-1 assay (section 2.5.1). 
 
2.5.1.2 Analysis of RDPC cell growth following HGF supplementation 
 
RDPCs were seeded at a density of 1.0 x 10
4
 in each well of a 48-well plate using standard 
medium and allowed to equilibrate for 24 hours. The medium was then replaced with 
mineralisation medium, which comprised α-MEM containing 5% FBS, 5 mM BGP, 2 mM l-
Glutamine and 1% penicillin / streptomycin (section 2.4.1.3). Cultures were infected with the 
recombinant adenovirus for either AdHGF or AdNK4 at a MOI of 250 particles / cell as 
previously described in section 2.4.4.1 or supplemented with recombinant human HGF 
(Sigma Life Sciences, St Louis, USA) at concentrations of 5 to 20 ng/mL. To generate a 
standard curve of absorbance against cell number, 48-well plates were seeded at the following 
densities: 3125, 6250, 12500, 25000, 50000 and 100000. Four biological replicates for each 
group were analysed and medium was replenished every 48 hours; cultures were maintained 
for up to 15 days. At each time point (6, 8, 12, 13, 14 and 15 days), 20 μL of WST-1was 
added to the 180 μL of medium in each well. Cell number was calculated using a standard 
curve as described previously in section 2.5.1.  
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2.5.2 Chemotaxis transwell assay 
To determine the chemotactic ability of HGF, migration assays were performed using a two 
chamber, 96-well plate assay system with 8 μm pore size and hydrophilic membrane 
(ChemoTx, Neuro Probe, Gaithersburg, MD, USA). Quiescence was induced in RDPCs by 
culture in maintenance medium (section 2.4.1.2) with 1% FBS 24 hours prior to the assay to 
induce a quiescent non-mitogenic state. Following this, cells were released as described 
previously and suspended at a concentration of 2.5 x 10
5
 per mL. To fluorescently label cells, 
5 μg/mL of calcein AM (Biotium Inc, Hayward CA, USA) was added to the cell suspension 
prior to incubation at 37 °C in 5% CO2 for 30 minutes. Cells were pelleted by centrifugation 
at 800 g for 3 minutes, washed three times with PBS and re-suspended at a concentration of 
1.0 x 10
6
 per mL in medium containing no FBS. The lower chamber was prepared with either 
medium containing 30 μL of 10% FBS (positive control), 0% FBS (negative control) or 
dECM preparations extracted by EDTA, calcium hydroxide, white MTA and grey MTA at 
concentrations between 0.1 and 100 μg/mL or the following concentrations of recombinant 
HGF: 5, 10, 15 or 20 ng/mL. 30 μL of labelled (calcein AM) cell suspension was pipetted 
carefully onto the upper chamber and the plate was incubated for 45 minutes at 37 °C in 5% 
CO2. The number of cells which had migrated to the lower chamber was determined using a 
microplate fluorometer (Twinkle LB970, Berthold Technologies, Harpenden, UK) at an 
excitation wavelength of 494 nm and emission 517 nm. Cell number was calculated from a 
standard curve (Figure 2.13) and four biological replicates were used for each condition. 
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Figure 2.13 Representative example of standard curve used to determine cell number with 
calcein AM fluorescent label as described in section 2.5.2. The R
2 
coefficient (>0.9) and 
linear regression equation are displayed next to the line of best fit. Em refers to emission 
wavelength. 
 
2.5.3 Alizarin red staining in RDPC cultures exposed to ADNK4, AdHGF and 
recombinant HGF 
 
To determine the ability of HGF to induce mineralisation of RDPCs, a semi-quantitative 
alizarin red staining (ARS) method was applied (Gregory et al., 2004). Alizarin red forms a 
complex with calcium through a chelation process and extraction of this complex produces an 
orange red solution whose absorbance can be quantified at 405 nm. The concentration of 
calcium can then be extrapolated from a standard curve; see Figure 2.14 for a representative 
example. 
 
At each time point, cultures were washed with excess PBS and fixed with 10% 
paraformaldehyde (VWR, UK) for 15 minutes at room temperature. Cultures were washed 
again, twice with distilled water and incubated with 200 μL of 40 mM alizarin red (BDH 
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Laboratory Supplies, UK) at room temperature for 20 minutes with gentle agitation using an 
orbital shaker. Wells were gently washed four times with distilled water and stained cultures 
were captured under illumination from a light box using a Nikon Coolpix 950.  
 
To enable quantification of staining, 200 μL 10% (v/v) acetic acid was added to each well and 
incubated at room temperature for 30 minutes with gentle agitation. Monolayers were 
subsequently removed from plates using a cell scraper and transferred to 1.5 mL 
microcentrifuge tubes. After vortexing for 30 seconds, the slurry was overlaid with 100 μL 
mineral oil (Sigma–Aldrich, UK), heated to 85 °C for 10 minutes and transferred to ice for 5 
minutes. The slurry was then centrifuged at 20,000 g for 15 minutes and 500 μL of the 
supernatant was transferred to a new 1.5mL microcentrifuge tube. 200 μL of 10% (v/v) 
ammonium hydroxide was added to neutralise the acid. The absorbance values of aliquots 
(150 μL) of the supernatant were read in triplicate at a wavelength of 405 nm in 96-well 
format in a Biotek ELx800 microplate reader (Biotek, Winooski, VT USA) for each 
biological replicate. 
 
 
 
 
Figure 2.14 Representative example of standard curve used to determine mineral deposition 
by RDPCs using alizarin red staining as described in section 2.5.3. The R
2 
coefficient (>0.9) 
and linear regression equation are displayed next to the line of best fit.  
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2.6 Gene expression analysis 
 
2.6.1 RDPC exposure to HGF for gene expression analysis 
 
RDPCs were seeded at a density of 5 x 10
4
 in 500 μL culture medium in the centre of each 
well of a 6-well plate (Appleton Woods, UK). Following cell attachment after 6 hours, a 
further 2.5 mL of standard medium was added to each well. Twenty four hours after seeding 
the cells, the medium was replaced with optimised mineralisation medium (section 2.4.1.3) 
supplemented with PBS (control) or 5 ng/mL or 20 ng/mL of recombinant HGF. Medium was 
replaced every 48 hours and cells were cultured for up to 12 days. At days 1, 7 and 12, RNA 
was isolated as described in section 2.6.2. Three biological replicates for each control and 
experimental group were analysed. 
 
2.6.2 RNA isolation from mammalian tissue and cell cultures 
 
Total RNA was extracted using the same approach for all tissues or monolayer cell cultures 
using the RNeasy® minikit (Qiagen, West Sussex, UK) as per the manufacturer’s 
instructions. For mammalian tissues, 20 mg of tissue was coarsely minced with a scalpel 
blade and placed in 500 μL of lysis buffer containing 1% (v/v) beta-mercaptoethanol (β-ME) 
(Promega, Wisconsin, USA) and disrupted with a Turrax Homogenizer (IKA, Staufen, 
Germany). For RDPCs, medium was removed and the cells were washed with warmed sterile 
PBS. RDPCs were then directly lysed in situ using 500 μL of lysis buffer (Qiagen, West 
Sussex, UK) containing 1% β-ME and then passed through a 25G gauge needle three times to 
aid cellular disruption. The resultant lysates were mixed with 500 μL 70% molecular grade 
ethanol (Sigma-Aldrich, UK) and transferred to a spin column assembly provided in the 
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RNeasy® minikit. The spin column was centrifuged for 15 seconds at 8,000 g (5415D 
Microcentrifuge, Eppendorf, UK) and the eluate discarded. Total RNA binds to the membrane 
and additional steps were used to aid removal of genomic DNA. The membrane was initially 
washed with 350 μL of wash buffer RW1 (RNeasy® minikit) and centrifuged for 15 seconds 
at 8,000 g prior to a DNase digestion step. 
 
Digestion of contaminating genomic DNA was performed by treating the membrane with 80 
μL of DNase 1 (RNase-Free DNase Set, Qiagen, UK) for 15 minutes at room temperature. 
Further wash steps were undertaken according to the manufacturer’s instructions and the 
membrane finally dried by centrifugation of the spin column assembly at 11,000 g for 1 
minute. The RNeasy® spin column was transferred to a collection tube and 40 μL of RNase 
free water was added directly to the membrane; this was centrifuged at 8,000 g for 1 minute to 
elute the RNA. 
 
RNA concentration was estimated using a spectrophotometer (BioPhotometer, Eppendorf, 
UK) which measured absorbance at 260 nm and the purity determined from the ratio of 
absorbance at 260 and 280 nm with pure RNA has a A260/A280 ratio of 1.9-2.1. RNA integrity 
was further analysed by agarose gel electrophoresis (section 2.6.6) and inspection whereby 
the ratio of 28s ribosomal RNA band to the 18s band should be approximately 2:1 (Figure 
2.15).  
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Figure 2.15 Representative image of total RNA extracted from RDPCs exposed to different 
concentrations of recombinant HGF with the RNeasy® mini kit and visualised using a SYBR 
gold 1.5% agarose gel separated by electrophoresis.   
 
 
2.6.3 Reverse transcription 
 
To generate single stranded DNA complementary to the mRNA samples isolated above 
(section 2.6.2), a reverse transcription (RT) step using a High Capacity RNA-to-cDNA Kit™ 
(Applied Biosystems, Paisley, UK) was used. 1-2 μg of RNA was added to the reaction 
mixture detailed in Table 2.3 according to the manufacturer’s instructions. This mix was 
incubated in a thermal cycler (Mastercycler® Gradient, Eppedorf, UK) at 37 °C for 60 
minutes to enable extension of transcription product and finally, at 95 °C for 5 minutes to 
denature the reverse transcriptase enzyme. The mix was then rapidly cooled to 4 °C prior to 
purification. 
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Table 2.3 The components and volumes for each constituent of a 20 μL reverse transcription 
reaction to convert RNA to single stranded cDNA. 
 
 
Component Component Volume (μL) 
2✕ RT Buffer 10.0 
20✕ RT Enzyme Mix 1.0 
Sample RNA ≤ 5 
Nuclease-free water Made up to 20 
Total volume per reaction 20.0 
 
2.6.4 Concentration and purification of cDNA 
 
To purify and concentrate cDNA, the unincorporated RT reaction components were removed 
as they could interfere or inhibit downstream analyses. Samples of cDNA were diluted with 
480 μL of RNA-free water and added to the membrane of a Microcon YM-30 filter device 
(Millipore, UK), which was centrifuged at 10,000 g for 6 minutes. Single stranded cDNA 
molecules less than 60 nucleotides in length are removed and eluted with the water using this 
approach. Samples were washed with a further 500 μL of RNA-free water and centrifuged at 
10,000 g for 8 minutes. The volume was measured with a pipette and further centrifugation 
was performed until a volume of less than 50 μL was obtained. To collect the cDNA, the 
Microcon device was inverted and placed in a 1.5 mL microcentrifuge tube and the assembly 
was centrifuged at 1,000 g for 3 minutes. The concentration of cDNA was established in a 
cuvette with a dilution of 1 μL in 69 μL of Nuclease-free water (Ambion, CA, USA) using a 
spectrophotometer (A260) (BioPhotometer, Eppendorf, UK).   
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2.6.5 Polymerase chain reaction 
 
2.6.5.1 Preparation and reaction conditions 
 
Preparation for all polymerase chain reactions (PCRs) was performed on ice to prevent primer 
dimer formation and premature initiation of the reactions. Lyophilised oligonucleotide 
primers (Invitrogen, UK) specific to human and rat species were dissolved in DNase free 
water according to manufacturer’s instructions. These were further diluted to a concentration 
of 25 μM and stored at -20 °C as working stocks. PCR assays were performed using the 
REDTaq® PCR system (Sigma-Aldrich, UK) according to manufacturer’s instructions. The 
REDTaq system contains: 20 mM Tris-HCl, pH 8.3, with 100 mM KCl, 3 mM MgCl2, 
0.002% gelatin, 0.4 mM dNTP mix (dATP, dCTP, dGTP, TTP), stabilizers, and 0.06 unit/µL 
of Taq DNA Polymerase. For each set of primers (Table 2.4 provides primer sequences and 
cycling conditions), a master mix was prepared (Table 2.5) and placed in a 200 μL PCR tube 
(Appleton Woods, UK). 
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Table 2.4 PCR primer sequences, accession number, product size and assay conditions for 
human and rat primers. (GAPDH, glyceraldehyde 3-phosphate dehydrogenase; HGF, 
Hepatocyte growth factor; DMP-1, dentine matrix phosphoprotein-1; ALP, alkaline 
phosphatase; Col-Iα, collagen type I alpha). 
 
  
Gene Primer sequence (5′ to 3′) Accession 
Number 
Product Size 
(bp) 
Tm 
(°C) 
Cycle 
Number 
H
u
m
a
n
 
 
GAPDH 
 
F-TCT AGA CGG CAG GTC AGG TCC 
R-CCA CCC ATG GCA AAT TCC ATG 
 
 
NM001256799.1 
 
598 
 
60 
 
30 
HGF F – ACC ACA CGA ACA CAG CTT TTT GCC 
R – CCC CAG AGG GAT GTC TCA GGC AG 
NM001010934 408 60 40 
c-Met F – GCT GGT CCA GGC AGT GCA GC 
R – AGC ACG CCA AAG GAC CAC ACA 
NM001127500.1 633 60 36 
R
a
t 
 
GAPDH 
 
F – CCC ATC ACC ATC TTC CAG GAG C 
R – CC AGT GAG CTT CCC GTT CAG C 
 
 
XM576394.4 
 
473 
 
60 
 
23 
HGF F – TCA CAC AGA ATC AGG CAA 
R – TGC ATT TGA AGT TCT CGG 
NM017017.2 368 55 45 
c-Met F – ACC CAG ATT GTT TTC CTT 
R – AAT GCA ATG AAT AAT CGG 
NM031517.1 366 55 45 
DMP-1 F – CGG CTG GTG GTC TCT CTA AG  
R – CAT CAC TGT GGT GGT CCT TG 
NM_203493.3 248 60.5 31 
Nestin F – CAT TTA GAT GCT CCC CAG GA 
R – AAT CCC CAT CTA CCC CAC TC 
NM_012987.1 285 60.5 35 
ALP F – CTC CGG ATC CTG ACA AAG AA  
R – ACG TGG GGG ATG TAG TTC TG 
J03572.1 499 60.5 28 
Col-Iα F – GGGCAAGACAGTCATCGAAT  
R – TTGGTTTTTGGTCACGTTCA 
BC133728 336 60 30 
Osteopontin F – AAG CCT GAC CCA TCT CAG AA  
R – GCA ACT GGG ATG ACC TTG AT 
NM_012881.1 445 60.5 24 
Osterix F – GCT GCC TAC TTA CCC GTC TG  
R – TGT GAA TGG GCT TCT TCC TC 
NM001037632.1 302 60 30 
Osteocalcin F – TCC GCT AGC TCG TCA CAA TTG G 
R – CCT GAC TGC ATT CTG CCT CTC T 
J04500.1 699 60 28 
Runx2 F – GCC ACC GAG ACC AAC CGA GTC 
R – GAA ACT CTT GCC TCG TCC GCT CC 
NM053470.2 736 60 28 
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Table 2.5 Reagents and volumes used for each PCR analysis. 
 
Based on spectrophotometer readings, 50 ng of cDNA was added to the master mix in the 
PCR tube with a gentle pipetting action to agitate the mixture. Reactions were amplified in a 
thermal cycler (GeneAmp PCR system 2700 Applied Biosystems, Foster City CA, USA) 
according to the conditions in Table 2.5 and Table 2.6 for each target. 6 μL of product was 
removed from the PCR tube once the relevant cycle number had been reached for subsequent 
visualisation using gel electrophoresis (section 2.6.6).  
Table 2.6 Typical temperature and timings for each stage of the PCR performed in a thermal 
cycler (GeneAmp PCR system 2700 Applied Biosystems, Foster City CA, USA). 
  
Reagent Volume (μL) Concentration 
REDTaq® ReadyMix™ 12.5 1 x 
Forward Primer(25 mM) 0.5 25 mM 
Reverse Primer (25 mM) 0.5 25 mM 
RNase Free Water make up to 25 N/A 
cDNA ≤ 2 50 ng 
Reaction stage Temperature (°C) Time (minutes )  
Denaturation 94 5 
Denaturation 94 30 seconds 
Annealing Primer specific 
(See Table 2.4) 
30 seconds 
Polymerisation 72 30 seconds 
Polymerisation 72 7 
cycle 
number 
dependent 
upon gene 
assay 
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2.6.5.2 Sample normalisation 
 
To compare gene expression changes between control and experimental samples, band 
intensity of the target gene was normalised against the housekeeping gene, glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) (McKinney and Robbins, 1992, Robbins and McKinney, 
1992). To ensure that the amount of amplified product was comparable in each subsequent 
PCR for test genes, volumes of each control and experimental sample to be compared were 
adjusted until the intensity of each GAPDH product [calculated using image analysis software 
(section 2.6.6)] was within 10%.  
 
2.6.6 Gel electrophoresis and imaging 
 
Isolated RNA and PCR products were visualised using non-denaturing agarose gel 
electrophoresis. Agarose gels were prepared using 1.0% (for RNA) or 1.5% (for DNA) (w/v) 
agarose (WebScientific, UK) in 1xTris-acetate EDTA (TAE) buffer (Helena Biosciences, 
UK) by boiling in a microwave (M1714 Samsung, Korea) for approximately 2 minutes at 850 
W until the agarose had dissolved. Once the gel had cooled, 10 mg/mL of SYBR gold 
(Molecular probes, UK) for RNA gels or 10 mg/mL ethidium bromide (Helena Bioscience, 
UK) for PCR product analysis were added to the gel solution. The gel was poured into an 
appropriate gel casting tray and a comb added to create wells within the gel. All air bubbles 
were removed. Prior to loading RNA, 6X bromophenol blue loading dye (Merck, UK) was 
added to each sample. 5 μL of RNA with loading dye (Bioline, UK), PCR product or 
Hyperladder IV (Bioline, UK) as a nucleic acid standard were loaded into the wells of the gel 
prior to electrophoresis at 80-120 v for 25-35 minutes. Gel imaging was performed using the 
G:BOX gel imaging system (Syngene, Cambridge, UK) for image capture under UV 
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illumination. The resultant image was analysed with GeneSnap image acquisition software 
(Syngene, Cambridge, UK) to determine the band density for control and experimental 
targets. Semi-quantitative gene expression changes were conveyed as a percentage increase or 
decrease compared with control. 
 
2.7 Statistical analysis 
 
The individual experiments were performed with at least 3 biological replicates per control or 
experimental group. Normal distribution was tested for using the Shapiro-Wilk test. Statistical 
differences between the experimental and control groups were determined using one way 
ANOVA with Bonferroni post hoc analysis or Student's t test for normally distributed data. 
Statistical analysis was performed using Microsoft Excel (Microsoft Corporation, USA) or 
SPSS software (SPSS Inc, USA) with p<0.05 deemed to be statistically significant from 
control. 
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3.0 RESULTS CHAPTER 1 
 
Analysis of dentine extracellular matrix (dECM) liberated by the soluble components of 
therapeutic pulp capping agents 
 
Although tissue repair and regeneration of the dental pulp via iatrogenic material induction 
has been recognised since the early twentieth century (Hermann, 1920), the underlying 
biological repair mechanisms remain poorly understood. Numerous different therapeutic 
agents have been used to create an environment in which pulpal repair will occur and until 
recently, calcium hydroxide was deemed to be the gold standard. The effects of calcium 
hydroxide were originally attributed to three mechanisms: i) hydroxyl ion release and 
maintenance of a high pH (Kardos et al., 1998), ii) bactericidal activity (Horsted-Bindslev et 
al., 2003), and iii) chemical injury initiating a superficial layer of necrosis (Goldberg et al., 
2003b, Schroder and Granath, 1971, Schroder and Sundstrom, 1974). Recently, our laboratory 
postulated that calcium hydroxide released growth factors sequestered in the dentine which 
subsequently stimulate pulpal healing (Graham et al., 2006). Little is yet known about the 
ability of more contemporary and predictable therapeutic pulp capping agents, such as MTA 
(Nair et al., 2008), to solubilise dECM components.  
 
In this study, dECM components were isolated from powdered sound human dentine using 
solutions prepared from a routinely used agent 10% EDTA (control) and the soluble products 
from recognised therapeutic pulp capping agents, including calcium hydroxide and the 
calcium silicate cements of white MTA, grey MTA and Biodentine®. Notably, previous 
studies have shown that 10% EDTA and a super saturated solution of 0.02M calcium 
hydroxide are effective at solubilising dECM from powdered dentine using a well 
characterised in vitro extraction technique (Smith and Leaver, 1979, Graham et al., 2006). 
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This chapter investigates the soluble components of MTA using atomic absorption 
spectroscopy (AAS) and includes an analysis of liberated dECM components using 
biochemical techniques, gel electrophoretic separation, conventional and multiplex ELISA. 
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3.1 Spectroscopic analysis of extraction solutions 
To characterise the solubilised metallic ion composition of solutions of EDTA, calcium 
hydroxide, white MTA and grey MTA prior to their use in dECM extraction, atomic 
absorption spectroscopy (AAS) was employed (Table 3.1). All ions analysed, including 
aluminium, calcium, iron, magnesium, potassium and sodium, were potentially able to be 
liberated from MTA as identified by the manufacturer’s (Dentsply Tulsa Dental, USA) 
contents list.  
 
Notably, the EDTA solution had a high concentration of sodium ions due to the addition of 
sodium hydroxide, which was used to neutralise the pH to 7.2. White and grey MTA liberated 
similar amounts of each metallic ion assessed, with calcium being the most abundant. No iron 
was detectably solubilised by the grey MTA using this method of dissolution, although 
aluminoferrite is described as one of its constituents. The calcium ion concentration in the 
calcium hydroxide solution was four times greater than that detected in white or grey MTA 
solutions. Potassium and sodium ions were detected in both white and grey MTA at similar 
concentrations.  
 
Table 3.1 Data for the mean concentrations (mg/L) of ions present in each of the extraction 
solutions of EDTA, calcium hydroxide [Ca(OH)2], white MTA (WMTA) and grey MTA 
(GMTA), as determined by atomic absorption spectroscopy. (All experiments were performed 
in triplicate and data are expressed as mean values ±SD). 
 
Ion EDTA (mg/L) Ca(OH)2 (mg/L) WMTA (mg/L) GMTA (mg/L) 
Aluminium 0.00 0.00 25.42 (±2.29) 21.48 (±3.67) 
Calcium 0.00 1725.49 (±160.50) 405.23 (±274.74) 444.44 (±114.89) 
Iron 0.00 0.00 0.00 0.00 
Magnesium 0.00 0.00 0.00 0.00 
Potassium 0.00 0.00 10.41 (±0.64) 10.04 (±0.64) 
Sodium 46727.00 (±910.0) 12.30 (±2.62) 10.94 (±0.52) 12.46 (±0.78) 
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3.2 Extraction profile analysis 
dECM components were extracted over a 14 day period as described in section 2.1.3. In order 
to monitor changes in extraction conditions during this period and determine the rate at which 
dECM components were released, pH and protein content was measured daily.  
 
3.2.1 pH of supernatant over 14 day extraction  
 
The addition of protease inhibitors n-ethylmaleimide and phenyl-methyl-sulphonylfluoride 
resulted in the therapeutic pulp capping agent solutions becoming mildly acidic (pH 5.1-5.5) 
compared to their initial pH values which were: calcium hydroxide (11.9), white MTA (11.7), 
grey MTA (11.7) and Biodentine® (11.5) respectively. However, after one day of contact 
with dentine powder in solution, this acidity was neutralised (Figure 3.1) and the pH of the 
pulp capping agents ranged from 7.5 to 8.2. Over the 14 day extraction period, the pH of 
recovered supernatant for the EDTA solution varied minimally with the lowest pH on day 7 
being 6.7; it returned to 7.2 by day 14. All pulp capping materials demonstrated a similar 
trend over the 14 day period (apart from calcium hydroxide) and the recovered supernatants 
showed a general decline in pH after day 1 for white MTA, grey MTA and Biodentine®. 
After incubation with dentine powder, the calcium hydroxide recovered supernatant decreased 
in pH after day 1 to 6.7 by day 3; from that point in time there was a gradual daily increase in 
pH, reaching 11.2 by day 14. 
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Figure 3.1 pH of extraction solutions for EDTA, calcium hydroxide [Ca(OH)2], white MTA, 
grey MTA and Biodentine®, prior to isolation (day 0) with supernatant from dentine 
dissolution and profiled over the 14 day extractant period.  
 
3.2.2 Protein release over 14 day extraction period of recovered supernatants  
 
Protein content of recovered supernatant for each extraction was determined on a daily basis 
throughout the extraction period by measuring absorbance at 280 nm as a surrogate marker 
(Figure 3.2). The pattern of protein release from dentine by the control, EDTA during the 
extraction period, was comparable with that of previous in-house and published data (Graham 
et al., 2006), whereby absorbance was relatively high on the first day of extraction (3.51 units) 
and this gradually declined throughout the extraction period, in this case to 1.77 units by day 
14. The pulp capping agents demonstrated analogous protein profile release with each other, 
apart from grey MTA where daily protein release was similar throughout the extraction 
period. Calcium hydroxide, white MTA and Biodentine® solutions demonstrated that protein 
release from powdered human dentine decreased between day 1 and 2 and plateaued for the 
remaining extraction period. Only calcium hydroxide demonstrated a slight deviation from 
this pattern, with a sharp decrease in absorbance detected between day 13 (1.90 units) and day 
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14 (1.44 units). In contrast, the protein release in the extractant supernatant for grey MTA 
showed a gradual increase over the 14 day extraction period with the absorbance value rising 
gradually from 1.53 units on day 1 to 2.30 units on day 12. There was a slight decrease over 
the final two days of the extraction period to 2.12 units. 
 
 
 
 
 
 
 
 
 
 
Figure 3.2 Estimation of protein content using absorbance profile at 280 nm as a surrogate 
marker, over the 14 day extraction period, for dissolution of dECM by EDTA, calcium 
hydroxide, white and grey MTA and Biodentine® solutions. 
 
3.2.3 Percentage yield of recovered dECM components following extraction with EDTA, 
calcium hydroxide, white MTA, grey MTA and Biodentine® solutions 
 
The total yield of dECM components was calculated as a percentage of the total weight of 
dentine powder originally used in the extraction, as shown in Table 3.2. The highest yield of 
dECM resulted from the EDTA extraction solution, with 4.35% of human dentine powder 
solubilised and recovered as ECM components. Of the remaining solutions, white MTA 
produced the second highest yield (0.91%) followed by grey MTA (0.64%) calcium 
hydroxide (0.32%) and Biodentine® (0.16%). 
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Table 3.2 Percentage yield of recovered extracted dECM components following extraction 
for 14 days with EDTA, calcium hydroxide, white and grey MTA and Biodentine®. 
 
Extraction 
Solution 
Weight of powdered 
dentine (g) 
Weight of recovered 
extract (g) Yield (%) 
EDTA 10.07 0.439 4.35 
Ca(OH)2 25.05 0.081 0.32 
WMTA 25.05 0.228 0.91 
GMTA 25.10 0.162 0.64 
Biodentine® 20.01 0.033 0.16 
 
 
3.3 Characterisation of dECM components 
 
dECM composition includes collagenous and non-collagenous proteins (NCPs), 
glycosaminoglycans (GAGs) and proteoglycans (Linde, 1985). To characterise solubilised 
dECM components extracted by each control and test agent, several methodological 
approaches were applied, including biochemical analysis using dye binding assays, separation 
by molecular weight using 1D SDS PAGE and cytokine antibody array analysis for different 
growth factor content. 
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3.3.1 Non-collagenous protein (NCP) and glycosaminoglycan (GAG) analysis of dECM 
extracts 
 
Dye binding assays based on the Bradford assay (Bradford, 1976) and Bicinchoninic acid 
(BCA) assay (Smith et al., 1985) were used to determine the concentration of NCPs in dECM 
extracts. The Farndale assay (Farndale et al., 1986) was used to determine the concentration 
of GAGs in each sample of dECM components. Data are summarised in Table 3.3 
 
Table 3.3 Table showing a comparison of total weight (per mg of extract or per gram of 
dentine) of non-collagenous proteins (NCPs) and glycosaminoglycans (GAGs) extracted by 
EDTA, calcium hydroxide, white and grey MTA and Biodentine®, as determined by the 
Bradford, Bicinchoninic acid (BCA) or Farndale assays, respectively.  
 
Extraction 
Solution 
Bradford assay BCA assay Farndale assay 
 μg NCP 
per mg of 
extract 
μg NCP 
per gram 
of 
dentine 
μg NCP 
per mg of 
extract 
μg NCP 
per gram 
of 
dentine 
μg GAGs 
per mg of 
extract 
μg GAGs 
per gram 
of 
dentine 
EDTA 53.96 2350 62.14 2703 50.10 2180 
Calcium 
Hydroxide 49.48 160 66.54 210 48.39 154 
WMTA 27.49 250 66.54 610 32.90 299 
GMTA 36.75 235 96.52 616 39.74 254 
Biodentine® 30.18 48 84.70 136 32.70 52 
 
When comparing the quantity of NCP per gram of dentine released using the Bradford and 
BCA assays, the results demonstrated a similar trend, however, the BCA assay demonstrated 
greater amounts of NCPs released, suggesting it may be a more sensitive detection method for 
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NCPs. EDTA solubilised the greatest amount of NCPs from dentine as determined by the 
Bradford (2350 μg per gram of dentine) and the BCA (2703 μg per gram of dentine) assays. 
The proportion of NCPs in samples solubilised by white and grey MTA was the greatest for 
all of the pulp capping agents tested, as detected by the Bradford assay [WMTA (250 μg per 
gram of dentine) and GMTA (235 μg per gram of dentine)] and the BCA assay [WMTA (610 
μg per gram of dentine) and GMTA (616 μg per gram of dentine)]. Biodentine® solubilised 
the least amount of NCPs of all extraction agents used: Bradford assay (48 μg per gram of 
dentine) and the BCA assay (136 μg per gram of dentine).  
 
The release of GAGs, as determined by the Farndale assay, by the extraction solutions 
demonstrated a similar pattern of results to those obtained with the NCP dye binding assays. 
The EDTA extraction solution solubilised the most GAGs (2180 μg per gram of dentine) and 
Biodentine® solubilised the least (52 μg per gram of dentine). The ratio of NCPs (Bradford) 
to GAGs for each solution was as follows: EDTA (1:1.07), calcium hydroxide (1:1.03), white 
MTA (1:0.84), grey MTA (1:0.93) and Biodentine® (1:0.92). 
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3.3.2 One dimensional polyacrylamide gel electrophoretic analysis of dECM extracts 
 
1D SDS PAGE analysis was performed to compare the profile of proteins that were 
solubilised by solutions of EDTA, calcium hydroxide, white MTA and grey MTA, based on 
molecular weight. Figures 3.3 to 3.5 show representative images of Tris-Acetate and Bis-Tris 
gels, which separate high and low molecular weight proteins, visualised using the Coomassie 
blue and silver staining methods. GeneTools software (Syngene, Cambridge, UK) analysis 
enabled automatic determination of the number of bands separated along with their individual 
molecular weights; these data are summarised in Table 3.4. 
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Figure 3.3 (opposite) Histogram analysis of gel above using GeneTools software (Syngene, 
UK) to automatically identify peaks and molecular weight of bands separated in dECM 
components extracted by: A) EDTA, B) calcium hydroxide, C) white MTA and D) grey 
MTA. (above) E) SDS PAGE protein separation of dECM components extracted by EDTA, 
calcium hydroxide (Ca(OH)2), white MTA (WMTA) and grey MTA (GMTA) with Tris-
Acetate 3-8% gel stained using Coomassie blue. MW=molecular weight marker MARK 12 
(Invitrogen,UK).  
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Figure 3.4 (opposite) Histogram analysis of gel above using GeneTools software (Syngene, 
UK) to automatically identify peaks and molecular weight of bands separated in dECM 
components extracted by: A) EDTA, B) calcium hydroxide, C) white MTA and D) grey 
MTA. (above) E) SDS PAGE protein separation of dECM components extracted by EDTA, 
calcium hydroxide (Ca(OH)2), white MTA (WMTA) and grey MTA (GMTA) with Tris-
Acetate 3-8% gel stained using silver stain. MW=molecular weight marker MARK 12 
(Invitrogen,UK).
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Figure 3.5 (opposite) Histogram analysis of gel above using GeneTools software (Syngene, 
UK) to automatically identify peaks and molecular weight of bands separated in dECM 
components extracted by: A) EDTA, B) calcium hydroxide, C) white MTA and D) grey 
MTA. (above) E) SDS PAGE protein separation of dECM components extracted by EDTA, 
calcium hydroxide (Ca(OH)2), white MTA (WMTA) and grey MTA (GMTA) with 10% Bis-
Tris gel stained using silver stain. MW=molecular weight marker MARK 12 (Invitrogen, 
UK). 
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Table 3.4 Summary of analysis using GeneTools software (Syngene, Cambridge, UK) of 1D 
SDS PAGE separation of solubilised dECM components by EDTA, calcium hydroxide, white 
and grey MTA. Molecular weights of each individual band rounded to the nearest whole 
value. 
 
 
   EDTA Calcium 
Hydroxide 
White MTA Grey MTA 
C
o
o
m
a
ss
ie
 
B
lu
e 
T
ri
s-
A
ce
ta
te
 No. of bands 
detected 
2 5 1 3 
Molecular weight 
of identified 
bands (KDa) 
89, 30 74, 63, 53, 
43, 29 
28 117, 91, 28 
S
il
v
er
 S
ta
in
 T
ri
s-
A
ce
ta
te
 
No. of bands 
detected 
3 26 2 12 
Molecular weight 
of identified 
bands (KDa) 
59, 44, 37 170, 165, 
153, 150, 
121, 103, 98, 
96, 92, 81, 
77, 75, 70, 
67, 58, 51, 
48, 46, 44, 
43, 42, 40, 
39, 38, 36, 34 
77, 62 104, 99, 78, 
67, 63, 53, 
46, 43, 41, 
40, 39, 38 
B
is
-T
ri
s 
No. of bands 
detected 
6 18 8 17 
Molecular weight 
of identified 
bands (KDa) 
139, 70, 64, 
54, 51, 3 
130, 113, 90, 
81, 68, 61, 
52, 42, 28, 
22, 21, 16, 
14, 13, 10, 9, 
7, 5 
143, 130, 
118, 84, 66, 
63, 55, 5 
144, 131, 
108, 86, 66, 
61, 56, 52, 
44, 41, 40, 
35, 23, 21, 
16, 15, 5 
 
Visual inspection of the gels indicated that each extractant solubilised a different protein 
profile of dECM components, although some similarities existed. The same pattern of protein 
separation was resolved using both staining techniques, although it was possible to see more 
bands within the gel stained with silver. Comparisons of different staining techniques under 
the same conditions indicated that the silver staining method allows greater discrimination 
between protein bands than the Coomassie blue staining technique with visual inspection and 
using GeneTools software. Indeed, for the calcium hydroxide sample of dECM components, 
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it was possible to distinguish 26 bands using the silver staining method; however, only 5 
bands could be identified with Coomassie blue (Figure 3.3) using the automated GeneTools 
software analysis approach (Table 3.4).  
 
Six distinct bands were identified in the sample extracted by EDTA separated in the Bis-Tris 
gel ranging from 3 - 139 KDa (Figure 3.5). The histogram for EDTA and white MTA (Figure 
3.5 A and C) shows similar characteristics with most of the dECM components extracted 
being in the higher molecular weight range (greater than 20 KDa). The calcium hydroxide and 
grey MTA samples of dECM components contained protein bands resolved at high and low 
molecular weights, showing similar characteristics in histogram profiles in the Tris-Acetate 
(Figure 3.4) and Bis-Tris gels (Figure 3.5). 
 
3.3.3 Growth factor cytokine array analysis of extracted dECM components 
 
A cytokine array, which employed a sandwich ELISA technique, was used to analyse dECM 
components extracted with EDTA, calcium hydroxide, white MTA and grey MTA (section 
2.2.4). This approach enabled a broad characterisation of growth factors, their binding 
proteins and some soluble receptors to be evaluated within samples of solubilised dECM 
components. A total of forty-one different cytokines were analysed and an autoradiographic 
image for each sample of dECM components assessed was produced using this technique. A 
representative negative autoradiographic image is displayed in Figure 3.6. Image analysis was 
subsequently used to determine the relative radiographic intensity for each cytokine in each 
sample of dECM components and this is shown in Figures 3.7 to 3.9. The cytokines analysed 
have been grouped together as follows: transforming growth factor- (TGF- family 
members, angiogenic growth factors including related soluble receptors, insulin-like growth 
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factor (IGF) family members including their binding proteins (BP), fibroblast growth factor 
(FGF) family members, epidermal growth factor (EGF) family members including related 
soluble receptor, neurotrophic growth factor family members, colony stimulating growth 
factor (CSF) family members and hepatocyte growth factor (HGF).  
 
Radiographic intensities of the dECM components tested ranged from 5.0 to 2791.5 units for 
all forty-one cytokines analysed. The mean intensities of the positive and negative controls 
were 39666 (±1119) and 3.25 (±0.323) units, respectively. Figure 3.6 shows the cytokine 
antibody array map and representative negative autoradiographic images for each sample of 
dECM components tested.  
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Figure 3.6 A) Cytokine antibody array map. (B-E) Negative autoradiographic images of 
cytokine array membranes following exposure with dECM components extracted by B) 
EDTA, C) calcium hydroxide, D) white MTA and E) grey MTA.  
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Figure 3.7 Relative intensity levels of cytokines found in dECM extracted by EDTA, calcium 
hydroxide, white and grey MTA. Members of A) transforming growth factor- family (TGF-
β), B) angiogenic growth factors including related soluble receptors (PDGF = platelet derived 
growth factor, VEGF = vascular endothelial growth factor, PlGF = placental growth factor, 
SCF = stem cell factor, R = receptor) and C) insulin-like growth factor family (IGF, SR = 
surface receptor, BP = binding protein). 
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Figure 3.7A shows the relative intensities for TGF-β1, -β2 and -β3 in dECM components 
extracted by EDTA, calcium hydroxide, white and grey MTA. The signal intensity for TGF-
β1 extracted by EDTA was relatively high (2001 units) when compared with the detected 
intensity for other cytokines and the intensity for TGF-β1 in dECM extracted by the other 
agents. The signal intensity for TGF-β2 was highest in the dECM components extracted by 
EDTA (223.5 units). Signal intensity for TGF-β3 was relatively low for each sample of 
dECM components tested and ranged between 19.5 (grey MTA) to 32.6 units (white MTA). 
 
Levels of eight of the angiogenic growth factors including PDGF-AA, PDGF-AB, PDGF-BB, 
VEGF, VEGF-D, PlGF and SCF were assessed using this array together with five of their 
respective receptors (PDGF R a and b, VEGF R2 and 3, and SCF R). Data generated are 
shown in Figure 3.7B. The signal intensity for PDGF-AA in dECM components extracted by 
EDTA was relatively high (262 units) in comparison with the other growth factors and 
samples in which signal intensity ranged from 5.3 to 49.5 units. For all growth factors except 
SCF, the relative intensity followed the same pattern whereby signal intensity was highest in 
dECM components extracted by EDTA, followed by white MTA, calcium hydroxide and grey 
MTA, respectively. The relative intensities of receptors identified in dECM components 
followed the same rank order as described above apart from VEGF R3 whose relative 
intensity was greatest for EDTA followed by calcium hydroxide, white MTA and grey MTA, 
respectively. 
 
Assessment of the relative intensity levels for insulin-like growth factor family members is 
shown in Figure 3.7C including IGF-I and -II, IGFBP-1, -2, -3, -4, 6 and IGF-I SR. The 
intensity for IGFBP-1 in dECM components extracted by EDTA was relatively high (2791.5 
units); it was ~10-fold greater than that observed for the dECM extract obtained using 
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calcium hydroxide and ~6.5-fold greater than that observed for white and grey MTA extracted 
samples of dECM components. Intensity of signal for IGF-II (561.5 to 1337.5 units) was 
considerably greater than IGF-I (25.5 to 39.5 units) for all samples. The intensity for IGF-II 
was greatest in dECM components extracted by white MTA. For all IGFBPs, the relative 
intensity was the greatest for the EDTA followed by white MTA extracts. 
 
Four members of the twenty-two members of the fibroblast growth factor family were 
analysed using the cytokine array including FGF-2, -4, -6 and -7. The relative intensities for 
each cytokine are shown in Figure 3.8A. The radiographic intensity for FGF-2 was greatest in 
the white MTA sample (67.3 units) of dECM components and lowest in the grey MTA 
sample (55 units). The pattern of intensity for FGF-4 was similar to that for a number of other 
growth factors tested in the array, whereby EDTA showed greatest intensity followed by 
white MTA, calcium hydroxide and grey MTA. The patterns for FGF-6 and -7 intensities 
were the same where ranking was as follows from highest to lowest intensity: EDTA > 
calcium hydroxide > white MTA > grey MTA. 
 
The relative radiographic intensities for four members of the epidermal growth factor family 
including AR, EGF, HB-EGF and TGF-α, generated from the dECMs solubilised by the four 
extractants, are shown in Figure 3.8B. The radiographic intensities ranged from 13 - 109 units 
amongst all growth factors and samples. AR and HB-EGF followed a pattern frequently 
detected in the array whereby EDTA extracts showed greatest intensity followed by white 
MTA, calcium hydroxide and grey MTA. The greatest relative intensities for EGF and TGF-α 
were detected in dECM components solubilised by white MTA compared with the other 
extraction agents. 
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Four members of the neurotrophic growth factor family were analysed using these arrays 
including NGF, GDNF, NT-3 and NT-4 (Figure 3.8C). EDTA solubilised dECM components 
demonstrated the greatest radiographic intensity for all neurotropic growth factor studied. The 
overall range for radiographic intensity was relatively narrow for all extracted samples and 
cytokines (32 - 63 units).  
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Figure 3.8 Relative signal intensity levels for A) fibroblast growth factor family (FGF), B) 
epidermal growth factor family (EGF, AR = amphiregulin, HB = heparin-binding, TGF-a =  
transforming growth factor-α) including related soluble receptor and C) neurotrophic factors 
(NGF = nerve growth factor, GDNF = glial cell line-derived neurotrophic factor, NT = 
neurotrophin), found in dECM extracted by EDTA, calcium hydroxide, white and grey MTA. 
C 
0.00
10.00
20.00
30.00
40.00
50.00
60.00
70.00
NGF GDNF NT-3 NT-4
R
a
d
io
g
ra
p
h
ic
 I
n
te
n
si
ty
 (
u
n
it
s)
EDTA
Calcium
Hydroxide
White MTA
Grey MTA
 126 
 
0.00
20.00
40.00
60.00
80.00
100.00
120.00
HGF
R
a
d
io
g
ra
p
h
ic
 I
n
te
n
si
ty
 (
u
n
it
s) EDTA
Calcium
Hydroxide
White MTA
Grey MTA
B 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.9 Relative signal intensity levels for A) colony stimulating growth factor family 
(CSF, G = granulocyte, GM = granulocyte macrophage, R = receptor) and B) hepatocyte 
growth factor (HGF), found in dECM extracted by EDTA, calcium hydroxide, white and grey 
MTA. 
 
Assessment of relative signal intensity levels for three colony stimulating factors (CSFs) and 
one respective receptor were performed using the arrays and included G-CSF, GM-CSF, M-
CSF and its receptor. Results from this analysis are presented in Figure 3.9A. The relative 
pattern for each of these growth factors was as follows: EDTA extract demonstrated highest 
radiographic intensity followed by white MTA, calcium hydroxide and grey MTA extracts. 
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Relative signal intensity levels for hepatocyte growth factor (HGF), which does not reportedly 
belong to a specific growth factor family, were assessed using the cytokine array and results 
are provided in Figure 3.9B. The radiographic intensity detected for the extracts was greatest 
for EDTA (97.0 units) followed by white MTA (29.1 units) grey MTA (19.6 units) and 
calcium hydroxide (11.6 units), respectively. 
 
3.4 Characterisation of individual growth factors in dECM extracts 
 
The aim of this study was to more accurately characterise individual growth factors TGF-β1 
and Adrenomedullin (ADM) that were solubilised from the dECM by EDTA, calcium 
hydroxide, white MTA, grey MTA and Biodentine®. 
 
TGF-β1 is well documented as a mediator of pulpal repair and regeneration (Smith, 2003) and 
has previously been shown to be present in dECM components solubilised by EDTA (Cassidy 
et al., 1997, Smith et al., 1998). ADM has been implicated in pulpal repair (Cooper et al., 
2011) through its multiple roles as an initiator and regulator of inflammation (Wong et al., 
2005), its broad antimicrobial properties (Allaker et al., 1999), its expression in the dental 
pulp (McLachlan et al., 2005) and its promotion of pulp cell proliferation and mineralisation 
(Musson et al., 2010). Release of TGF-β1 and ADM by control and test agents was 
determined using conventional well plate ELISA.  
 
To further explore the findings of the antibody array data, a bespoke multiplex ELISA was 
also undertaken to determine the concentrations of previously reported and novel growth 
factors identified in each sample of dECM extracted by control and test agents.  
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3.4.1 Concentration of TGF-β1 and ADM in dECM extracts 
 
To determine the specific concentrations of TGF-β1 and ADM in dECM components released 
by EDTA, calcium hydroxide, white MTA and grey MTA, sandwich ELISAs were performed 
(section 2.2.3.2 and 2.2.3.3). TGF-β1 was detected in all extracts of dECM (Figure 3.10) with 
the mean concentration of dECM components extracted by EDTA (209.09 ±3.36 pg/mg) 
being significantly greater than that extracted by calcium hydroxide (77.31 ±4.99 pg/mg), 
white MTA (121.47 ±8.64 pg/mg) or grey MTA (90.99 ±3.48 pg/mg), p<0.0001. White MTA 
dECM components contained significantly more TGF-β1 than grey MTA (p=0.01) and 
calcium hydroxide (p<0.0001); grey MTA dECM components contained significantly more 
TGF-β1 than calcium hydroxide dECM components (p=0.002).  
 
 
 
 
 
 
 
 
 
Figure 3.10 Mean concentration of TGF-β1 in dECM extracted by EDTA, calcium 
hydroxide, white or grey MTA. Error bars represent one standard deviation from the mean for 
triplicate analyses. *p≤0.005 when compared using one-way ANOVA. 
 
 
ADM was also detected in all extracts of dECM analysed (Figure 3.11) with the greatest 
amount present in calcium hydroxide liberated samples (420.83 ±175.27 pg/mg); this was 
significantly greater than the amount released by EDTA (50.57 ±15.93 pg/mg, p=0.029) or 
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white MTA (57.4 ±35.4 pg/mg, p=0.032). Grey MTA released dECM components contained 
278.3 ±152.5 pg/mg of ADM.  
 
 
 
 
 
 
 
 
 
Figure 3.11 Mean concentration of ADM in dECM extracted by either EDTA, calcium 
hydroxide (Ca(OH)2), white (W) or grey (G) MTA. Error bars represent one standard 
deviation from the mean for triplicate analyses. *p≤0.05 when compared using one-way 
ANOVA. 
 
 
3.4.2 Multiplex sandwich ELISA of dECM extracts  
 
Further to the growth factor cytokine array analysis (section 2.2.5), confirmation of the 
presence of newly identified growth factors in dECM was sought and their concentrations 
determined. Given the relatively high cost of individual ELISAs and the precious nature of 
recovered dECM components, a multiplex sandwich ELISA technique was performed to 
concomitantly assess levels of several cytokines. This approach allowed specific 
concentrations of each target protein to be determined in dECM extracts using relatively low 
volumes analysed on a customised glass slide array. The slide was spotted with specific test 
antibodies and provision was made to assay cytokine standards in parallel to enable 
calculation of concentrations of each cytokine. Figure 3.12 shows a photographic 
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representation of a glass slide under fluorescent light with a close up view of the array capture 
for one dECM sample, with key provided.  
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Figure 3.12 Multiplex sandwich ELISA array system showing: A) representative laser 
scanned image of whole glass chip, B) close up of array captured for one EDTA dECM 
component sample, and C) cytokine array key for image B).  
POS 1 POS 2 
FGF BMP-4 
BMP-7 NGF 
EGF G-CSF 
GDNF GM-CSF 
HGF IGF-BP1 
IGF-I IGF-II 
IGF-1SR M-CSF 
NT-3 NT-4 
PDGF-AA SCF 
TGF-β1 VEGF 
A 
B 
C 
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The levels of twenty proteins were analysed, including the angiogenic growth factors (VEGF, 
PDGF – AA, SCF), colony stimulating factors (G-CSF, GM-CSF, M-CSF), insulin-like 
growth factors, surface receptor and binding protein (IGF-I, IGF-II, IGF-I SR, IGFBP-1), 
neurotrophic growth factors (NGF, NT-3, NT-4, GDNF) and bone morphogenetic proteins 
(BMP-4, BMP-7) as well as several others (TGF-β1, EGF, FGF-2, HGF). The results are 
presented in groups, where possible, to aid interpretation (Figures 3.13 and 3.14). 
 
All angiogenic growth factors (VEGF, PDGF-AA, SCF) assessed were detected in the dECM 
extracts (Figure 3.13A). VEGF was present in all extracts, with white and grey MTA extracts 
containing the highest concentrations, 107.27 ±17.79 pg/mL and 189.47 ±14.33 pg/mL, 
respectively. These concentrations were significantly greater (p≤0.0001) than those detected 
for extracts obtained using EDTA (53.93 ±8.19 pg/mL), calcium hydroxide (26.8 ±6.26 
pg/mL) and Biodentine® (81.23 ±4.07 pg/mL). The mean concentration of VEGF detected in 
Biodentine® extracts was significantly greater than that for the calcium hydroxide extracts 
(p=0.04). PDGF-AA was extracted by EDTA (4386.6 ±224.15 pg/mL) with trace amounts 
detected in white MTA (7.9 ±0.59 pg/mL) and grey MTA (2.63 ±1.69 pg/mL) extracts. Only 
grey MTA was able to extract significant quantities of SCF (25.05 ±0.17 pg/mL).  
 
The concentrations of the colony stimulating factors, including G-CSF, GM-CSF, M-CSF, 
were assayed by multiplex ELISA (Figure 3.13B) and data indicated that for all dECM 
extracts, G-CSF levels were below the level for accurate detection. M-CSF was detected in 
the dECM components extracted by white MTA (5.75 ±1.56 pg/mL) and grey MTA (4.1 
±1.99 pg/mL) only and there was no statistical difference between groups. GM-CSF was 
detected in dECM components extracted by EDTA (15.3 ±0.46 pg/mL), calcium hydroxide 
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(20.95 ±7.8 pg/mL), white MTA (17.33 ±8.7 pg/mL) and Biodentine® (37.85 ±4.33 pg/mL). 
There were no statistically significant differences between concentrations detected.  
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Figure 3.13 Mean concentrations of A) angiogenic growth factors, B) colony stimulating factors and C) insulin-like growth factors and 
binding protein (pg/mL) present in dECM components released from human dentine by solutions of EDTA, calcium hydroxide, white MTA, 
grey MTA and Biodentine®, as determined by multiplex ELISA (±SD, n=3). * indicates statistically significant difference (p<0.05) using one 
way ANOVA. 
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Proteins involved in signalling along the IGF axis, including IGF-I, II, IGFBP-1 and IGF-I 
SR, were analysed for their presence in dECM extracts (Figure 3.13C). IGF-I SR was not 
detected in any of the extracts of the dECM components. IGF-I was detected in dECM 
components extracted by EDTA (19963 ±7890.10 pg/mL), white MTA (10119 ±1122.40 
pg/mL) and grey MTA (9128.7 ±483.93 pg/mL). IGF-II was extracted by all agents; EDTA 
(2502.9 ±720.04 pg/mL), calcium hydroxide (1042.6 ±39.78 pg/mL), white MTA (210.3 
±61.08 pg/mL), grey MTA (353.07 ±47.70 pg/mL) and Biodentine® (1417.4 ±559.52 
pg/mL). The concentration of IGF-II was statistically significantly higher in dECM 
components extracted by EDTA when compared with white MTA (p=0.012) and grey MTA 
(p=0.009). The concentration of IGFBP-1 in EDTA extracted dECM components was 
demonstrably greater than 100000 pg/mL and this intensity of fluorescence was beyond the 
upper limits for accurate quantitative detection. Other extracting agents extracted similar 
levels of IGFBP-1 to each other with no statistical differences found; calcium hydroxide 
(6507 ±1431.3 pg/mL), white MTA (4107.5 ±667.86 pg/mL), grey MTA (4903.1 ±137.02 
pg/mL) and Biodentine® (6105.5 ±457.96 pg/mL). 
 
Analysis of neurotrophic growth factors (GDNF, NGF, NT-3, NT-4) showed that NT-3 and 
NT-4 were not detected in any samples using this methodology. GDNF was detected in all 
samples of dECM components (Figure 3.4.5A); the highest concentration of which was found 
in the dECM extract released by calcium hydroxide (233.43 ±55.4 pg/mL), which was 
significantly greater than EDTA (53.53 ±17.50 pg/mL) (p<0.0001), white MTA (98.3 ±3.85 
pg/mL) (p=0.02) and grey MTA (63 ±2.92 pg/mL) (p<0.0001). Biodentine® released the 
second highest concentration of GDNF (155.7 ±6.30 pg/mL), which was significantly greater 
than EDTA (p=0.016) and grey MTA (p=0.031). NGF was detected in dECM components 
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released by EDTA (23.63 ±3.12 pg/mL), white MTA (1.15 ±0.4 pg/mL) and grey MTA (2.05 
±0.06 pg/mL).  
 
 
 
 
 
  
Figure 3.14 Mean concentration of A) neurotrophic growth factors, B) BMP-7, C) TGF-β1, 
D) EGF and E) FGF-2 (pg/mL) in dECM components released from human dentine by 
solutions of EDTA, calcium hydroxide, white MTA, grey MTA and Biodentine®, as 
determined by multiplex ELISA (±SD, n=3). * indicates statistically significant difference 
(p<0.05) using one way ANOVA. 
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The BMP-4 and -7 growth factors associated with mineralised tissue formation and repair 
were also assessed using multiplex ELISA and results are shown in Figure 3.14B. Only BMP-
7 was detected in dECM released by EDTA (33584 ±7086.2 pg/mL). TGF-β1 analysis 
showed that dECM extract for EDTA was beyond the upper limit for accurate quantitative 
detection, indicating that the concentration was greater than 100000 pg/mL. Biodentine® 
extracts exhibited the highest concentration of TGF-β1 (69256 ±9470 pg/mL), which was 
significantly greater than those detected for calcium hydroxide (11427 ±2802.2 pg/mL) 
(p<0.0001), white MTA (30203 ±1700.3 pg/mL) (p<0.0001) and grey MTA (27066 ±1500.8 
pg/mL) (p<0.0001) (Figure 3.14C). EGF was detected at relatively low levels in all samples 
of dECM components (Figure 3.14D): EDTA (4.7 ±0.46 pg/mL), calcium hydroxide (24.33 
±6.48 pg/mL), white MTA (22.17 ±1.9 pg/mL) and Biodentine® (14 ±2.43 pg/mL). There 
were significantly lower concentrations of EGF detected in EDTA extracted samples 
compared with those extracted by calcium hydroxide (p=0.004) and white MTA (p=0.009). 
Using this methodology, FGF-2 was only detected in dECM extracted by EDTA (2227.9 
±308.48 pg/mL) (Figure 3.14E). 
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4.0 RESULTS CHAPTER 2 
 
Effects of dentine extracellular matrix (dECM) components on dental pulp cells 
 
Following tissue injury, a complex series of events is initiated, involving various intra- and 
extra-cellular signalling pathways, which aim to facilitate tissue repair if favourable 
environmental factors predominate (Gurtner et al., 2008). Wound repair follows a sequence of 
overlapping stages that include cell homing of progenitor cells to the site of injury, cellular 
differentiation, proliferation and deposition of extracellular matrix (Kang et al., 2012). The 
necessary cues and signals required for progenitor cell recruitment, proliferation and 
differentiation in pulpal tissue remain poorly understood. In 3.0 Results Chapter 1, it was 
demonstrated that the soluble products of therapeutic pulp capping materials could release 
dECM components that comprised a complex cocktail of non-collagenous proteins. Further 
analysis showed that these dECM components contained a broad range of signalling 
molecules and growth factors, some of which have not been previously reported in this dental 
tissue. These molecules may play key roles in regulating the process of wound repair during 
pulp healing and regeneration. The interaction of pulp capping agents with the dECM may 
initiate the release of cytokines and growth factors, which could induce reparative processes 
leading to dentine-pulp complex repair. 
 
The aim of the work documented in this chapter was to investigate the effect of dECM 
components, released by therapeutic pulp capping agents, on two important processes which 
occur during wound healing and tissue regeneration, namely chemotaxis and proliferation.  
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4.1 The influence of dECM components on rat dental pulp cell (RDPC) migration 
The chemotactic potential of dECM components was assessed using a transwell plate assay 
(section 2.5.2). The number of RDPCs moving towards medium supplemented with dECM 
components was determined and compared with appropriate positive and negative controls.  
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4.1.1 Chemotactic analysis of RDPCs in response to EDTA soluble dECM components 
 
Within 45 minutes of cells being exposed to stimulus, 88% of RDPCs in the positive control 
group had migrated to the medium containing 10% FBS while, in contrast, for the negative 
control, a significantly lower proportion (p<0.0001) of the RDPCs (36%), had migrated to the 
medium without FBS. These data indicated that FBS exerted a strong chemotactic influence 
and served as an appropriate positive control (Figure 4.1). All concentrations of EDTA 
soluble dECM components studied attracted more RDPCs to the lower chamber of the 
transwell plate than the medium containing no FBS supplementation, however, this was only 
statistically significant for the following concentrations: 1.0 μg/mL (p=0.04), 10 μg/mL 
(p=0.01) and 100 μg/mL (p=0.02). No statistically significant differences were detected 
between the different concentrations of EDTA dECM components in terms of the number of 
RDPCs that migrated when compared between groups. 
 
 
 
 
 
 
 
 
 
Figure 4.1 RDPC migration induced by EDTA extracted dECM components at 
concentrations between 0.1 - 100 μg/mL. Positive control (FBS +ve) included 10% FBS and 
negative control was medium without FBS (FBS -ve). All experiments were performed in 
quadruplicate and data are expressed as mean values ±SD. *p≤0.05, **p≤0.001 when 
compared with negative control using one-way ANOVA.  
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4.1.2 Chemotactic analysis of RDPCs in response to calcium hydroxide soluble dECM 
components 
 
Figure 4.2 shows data demonstrating that all concentrations of dECM components extracted 
by calcium hydroxide induced significantly (p<0.05) more cell migration compared with FBS 
unsupplemented medium. A comparison of different concentrations of calcium hydroxide 
extracted dECM components showed that both 1.0 μg/mL and 10 μg/mL induced significantly 
more RDPC migration compared with the lower concentration of 0.1 μg/mL (p=0.022 and 
p=0.004, respectively). 
 
 
 
 
 
 
 
 
 
 
Figure 4.2 RDPC migration induced by calcium hydroxide extracted dECM components at 
concentrations between 0.1 - 100 μg/mL. Positive control (FBS +ve) included 10% FBS and 
negative control was medium without FBS (FBS -ve). All experiments were performed in 
quadruplicate and data are expressed as mean values ±SD. *p≤0.05, **p≤0.001 when 
compared with negative control using one-way ANOVA. 
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4.1.3 Chemotactic analysis of RDPCs in response to white MTA soluble dECM 
components 
 
Figure 4.3 shows that all concentrations of dECM components extracted by white MTA 
induced significantly more RDPC migration compared with medium alone, p≤0.001 for all 
assay groups analysed. The highest concentration tested (100 μg/mL) induced significantly 
more cell migration than the 0.1 μg/mL (p=0.04) exposure. Combined data for all 
concentrations show that, on average, within the 45 minute assay period, 55% of RDPCs 
migrated to dECM components extracted by white MTA compared with 21% for the negative 
control. 
 
 
 
 
 
 
 
 
 
 
Figure 4.3 RDPC migration induced by white MTA extracted dECM components at 
concentrations between 0.1 - 100 μg/mL. Positive control (FBS +ve) included 10% FBS and 
negative control was medium without FBS (FBS -ve). All experiments were performed in 
quadruplicate and data are expressed as mean values ±SD. *p≤0.05, **p≤0.001 when 
compared with negative control using one-way ANOVA. 
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4.1.4 Chemotactic analysis of RDPCs in response to grey MTA soluble dECM 
components 
 
Figure 4.4 demonstrates that all concentrations of grey MTA extracted dECM components 
induced significantly more RDPC migration compared with negative control (p<0.0001). Data 
combined for all dECM concentrations analysed showed that, on average, 54% of RDPCs 
migrated towards the lower chamber of the transwell plate. For medium with no additional 
supplement, only 17% of cells were found to migrate across the membrane. 
 
 
 
 
 
 
 
 
 
 
Figure 4.4 RDPC migration induced by grey MTA extracted dECM components at 
concentrations between 0.1 - 100 μg/mL. Positive control (FBS +ve) included 10% FBS and 
negative control was medium without FBS (FBS -ve). All experiments were performed in 
quadruplicate and data are expressed as mean values ±SD. *p≤0.05, **p≤0.001 when 
compared with negative control using one-way ANOVA. 
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4.2 The influence of dECM components on pulp cell proliferation 
 
To determine the effect of solubilised dECM components on pulp cells in terms of their 
capacity to potentially enhance the proliferative phase of wound healing processes, the WST-
1 (Roche Applied Biosciences, Mannheim, Germany) assay was applied. Primary RDPCs and 
the odontoblast-like cell line (MDPC-23 cells) were utilised for comparison and exposed to a 
range of concentrations of dECM components extracted by EDTA, calcium hydroxide, white 
MTA or grey MTA (section 2.5.1). Medium was changed every 48 hours. Two different types 
of pulp cells were used in this experiment as the primary RDPC cultures provide a 
heterogeneous pulp cell population (Patel et al., 2009) whereas MDPC-23 cells are regarded 
as being homogeneous and more highly differentiated along an odontoblast-like lineage 
(Hanks et al., 1998a).  
  
 145 
 
0
10000
20000
30000
40000
50000
60000
70000
0 1 3 5 7
N
u
m
b
e
r 
o
f 
C
el
ls
Day
Control
0.1 μg/mL
1.0 μg/mL
10 μg/mL
100 μg/mL
4.2.1 Growth of RDPCs exposed to EDTA extracted dECM components 
On days 5 and 7, the cell counts for RDPCs exposed to dECM components extracted by 
EDTA at concentrations of 0.1, 1.0 and 10 μg/mL were greater than unstimulated controls, 
however, this was not statistically significant (p>0.05) (Figure 4.5). There appeared to be 
minimal difference in numbers of RDPCs in the control group compared with those exposed 
to dECM components at a concentration of 100 μg/mL, at each time-point analysed. EDTA 
extracted dECM components at this concentration therefore appeared to have minimal effect 
on primary RDPC growth. 
 
 
 
 
 
 
 
 
 
Figure 4.5 RDPC growth over 7 days following exposure to a range of concentrations of 
dECM components extracted by EDTA as determined by the WST-1 assay. Error bars 
represent one standard deviation from the mean for quadruplicate analyses. *p≤0.05 when 
compared with control using one-way ANOVA. 
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4.2.2 Growth of RDPCs exposed to calcium hydroxide extracted dECM components 
 
During the first three days of culture, there was minimal difference in cell number when 
experimental groups were compared (Figure 4.6). At day 5, however, mean cell numbers were 
greater for cultures exposed to dECM components extracted by calcium hydroxide at 
concentrations of 0.1 μg/mL (36,000 cells), 1.0 μg/mL (40,000 cells), 10 μg/mL (41,000 cells) 
and 100 μg/mL (41,000 cells) compared with control (32,000 cells). These differences were 
not statistically significant (p>0.05). On day 7, mean numbers of RDPCs were greatest for 
cultures exposed to dECM components at a concentration of 10 μg/mL (62,200 cells). There 
were no statistically significant differences detected between any of these groups when 
compared (p>0.05). The highest concentration of dECM components, 100 μg/mL exerted 
minimal effect when compared with control at all time-points analysed. 
 
 
 
 
 
 
 
 
Figure 4.6 RDPC growth over 7 days following exposure to a range of concentrations of 
dECM components extracted by calcium hydroxide as determined by the WST-1 assay. Error 
bars represent one standard deviation from the mean for quadruplicate analyses. *p≤0.05 
when compared with control using one-way ANOVA.  
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4.2.3 Growth of RDPCs exposed to white MTA extracted dECM components 
 
RDPCs exposed to all concentrations of dECM components extracted by white MTA 
demonstrated no significant differences to the control over the first three days of the culture 
period (Figure 4.7). However, data from day 5 of culture demonstrated that RDPC numbers 
were increased by all concentrations when compared with control. The mean difference 
between control (31,000 cells) and 0.1 μg/mL (37,000 cells) was not statistically significant 
(p>0.05), however, statistically significant differences were detected for all other 
concentrations applied including 1.0 μg/mL (43,000 cells, p=0.013), 10 μg/mL (43,500 cells, 
p=0.01) and 100 μg/mL (42,000 cells, p=0.027). On day 7, RDPC numbers increased in a 
dose dependent manner, with increasing concentrations of white MTA extracted dECM 
components, up to 10 μg/mL: 0.1 μg/mL (48,500 cells), 1.0 μg/mL (53,000 cells), 10 μg/mL 
(58,500 cells) versus control (43,000 cells). Comparison with control demonstrated that the 10 
μg/mL dECM exposure was statistically significant (p=0.014). At the highest concentration 
(100 μg/mL) of dECM components applied, the cell numbers were similar to those of the 
control (40,000 cells). 
 
 
 
 
 
 
 
Figure 4.7 RDPC growth over 7 days following exposure to a range of concentrations of 
dECM components extracted by white MTA as determined by the WST-1 assay. Error bars 
represent one standard deviation from the mean for quadruplicate analyses. *p≤0.05 when 
compared with control using one-way ANOVA.  
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4.2.4 Growth of RDPCs exposed to grey MTA extracted dECM components 
 
During the first three days of culture, RDPCs exposed to the concentrations of dECM 
components extracted by grey MTA showed minimal variation in cell number compared with 
control. Day 5 data demonstrated that the mean cell numbers for 1.0 μg/mL (51,000 cells) and 
10 μg/mL (50,000 cells) dECM exposure were only marginally greater than control (43,500 
cells), and no statistically significant differences were detected (p>0.05). On day 7, mean cell 
numbers were greater for dECM exposures at 0.1 μg/mL (69,000 cells), 1.0 μg/mL (74,000 
cells) and 10 μg/mL (72,500 cells) compared with control (60,000 cells). Statistically 
significant differences were only identified for the concentration of 1.0 μg/mL (p=0.05). 
Mean cell number for the highest concentration (100 μg/mL: 63,000 cells) was similar to that 
of control.  
 
 
 
 
 
 
 
 
Figure 4.8 RDPC growth over 7 days following exposure to a range of concentrations of 
dECM components extracted by grey MTA as determined by the WST-1 assay. Error bars 
represent one standard deviation from the mean for quadruplicate analyses. *p≤0.05 when 
compared with control using one-way ANOVA. 
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4.2.5 Growth of MDPC-23 cells exposed to EDTA extracted dECM components 
 
Lower concentrations (0.1 and 1.0 μg/mL) of dECM components extracted by EDTA 
increased growth of MDPC-23 cells compared with control (Figure 4.9). The differences in 
means were not statistically significant at earlier time-points, until day 4, when the mean cell 
number for control was 18,500 and for a concentration of 1.0 μg/mL dECM was 22,300 
(p=0.003). The higher concentration of dECM components appeared to have a deleterious 
effect on cell growth; on days 4 and 5, the mean cell numbers for the concentration of 100 
μg/mL were significantly lower than control, p=0.004 and p<0.0001, respectively. 
 
 
 
 
 
 
 
 
 
Figure 4.9 MDPC-23 cell growth following exposure to a range of concentrations of dECM 
components extracted by EDTA over 5 days as determined using the WST-1 assay. Error bars 
represent one standard deviation from the mean for quadruplicate analyses. *p≤0.05 when 
compared with control using one-way ANOVA. 
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4.2.6 Growth of MDPC-23 cells exposed to calcium hydroxide extracted dECM 
components 
 
Over the first three days of cell culture, there were minimal differences in mean cell numbers 
of MDPC-23 cells exposed to all concentrations of dECM components extracted by calcium 
hydroxide (Figure 4.10). Analysis of day 4 and 5 cell counts demonstrated that the highest 
concentration (100 μg/mL) of dECM inhibited cell growth as mean cell numbers at 100 
μg/mL exposure were significantly lower than control, p=0.03 and p=0.015, respectively. On 
day 5, concentrations of 0.1 and 1.0 μg/mL of dECM, resulted in the mean number of cells 
increasing above control, however, statistically significant differences were only detected for 
1.0 μg/mL dECM exposure (p=0.042). 
 
 
 
 
 
 
 
 
 
 
Figure 4.10 MDPC-23 cell growth following exposure to a range of concentrations of dECM 
components extracted by calcium hydroxide over 5 days as determined using the WST-1 
assay. Error bars represent one standard deviation from the mean for quadruplicate analyses. 
*p≤0.05 when compared with control using one-way ANOVA. 
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4.2.7 Growth of MDPC-23 cells exposed to white MTA extracted dECM components 
 
Lower concentrations (0.1, 1.0 and 10 μg/mL) of dECM components extracted using white 
MTA stimulated increases in cell numbers in exposed cultures by day 3 when compared with 
control (Figure 4.11). Day 4 data demonstrated statistically significant differences in cell 
numbers when control (17,900 cells) was compared with 1.0 μg/mL (28,200 cells) and 10 
μg/mL (28,150 cells) exposures of dECM components liberated by white MTA (p=0.005) 
indicating that these concentrations promoted cell growth. On day 5, cell numbers for the 
lowest dECM exposure concentrations (0.1 and 1.0 μg/mL) were significantly greater than 
those for control (p<0.0001), while cell numbers for cultures exposed to 100 μg/mL dECM 
were significantly lower than those of control (p<0.0001).  
 
 
 
 
 
 
 
 
 
 
Figure 4.11 MDPC-23 cell growth following exposure to a range of concentrations of dECM 
components extracted by white MTA over 5 days as determined using the WST-1 assay. Error 
bars represent one standard deviation from the mean for quadruplicate analyses. *p≤0.05 
when compared with control using one-way ANOVA. 
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4.2.8 Growth of MDPC-23 cells exposed to grey MTA extracted dECM components 
 
The dECM components extracted by grey MTA at the highest concentration of 100 μg/mL 
negatively affected cell growth throughout the 5 day culture period, however, differences 
were only statistically significant on days 2-5 of analysis (Figure 4.12). Mean cell numbers 
were greater than those for control on day 4 and 5 for medium supplemented with dECM 
components at concentrations of 0.1, 1.0 and 10 μg/mL. These comparisons were only 
statistically significant for dECM concentrations of 1.0 μg/mL (p=0.028) and 10 μg/mL 
(p=0.003) on day 4 and 10 μg/mL (p=0.028) on day 5. 
 
 
 
 
 
 
 
 
 
 
Figure 4.12 MDPC-23 cell growth following exposure to a range of concentrations of dECM 
components extracted by grey MTA over 5 days as determined using the WST-1 assay. Error 
bars represent one standard deviation from the mean for quadruplicate analyses. *p≤0.05 
when compared with control using one-way ANOVA. 
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5.0 RESULTS CHAPTER 3 
 
The role of hepatocyte growth factor in cellular processes associated with pulp wound 
healing 
 
In 3.0 Results Chapter 1, dECM was demonstrated to contain a rich cocktail of growth 
factors, which could be differentially released from human dentine by different pulp capping 
agents. Release of many of the molecules from dECM has not been previously reported. 
Indeed, cytokine array analysis demonstrated for the first time the presence of hepatocyte 
growth factor (HGF) in extracted dECM components (Figure 3.9B).  
 
The expression of HGF and c-Met has been shown in the developing tooth germs of mice 
(Sonnenberg et al., 1993, Kajihara et al., 1999) with its deletion in knock-out mice 
demonstrating abnormal tooth development (Tabata et al., 1996) suggesting it plays an 
important role in primary dentinogenesis (section 1.2.2). Together with its known 
functionalities in other tissues, this led to the hypothesis that HGF could play an important 
role in dental tissue regeneration. Therefore, the aims of the studies described below were to 
determine: i) the concentration of HGF in dECM components released by relevant pulp 
therapeutic agents (using quantitative ELISA), ii) if HGF and its receptor c-Met are expressed 
in RDPC cultures, human and rat pulp tissue, and iii) if HGF is able to activate pulp derived 
cells in terms of the repair-associated processes of chemotaxis, differentiation and 
mineralisation. 
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5.1 HGF analysis in human dentine 
 
To determine the concentration of HGF released from human dentine by solutions of EDTA 
and the pulp therapeutic agents calcium hydroxide, white MTA, grey MTA and Biodentine®, 
a multiplex sandwich ELISA was performed, as described previously (section 2.2.5). The 
presence of HGF was identified in dECM extracted by solutions of EDTA, white MTA and 
grey MTA (Figure 5.1), however, levels of HGF in dECM extracted by calcium hydroxide 
and Biodentine® solutions were lower than the detection level limit of this assay. EDTA 
extracted significantly more HGF (457.8 ±3.3 pg/mL) (p<0.0001) than the other extraction 
solutions of white MTA (28.8 ±4.3 pg/mL) and grey MTA (31.3 ±2.1 pg/mL). There were no 
significant differences in the amounts of HGF released by white and grey MTA (p=1.0). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1 Mean HGF concentration (pg/mL) in dECM released from human dentine by 
solutions of EDTA, calcium hydroxide (Ca(OH)2), white MTA (WMTA), grey MTA 
(GMTA) and Biodentine® (BD) as determined by ELISA (mean ±SD, n=3) * indicates 
statistically significant difference (p<0.05) using one-way ANOVA.  
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5.2 Expression of c-Met and HGF in human and rat cells and tissues 
 
To determine whether pulpal cells were likely to be able to respond to HGF signalling and 
therefore, whether HGF could potentially contribute to dental tissue repair and regeneration, 
the expression of HGF and its receptor c-Met in human pulp tissue was analysed. RNA was 
isolated from human pulp tissue and control RNA was obtained from commercial sources for 
a range of other tissues to act as comparators for expression levels. Qualitative RT-PCR 
analysis was performed to determine relative levels of expression. Both HGF and its receptor 
c-Met were strongly expressed in human pulp tissue, liver (control) and smooth muscle 
(control) compared with the other tissues analysed (Figure 5.2).  
 
 
 
 
 
 
 
 
 
 
Figure 5.2 Gel images showing relative gene expression levels of c-Met and HGF in human 
tissues (SM= Smooth Muscle) normalised to the GAPDH housekeeping gene. 
 
To determine whether rat dental pulp cells (RDPCs) in culture were likely to be able to 
respond to HGF via HGF/c-Met signalling, the expression of the c-Met receptor was 
analysed. Qualitative RT-PCR analysis was undertaken on several rat tissues including pulp, 
tongue, palatal mucosa, bone marrow and lung, as well as RDPC monolayer cultures, to 
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assess the expression of HGF and c-Met. Data demonstrated that both HGF and its receptor c-
Met were expressed in a variety of rat tissues as well as RDPCs. Interestingly, it appeared that 
higher expression levels of c-Met were detected in the RDPCs compared with other tissues 
while the converse was true for HGF expression (Figure 5.3). 
 
 
 
 
 
 
 
 
 
 
Figure 5.3 Gel images showing relative expression of c-Met and HGF in rat tissues [PM = 
Palatal Mucosa, BM = Bone Marrow, RDPC = Rat Dental Pulp Cells (two independent 
cultures were analysed)] normalised to the housekeeping gene GAPDH. 
 
5.3 Chemotactic activity of HGF 
 
To determine the ability of RDPCs to respond chemotactically to HGF, a two chamber 
transwell assay was employed. In the positive control group (10% FBS), 81% of RDPCs 
migrated to the lower chamber, whereas with the medium containing no FBS supplement 
(negative control) only 16% of cells migrated (Figure 5.4). Medium containing recombinant 
HGF in the concentration ranges of 5-20 ng/mL demonstrated statistically significant 
migration of RDPCs when compared with control medium with no supplement. Within the 45 
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minute assay period, the percentage movement of cells ranged from 48-59% for all HGF 
groups analysed.  
 
 
 
 
 
 
 
 
 
 
Figure 5.4 RDPC migration, induced by recombinant HGF at concentrations between 5-20 
ng/mL, within the 45 minute assay period. Positive control with 10% FBS (FBS +ve) and 
negative control without FBS (FBS –ve). All experiments were performed in quadruplicate 
and are expressed as mean values ±SD. *p≤0.05, **p≤0.005 when compared with medium 
containing no supplement using one-way ANOVA. 
 
5.4 Gene expression analysis of RDPCs exposed to HGF 
 
To investigate further the effects of HGF on RDPCs in terms of differentiation, gene 
expression analyses were performed for several transcripts associated with mineralisation. A 
panel of markers, that are considered to reflect dentinogenic and osteogenic phenotypic 
characteristics, were studied. For convenience of analysis, the markers were grouped as being 
predominantly either odontoblastic (McLachlan et al., 2003) or osteoblastic (Karsenty, 2000) 
as has been previously described. 
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RDPCs were cultured for up to 12 days and exposed to a range of concentrations of 
recombinant HGF (5 or 20 ng/mL). Gene expression analysis using semi-quantitative RT-
PCR was performed on days 1, 7 and 12 of culture and normalised against the housekeeping 
gene (GAPDH) levels. Transcript levels of general markers of mineralisation [alkaline 
phosphatase (ALP) and collagen 1 alpha (Col1α)], dentinogenic markers [dentine matrix 
protein-1 (DMP-1) and nestin] and osteogenic markers (osteopontin, osterix, osteocalcin, and 
Runx2) were compared with control using densitometric analysis. 
 
Figure 5.5 shows the gene expression changes of ALP and Col1α observed in RDPCs that 
were exposed to HGF (5 or 20 ng/mL) over the 12 day period. Expression levels of ALP in 
RDPCs did not vary considerably over this time period, nor in response to HGF 
supplementation. The greatest detectable change in expression of ALP during this period 
occurred when RDPCs were cultured for 12 days with 20 ng/mL of HGF supplement (8% 
increase), however, this was not statistically significant (p=1.0). Mean expression changes of 
Col1α appeared greater as there was reduced expression on day 1 [5 ng/mL (-15%), 20 ng/mL 
(-7%)] and increased expression for RDPCs exposed to 20 ng/mL HGF on day 7 (13%) and 
day 12 (14%), however, none of these changes were statistically significant.  
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Figure 5.5 RT-PCR analysis of RDPCs following culture for 1, 7 and 12 days in mineralising 
medium supplemented with recombinant HGF at concentrations of 5 or 20 ng/mL. Control 
(C) was supplemented with PBS instead of HGF. A) Representative gel images showing 
relative gene expression. B) Densitometric analysis of gel images showing differential gene 
expression of ALP (alkaline phosphatase) and Col-Iα (Collagen type I alpha); levels were 
normalised to the GAPDH housekeeping gene levels. Data are expressed as a relative increase 
compared with control cultures (mean ±SD, n = 3) *p≤0.05 when compared to control with 
one way ANOVA. 
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Expression changes of dentinogenic-related markers (DMP-1 and nestin) are displayed in 
Figure 5.6. Relative expression levels of DMP-1 in RDPCs did not change considerably on 
the first day of culture, however, on day 7, the expression level was statistically significantly 
(p=0.001) increased when the RDPCs were exposed to both the 5 ng/mL (164%) and 20 
ng/mL (178%) concentrations of HGF. These differences in expression were maintained until 
the end of the culture period on day 12, although at this point they were smaller in magnitude 
[5 ng/mL (65%) and 20 ng/mL (62%)], nevertheless remaining statistically significant 
(p≤0.002). HGF exposure exerted minimal effect on the expression levels of nestin in RDPCs 
during the culture period (Figure 5.6). 20 ng/mL of HGF decreased expression marginally on 
day 7 (-11%) and day 12 (-22%), however, none of these changes were statistically significant 
when compared with control. 
  
 161 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.6 RT-PCR analysis of RDPCs following culture for 1, 7 and 12 days in mineralising 
medium supplemented with recombinant HGF at concentrations of 5 or 20 ng/mL. Control 
(C) was supplemented with PBS instead of HGF. A) Representative gel images showing 
relative gene expression. B) Densitometric analysis of gel images showing differential gene 
expression of DMP-1 (dentine matrix protein-1) and nestin; levels were normalised to 
GAPDH housekeeping gene levels. Data are expressed as a relative increase compared with 
control cultures (mean ±SD, n= 3) *p≤0.05 when compared with control with one way 
ANOVA. 
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Gene expression analyses were performed for several transcripts associated with the 
osteogenic phenotype including osteopontin, osterix, osteocalcin, and Runx2 (Figure 5.7). 
Data demonstrated varying degrees of elevated cellular expression when RDPCs were 
exposed to recombinant HGF compared with unstimulated controls over the 12 day period. 
Mean expression of osteocalcin was up-regulated compared with control on all days, by both 
concentrations of HGF applied. On day 7, this was statistically significant for 5 ng/mL [49% 
increase (p=0.002)] and 20 ng/mL [67% increase (p<0.0001)] exposures. On the final day of 
analysis, only 5 ng/mL HGF exposure induced a statistically significant increase in expression 
compared with control [64% (p=0.002)]. 
 
Runx2 expression was statistically significantly up-regulated following HGF treatment at a 
concentration of 20 ng/mL [85% increase (p≤0.0001)] on day 1; no changes were detected for 
5 ng/mL HGF exposure when compared with control (p=0.617). By day 7, both 
concentrations of HGF (5 and 20 ng/mL) had induced increased expression of Runx2 to levels 
that were statistically significant, p=0.002 and p<0.0001, respectively. At the end of the 
culture period, only a concentration of 20 ng/mL HGF showed a statistically significant 
difference to control (p<0.0001).  
 
Osterix demonstrated considerable changes in transcript level expression (Figure 5.7) in 
RDPCs; in particular, on day 12 when expression increased significantly (p≤0.0001) for cells 
exposed to 5 ng/mL (264%) or 20 ng/mL (353%) recombinant HGF. Although transcript 
levels for osteopontin were up-regulated in comparison with control for RDPCs exposed to 5 
and 20 ng/mL HGF on days 7 and 12, the only statistically significant difference detected was 
in RDPC cultures exposed to 20 ng/mL on day 7 (p=0.014).   
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Figure 5.7 RT-PCR analysis of RDPCs following culture for 1, 7 and 12 days in mineralising 
medium supplemented with recombinant HGF at concentrations of 5 or 20 ng/mL. Control 
(C) was supplemented with PBS instead of HGF. A) Representative gel images showing 
relative gene expression. B) Densitometric analysis of gel images showing differential gene 
expression of osteocalcin, Runx2, osterix and osteopontin; levels were normalised to the 
GAPDH housekeeping gene levels. Data are expressed as a relative increase compared with 
control cultures (mean ±SD, n= 3) *p≤0.05 when compared to control with one way ANOVA.  
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5.5 HGF induced mineralisation in RDPC cultures 
 
HGF/c-Met signalling has previously been shown to be associated with mineralised tissue 
formation under pathological conditions (Liu et al., 2007, McKinnon et al., 2006); combined 
with the expression analyses data, this therefore highlights the potential for HGF involvement 
in both dental cell differentiation and mineralisation. Alizarin red staining (ARS) of RDPCs 
was used to determine the ability of HGF to induce mineral production in vitro. Adenoviral 
vectors were used to induce over-expression of HGF and NK4, in parallel with other 
experimental groups which were exposed to a range of concentrations of recombinant HGF. 
Prior to studying the effects of mineral production in RDPC cultures using this approach, the 
optimal adenoviral vector transfection efficiency [multiplicity of infection (MOI)] was 
determined and the most appropriate mineralisation medium composition for discrimination 
of experimental group differences was identified.  
 
5.5.1 Optimisation of medium for stimulation of mineralisation in RDPCs 
 
Initial experiments using standard mineralisation medium comprising beta-glycerophosphate 
disodium salt hydrate (BGP) and dexamethasone (Dex) demonstrated their potent ability to 
induce mineral production in RDPC cultures. Therefore, in order to discriminate the relative 
ability of different experimental groups to induce mineralisation, a less potent mineralisation 
supplement was identified.  
 
RDPCs were cultured for up to 16 days with six different types of media supplement 
comprising PBS (control); 50 μg/mL ascorbic acid + 10 mM BGP; 10 mM BGP; 5 mM BGP; 
10 mM BGP + Dex 10
-8
 and 5 mM BGP + Dex 10
-8
 (section 2.4.1.3). Mineral production was 
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determined using ARS (section 2.5.3) on days 5, 12 and 16 of culture and results are 
presented in Figure 5.8. Over the time course of this study, RDPCs supplemented with PBS 
(control) demonstrated a relatively weak and slow increase in mineral production: day 5 
(20.05 ±4.29 µM), day 7 (38.44 ±12.40 µM) and day 16 (51.07 ±4.75 µM). Medium 
supplemented with both BGP and Dex induced relatively high mineral production by day 5, 
however, mineral production did not increase significantly during the remaining time period 
of the experiment. A similar pattern of relatively high mineral production by day 5 was 
observed for RDPCs exposed to medium containing 50 μg/mL ascorbic acid + 10 mM BGP, 
however, in this instance, total mineral content continued to rise, reaching its maximum level 
on day 12 (110.34 ±15.10 µM). Medium supplemented with either 10 mM BGP or 5 mM 
BGP alone induced a gradually increasing rate of mineral production in RDPCs over the time 
course of 16 days with total mineral content being greater than control. The 5 mM BGP 
supplement induced the greatest amount of mineral on day 16 (113.14 ±42.02 µM). It was 
determined that medium supplemented with 5 mM BGP alone would be used as 
mineralisation medium. 
 
 
 
 
 
 
 
 
Figure 5.8 Mineral content analysis in RDPC cultures as determined by alizarin red staining 
following culture for 5, 12 and 16 days in medium supplemented with 1) PBS, 2) 50 μg/mL 
ascorbic acid + 10 mM BGP, 3) 10 mM BGP, 4) 5 mM BGP, 5) 10 mM BGP + Dex 10
-8
 and 
6) 5 mM BGP + Dex 10
-8
.   
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5.5.2 Optimisation of adenoviral transfection efficiency using an adenoviral vector 
expressing enhanced green fluorescent protein 
 
Infecting monolayer cultures of primary cells with adenoviral vectors can have a deleterious 
effect on cell behaviour, function and viability. To determine the optimal rate of infection, i.e. 
the ratio of infectious virus particles to the number of cells or multiplicity of infection (MOI), 
a fluorescently labelled viral vector was utilised. This enabled a high infection rate to be 
identified, which did not cause detrimental effects on cell viability. The adenoviral vector 
NK4 (AdNK4) expressed enhanced green fluorescent protein (EGFP); RDPCs were exposed 
to a range of MOIs (50-400) and cultured for up to 5 days. The percentage of positive EGFP 
cells viewed under a fluorescent microscope was calculated (section 2.4.4.1). Results are 
shown in Figure 5.9 and representative images of different MOI rates are also provided in 
Figure 5.10. 
 
Infection rates using 50 and 100 MOI were relatively low with only 9 ±3% of cells expressing 
EGFP over the 5 day culture period. MOI of 150, 200 and 300 produced much higher 
transfection rates with the highest being for a MOI of 250, on day 1 (65.67 ±4.04%), day 3 
(84.67 ±3.06%) and day 5 (84 ±7.55%). A MOI greater than 250 resulted in decreased 
transfection efficiency - this may have been due to the viral vector exerting a toxic effect on 
cultures. To analyse the effects of transfection with adenoviral vectors, an MOI of 250 was 
chosen. 
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Figure 5.9 Adenoviral transfection rate in RDPCs infected with AdNK4 expressing EGFP at 
a range of multiplicity of infections (MOIs) from 50-400 and cultured for up to 5 days (n=3). 
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Figure 5.10 Representative photographic image fields of RDPCs infected with EGFP labelled AdNK4 adenoviral vector at MOIs of 150, 200 
and 250. RDPCs were cultured for up to 5 days and viewed under a fluorescent microscope (Nikon Eclipse TE300 microscope). Scale bars are 
shown. 
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5.5.3 Alizarin red staining of RDPC cultures exposed to AdHGF, AdNK4 and 
recombinant HGF 
 
To assess the ability of HGF to promote mineralisation in RDPC cultures in vitro, alizarin red 
staining was performed following exposure of cultures to the adenoviral vectors, AdHGF and 
AdNK4 and recombinant HGF (Figure 5.11). Quantitative measurement of alizarin red 
staining (Figure 5.12) demonstrated significantly increased levels (p≤0.001) of mineralisation 
in RDPC cultures exposed to both AdHGF (63.05 ±17.57 μM) and recombinant HGF: 5 
ng/mL (69.82 ±18.43 μM), 10 ng/mL (63.69 ±11.64 μM), 15 ng/mL (56.74 ±8.45 μM) and 20 
ng/mL (64.59 ±14.74 μM), from day 8 onwards compared with controls (26.06 ±8.66 μM). 
This pattern continued until the end of the culture period (day 15); by this time, the 
differences were even greater: AdHGF (203.63 ±101.0 μM) and recombinant HGF: 5 ng/mL 
(106.57 ±18.43 μM), 10 ng/mL (198.9 ±47.82 μM), 15 ng/mL (233.01 ±98.98 μM) and 20 
ng/mL (324.96 ±118.1 μM), compared with control medium (51.61 ±17.89 μM). RDPCs 
infected with the AdNK4 control vector showed no significant difference from uninfected 
control. 
 
 
 
 
 
 
 
 
Figure 5.11 Photographic image (n=4) of 48-well plate stained with alizarin red following 15 
day culture of RDPCs exposed to adenoviral infection of HGF, NK4 or mineralising medium 
(5% FBS and 5 mM BGP) supplemented with 5-20 ng/mL of recombinant HGF. Control 
medium was mineralising medium supplemented with PBS instead of HGF.   
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Figure 5.12 Alizarin red staining analysis in RDPC cultures exposed to adenoviral infection of HGF, NK4 or medium supplemented with 5-20 
ng/mL of recombinant HGF cultured for up to 15 days. All experiments were performed in quadruplicate and are expressed as mean values 
±SD. Experimental groups were compared with control using the students t-test (*p≤0.05, **p≤0.01, ***p≤0.001). 
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5.5.4 Cell growth analysis in RDPCs exposed to AdHGF, AdNK4 and recombinant HGF 
 
No statistically significant differences in cell growth were detected between control and 
experimental cultures for any time point studied (Figure 5.13). Cell numbers were greatest for 
all groups on day 12; control medium (6.6x104 ±2530), AdC (6.2x104 ±3862), HGF 5 ng/mL 
(6.5x104 ±5090), HGF 10 ng/mL (6.7x104 ±2745), HGF 15 ng/mL (6.8x104 ±4002) and 
HGF 20 ng/mL (6.6x104 ±3027). Through day 13 to 15, cell numbers decreased each day for 
control medium (4.0x104 ±4363), AdC (3.7x104 ±3805), HGF 5 ng/mL (4.0x104 ±3451), 
HGF 10 ng/mL (3.9x104 ±3754), HGF 15 ng/mL (3.7x104 ±5040) and HGF 20 ng/mL 
(4.0x104 ±4112). 
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Figure 5.13 Cell growth as determined by WST-1 assay in RDPC cultures exposed to adenoviral infection of HGF, NK4 or medium 
supplemented with 5-20 ng/mL of recombinant HGF and cultured for up to 15 days. All experiments were performed in quadruplicate and data 
are expressed as mean values ±SD. Experimental groups were compared with control using one-way ANOVA, no statistical differences were 
found. 
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5.5.5 In vitro mineralisation in RDPCs exposed to AdHGF, AdNK4 and recombinant 
HGF 
 
To determine if mineral deposition was increased due to cell number, data were expressed as 
mineral content per cell (Figure 5.14). Statistically significant higher levels of mineralisation 
occurred in groups exposed to AdHGF or recombinant HGF from day 8, indicating that the 
increased mineral production was not simply the result of an increase in cell number. There 
was a dose-dependent trend of increasing mineralisation with increasing HGF concentration 
on day 15 in cultures exposed to recombinant HGF (5-20 ng/mL). 
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Figure 5.14 Alizarin red staining analysis in RDPC cultures exposed to adenoviral infection of HGF, NK4 or medium supplemented with 5-20 
ng/mL of recombinant HGF and cultured for up to 15 days. Data are expressed as mineral production per cell. All experiments were performed 
in quadruplicate and are expressed as mean values ±SD. Experimental groups were compared with control using the students t-test 
(*p≤0.05,**p≤0.01,***p≤0.001).
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6.0 DISCUSSION 
 
The potential for material-directed regeneration of the wounded dental pulp has been 
recognised for over ninety years (Hermann, 1920), however, the molecular events leading 
to the formation of reparative dentine are only just beginning to be understood. Since this 
pioneering work of Hermann (1920), calcium hydroxide has been considered to be the gold 
standard material for use in operative procedures for treating the injured pulp. However, 
more recently, Mineral Trioxide Aggregate (MTA), a calcium silicate cement, has 
consistently been shown to produce a more predictable hard tissue barrier, create less 
inflammation and have relatively easier handling characteristics than calcium hydroxide 
lining materials (Nair et al., 2008, Aeinehchi et al., 2003, Caicedo et al., 2006, Chacko and 
Kurikose, 2006, Iwamoto et al., 2006). There are a number of hypotheses attempting to 
explain the regenerative response of the injured pulp when treated with calcium hydroxide. 
A plausible explanation is that the interaction of calcium hydroxide with the surrounding 
dentine leads to the liberation of growth factors and bioactive molecules which then provide 
the necessary signals for pulpal repair (Graham et al., 2006) (section 1.7.1). When a 
biomaterial is introduced into a vital tissue, it elicits a biological response from the host 
whether it is desirable or undesirable (Anderson, 2001). The success of the material is 
dependent both on creating an environment that is conducive to healing, and on initiating 
the necessary physiological cues which enable wound repair. A broad aim of this study was 
to determine, in principle, at the molecular level, how calcium silicate cements induce 
healing and repair of the injured dentine-pulp complex and further investigate any other 
specific repair mechanisms that became apparent.  
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6.1 Ionic dissolution of dental materials at the tissue-material interface 
 
Therapeutic materials used in pulp capping (calcium hydroxide, calcium silicates: white 
MTA, grey MTA and Biodentine) are soluble to varying degrees. The solubility of 
calcium hydroxide preparations used in pulp capping is well known (Hwas and Sandrik, 
1984). In a clinical situation, calcium hydroxide cements will dissociate into Ca
2+
 and OH
- 
ions producing a calcium rich and high pH microenvironment, which will interact with 
local tissues (Glass and Zander, 1949, Schroder and Granath, 1971, Stanley and Lundy, 
1972). There is some difference in opinion amongst investigators as to the degree of 
solubility of MTA (Danesh et al., 2006, Fridland and Rosado, 2005, Islam et al., 2006, 
Poggio et al., 2007, Shie et al., 2009, Torabinejad et al., 1995b). This is likely to be due to 
the different methodologies used to assess this and the variation in interpretation of the term 
‘solubility’. Solubility can be defined as the maximum amount of solute that may be 
dissolved in a solvent (Parirokh and Torabinejad, 2010). The methodologies used in 
previously published studies ostensibly determined the percentage weight-loss of the solid 
material over time in a solvent. These methods do not, however, account for the net 
increase in weight of the solid due to chemical modification at the surface. It has been 
established, using techniques such as X-ray diffraction, dispersive X-ray spectroscopy, 
Fourier transform-infrared spectroscopy and X-ray fluorescence, that calcium phosphates 
precipitate on the surface of MTA when it is in contact with synthetic physiological 
solutions and that these calcium phosphates are principally hydroxyapatite (Bozeman et al., 
2006, Sarkar et al., 2005, Tay et al., 2007, Tingey et al., 2008). This suggests that there is a 
natural maturation of the material and a potential net gain in weight, thus explaining some 
of the variance and potential inaccuracies of solubility testing. The interaction with solvents 
also indicates that MTA liberates cations and anions from its surface when it contacts an 
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aqueous environment; this process is known as ionic dissolution. Using atomic absorption 
spectroscopy (AAS), water soluble components have been reported to include calcium 
(Ca
2+
), potassium (K
+
), sodium (Na
+
), iron (Fe
3+
) and sulphate (SO4
2-
) ions (Fridland and 
Rosado, 2003), whilst heavy metals, including chromium, arsenic and lead, are released by 
water and synthetic body fluid (Schembri et al., 2010).  
 
To model some of the dynamic interactions of therapeutic pulp capping agents (calcium 
hydroxide, white MTA, grey MTA and Biodentine®) with the dentine-pulp complex, 
solutions of ionic dissolution products were generated through their interaction with water. 
An assumption was made that similar products would be released from these pulp capping 
agents when interacting with tissue fluid in the clinical situation. Therefore, in this present 
study, EDTA was used as a well characterised positive control, while calcium hydroxide, 
white MTA, grey MTA and Biodentine® were analysed as known therapeutic pulp capping 
agents. Solutions of EDTA and calcium hydroxide were produced as reported previously 
(Smith and Leaver, 1979, Graham et al., 2006). The methodology for generating the MTA 
solutions was based on these previous studies, but was modified to allow for the fact that 
these materials undergo a complex setting reaction and have multiple constituents. The 
manufacturer’s data indicated that calcium oxide represented 65% (w/w) of anhydrous 
MTA and was predicted to react with water to form calcium hydroxide. Based on this, it 
was determined that, to achieve a final solution containing 0.02 M calcium hydroxide 
(maximum saturation), 1.72 g of MTA in 1 litre of water was required. To enable 
comparison with the in vivo setting situation, unreacted powdered MTA was solubilised 
under physiological conditions, i.e. 37 °C for 72 hours, resulting in hydrolysis of the set and 
setting constituents of MTA. This approach replicates the clinical scenario, in that, the 
material interfaces with biological tissues, in a setting and set state, under conditions where 
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local tissue fluids are constantly replenished. A Biodentine® solution could not be 
produced in exactly the same way because the liquid component of the unreacted material 
has active ingredients that contribute to its setting reaction. However, given that a precedent 
had been established here in terms of generating a solution from MTA, the solution of 
Biodentine® was generated in a similar way by mixing 1.72 g of powdered set material 
with 1 litre of distilled water under constant agitation at 37 °C for 72 hours. This allowed a 
direct comparison to be made with MTA solutions and their resultant dECM extracts.  
 
Analyses were undertaken using AAS to investigate the concentration of aluminium, 
calcium, iron, magnesium, potassium and sodium ions in solutions of EDTA, calcium 
hydroxide, white MTA and grey MTA only (this was prior to Biodentine® being launched 
onto the world market in 2010). These ions were selected for investigation as they are 
reported to be constituents of larger compounds (section 1.7.2) in MTA (Tulsa Dentsply, 
Oklahoma, USA) and therefore, potentially could be solubilised. In agreement with 
previous studies, the calcium hydroxide solution demonstrated a high level of calcium ions 
and the EDTA solution had high levels of sodium ions; the latter was due to use of sodium 
hydroxide to neutralise pH. The solution of grey MTA, produced here, contained similar 
proportions of calcium ions and potassium ions as has previously been reported (Fridland 
and Rosado, 2003, Camilleri, 2008). The studies undertaken here did not, however, detect 
any Fe
3+
 ions which Fridland and Rosado (2003) had shown to be present in very low 
concentrations. This unanticipated result may be explained by the different techniques used 
to treat the MTA in order to produce solutions for analysis with AAS. Indeed, the volume 
of water used to solubilise MTA was much greater in experiments here, which may have 
resulted in dilution of the Fe
3+
 ions to undetectable levels. To date, molecules leached from 
Biodentine® have not been reported.  
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6.2 Release of dECM components by therapeutic pulp capping agents 
 
When used clinically, therapeutic pulp capping agents have an intimate relationship with 
the surrounding dentine and actively modify the local environment, thus affecting the 
dentine structure. EDTA has been used in vitro as a standard for extracting dECM (Smith 
and Leaver, 1979, Cassidy et al., 1997, Lesot et al., 1988, Smith et al., 1990, Tziafas et al., 
1995, Zhao et al., 2000) and it has been proposed that it should be used as a therapeutic 
wash in cavity cleansing (Zhao et al., 2000) in order to expose bioactive molecules from the 
dentin. Notably, however, this clinical application has never been adopted widely. EDTA is 
a polyamino carboxylic acid; it is a hexadentate ligand made up of four carboxyl groups 
and two amino groups (Crouch et al., 2003). Each ligand reacts with a calcium ion in the 
hydroxyapatite crystalline structure of dentine and this potentially results in the 
demineralisation and release of sequestered dECM components. Calcium hydroxide is a 
highly alkaline inorganic compound that is sparingly soluble in water. White and grey 
MTA release calcium hydroxide when they are combined with water (Fridland and Rosado, 
2003, Fridland and Rosado, 2005, Camilleri, 2008, Camilleri, 2010, Camilleri et al., 2011) 
and have a similarly high alkalinity to calcium hydroxide when solubilised. However, the 
mechanism(s) by which calcium hydroxide and the calcium silicate cements solubilise 
dECM components is poorly understood. The total yield of dECM components solubilised 
by each agent used here varied appreciably and the rank order of total yield was as follows: 
EDTA > white MTA > grey MTA > calcium hydroxide > Biodentine® (Table 3.2.1). This 
suggests that the disruption of dECM and its subsequent release of soluble components is 
more “gentle” with therapeutic capping materials compared to EDTA. 
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Apatite crystals, which constitute the main inorganic component of dentine and other 
mineralised tissues, are well known to undergo ionic substitutions and participate in the 
process of ion exchange. Within dentistry, this ion exchange process is a familiar concept 
with the interaction between fluoride and hydroxyapatite in dental tissues known to prevent 
dental caries (Clarkson, 1991, Ten Cate, 2012). Ion exchange is also used in numerous 
industrial processes, for example, water softening where excess calcium and magnesium 
ions are removed from hard water (Helfferich, 1995, Carter and Gregorich, 2008). The 
electrolytic make-up of the ionic dissolution products from pulp capping agents, especially 
calcium silicates, may create an environment in which ion exchange occurs, such that, 
bioactive matrix bound non-collagenous proteins are released. This is possible because of 
the existence of a metastable hydrated layer of loosely bound ions on the crystalline surface 
of mineralised matrix that readily allows ion exchange (Cazalbou et al., 2005). It is 
proposed that this mechanism may allow a gradual release of dECM components as seen 
during in vitro extractions by pulp capping agents. Further analysis of these interactions and 
this hypothesis may produce some interesting findings.  
 
6.3 Major constituents of dECM released by therapeutic pulp capping agents 
 
Apart from type I collagen, the organic phase of dECM consists of non-collagenous 
proteins (NCPs) and proteoglycans. NCPs such as those of the SIBLING family, which are 
phosphorylated, include dentine sialoprotein (DSP), dentine phosphoprotein (DPP), bone 
sialoprotein (BSP), dentine matrix protein-1 (DMP-1), osteopontin, and matrix extracellular 
phosphoglycoprotein (MEPE) (Fisher and Fedarko, 2003); these play an important role in 
the regulation of dentine regeneration, as do non-phosphorylated small leucine-rich 
proteoglycans (SLRPs) such as decorin, byglycan fibromodulin, lumican, and osteoadherin 
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(Embery et al., 2001) (section 1.2.1). Dye binding assays to determine the amount of NCPs 
and GAGs in dECM preparations released by the pulp capping agents showed that, 
although the total yield of dECM components extracted by EDTA was the greatest, the total 
amount of NCPs and GAGs (w/w) in the EDTA extract was similar to those extracted by 
the pulp capping agents (Table 3.3). These data suggest that the extracts derived by 
treatment with the therapeutic pulp capping agents have greater concentrations of 
components that are NCPs or GAGs compared with the control agent, EDTA. The ratio of 
NCPs to GAGs for each extraction agent, determined as a proportion of recovered dECM 
preparation, was approximately equal. It is clear that the compositions of dECM 
preparations, extracted by EDTA and the other therapeutic pulp capping agents, vary; this 
was demonstrated visually by one dimensional sodium dodecyl sulphate polyacrylamide 
(1D SDS PAGE) analysis (excluding Biodentine®) and by the amounts of NCPs and GAGs 
in each extract. Reassuringly, the 1D SDS PAGE analyses showed that EDTA dECM 
preparations exhibited a similar profile to that of those previously demonstrated by Graham 
et al (2006). Profiles resolved from extracts produced by the ionic dissolution products of 
calcium hydroxide, white MTA and grey MTA showed that, a broad range of proteins were 
extracted which differed from one another. Therefore, the interaction of the different 
soluble constituents, from these pulp capping agents, with dentine, appears to differentially 
release different dECM components. As the ionic make-up of each solution was different, 
this may lend support to the hypothesis that the release of matrix bound proteins occurs due 
to ionic exchange between inorganic components of dentine and the ionic dissolution 
products of pulp capping materials. In this case, as dECM is disrupted differently by each 
solution, the resultant components that are solubilised will vary.  
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6.4 Growth factors in dECM released by therapeutic pulp capping agents 
 
Many growth factors are reported to be sequestered in dentine during primary 
dentinogenesis (Cassidy et al., 1997, Roberts-Clark and Smith, 2000, Musson et al., 2010, 
Graham et al., 2006, Finkelman et al., 1990) and the principle of their release and induction 
of cell signalling in tertiary dentinogenesis is well established (Tziafas et al., 2000, Smith 
and Lesot, 2001, Smith, 2002). Although many growth factors have previously been 
identified in dentine, including angiogenic growth factors (Roberts-Clark and Smith, 2000), 
insulin-like growth factors (Finkelman et al., 1990), transforming growth factor-β1 and -2 
(Cassidy et al., 1997) and bone morphogenetic proteins (Bessho et al., 1991), there are 
likely to be many more growth factors which play a vital role in the cell signalling 
processes which occur during the repair of the dentine-pulp complex. 
 
Protein array technology is increasingly being used on a high-throughput level to screen for 
proteins, especially those with a limited sample size. The initial semi-quantitative technique 
used here is well established (Kocaoemer et al., 2007, Dumortier et al., 2008, Ye et al., 
2008, Duncan et al., 2009). Analysis revealed that a large number of different growth 
factors are sequestered within the dECM and can be differentially released by the ionic 
dissolution products of pulp capping agents. Some of the growth factors identified using 
this array analysis approach are already known to play an important role in dentine-pulp 
complex repair, however, several others which were identified here have not previously 
been reported to be found within the dECM. Notably, many of these growth factors, ‘novel’ 
in dentine, are known to play a significant role in the repair and regulation of other tissues. 
The presence and the concentration of specific growth factors in dECM preparations was 
confirmed using quantitative sandwich ELISA techniques in both an individual and a novel 
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multiplex analytical approach (Willingham et al., 2009, El Karim et al., 2009). 
Transforming growth factor-β1 (TGF-β1), which has been intensively investigated for its 
role in tooth development (Begue-Kirn et al., 1992, Thyagarajan et al., 2001, Tjaderhane et 
al., 1998) and repair of the dentine-pulp complex (Dobie et al., 2002, Sloan et al., 2002, 
Sloan and Smith, 1999), was investigated using all three techniques of protein 
characterisation and used as a control. Results from these different techniques demonstrated 
good consistency in levels for the growth factors analysed. Indeed, the rank order of 
concentration / intensity of TGF-β1 followed the same pattern across all techniques applied: 
EDTA dECM preparation had the highest concentration / intensity followed by white 
MTA, grey MTA and calcium hydroxide. In addition, the signal intensity was beyond the 
detectable scale for the multiplex ELISA, indicating that the TGF- β1 concentration was too 
great in the samples tested to allow precise concentrations to be determined. This would 
corroborate data obtained from individual ELISAs where the concentration of TGF-β1 in 
the EDTA sample was nearly twice as high as that detected in the white MTA extracted 
samples. In some cases, however, although signal intensity was very low and according to 
the manufacturer’s guidelines the cytokine was regarded as being present, this was not 
confirmed using multiplex ELISA for NT-3, NT-4, G-CSF and IGF-1 SR and therefore, 
further analysis would be required to confirm the presence or absence of these cytokines. 
 
Several novel growth factors, which had not previously been reported to exist in human 
dentine, were shown to be sequestered in this tissue using the approaches applied here. 
Adrenomedullin (ADM) is a multipotent peptide that is known to play a key role in 
mammalian development (Ando and Fujita, 2003, Garayoa et al., 2002) and in regulating 
osteoblast activity and bone growth (Cornish et al., 1997, Naot et al., 2001, Uzan et al., 
2008). Previously, it has been shown to be significantly up-regulated during carious disease 
 184 
 
(McLachlan et al., 2005, Cooper et al., 2011) and can induce mineralisation processes in 
pulp-like cells (Musson et al., 2010). Its release by calcium hydroxide, white MTA and 
grey MTA during pulp capping procedures, as shown here, may also enhance repair of the 
dentine-pulp complex through its abilities to kill bacteria (Allaker et al., 1999), modulate 
inflammation (Elsasser and Kahl, 2002) and promote angiogenesis (Ribatti et al., 2007).  
 
The colony stimulating factors (CSFs) are an interesting group of growth factors not 
previously identified in human dentine. Analysis of CSF family members using the 
cytokine array suggested that granulocyte colony stimulating factor (G-CSF), macrophage 
colony stimulating factor (M-CSF) and granulocyte macrophage colony stimulating factor 
(GM-CSF) were released from the dECM by all agents. This data was not entirely 
corroborated by the multiplex ELISA studies as G-CSF was not detected, however, it was 
clear that M-CSF and GM-CSF were present and were released from dECM by pulp 
capping agents. The CSF group of glycoproteins stimulate the proliferation, differentiation, 
and survival of haematopoietic cells and also activate mature myeloid cell functions 
(Hamilton, 2008). Recently, it has been shown that M-CSF induces resident tissue 
macrophages to differentiate and proliferate in the dental pulp rather than a source of such 
cells being derived from circulating precursors (Iwasaki et al., 2011). Secretion of GM-CSF 
and osteopontin, at the pulp-dentine interface, by immunocompetent cells, such as 
macrophages and dendritic cells, locally induces maturation of dendritic cells, thus 
encouraging increased activity of odontoblasts and their differentiation from pulpal 
progenitors (Saito et al., 2011). In addition, G-CSF strongly enhances the production of 
neutrophils (Bensinger et al., 1993) and their mobilisation from bone marrow during 
inflammation (Lieschke et al., 1994, Saada et al., 1996). In methotrexate-induced 
neutropenic rats that underwent pulp exposure, G-CSF was shown to prevent a decrease of 
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neutrophils at the wound site compared with normal rats and this enabled the immune 
system to defend against bacterial invasion and reduce necrosis of the pulp (Yamasaki et 
al., 2008). G-CSF has been shown to be produced by dental pulp fibroblasts and its 
production is enhanced by inflammatory cytokines, such as tumour necrosis factor-α (TNF-
α) (Sawa et al., 2003). Also in this study, it was suggested that pulp fibroblasts, induced by 
TNF-α, had the ability to produce M-CSF and GM-CSF and that these CSFs contribute to 
the recruitment of leukocytes and immunological surveillance processes as part of the pulp 
defence system. Inflammatory cytokines have been shown to be present in dECM 
components released by lactic acid and calcium hydroxide (Cooper et al., 2010) and there is 
emerging evidence indicating that low level immune / inflammatory processes, induced by 
dental injury, may contribute to the regenerative mechanisms leading to pulpal repair 
(Cooper et al., 2010) (section 1.6.2). The discovery of CSFs in soluble dECM components 
and their release by pulp capping agents may suggest that they also play a role in the 
immunomodulating events involved in the wound healing of the pulp. 
 
Insulin-like growth factors (IGFs) are polypeptides which have a sequence similar to that of 
insulin. They operate within a system often referred to as the IGF-axis, which consists of 
two cell-surface receptors (IGF-IR and IGF-IIR), two ligands (IGF-I and IGF-II) and a 
family of six IGF binding proteins (IGFBP 1-6). The IGF-axis reportedly plays an 
important role in cell growth, differentiation and apoptosis in many different tissues (Jones 
and Clemmons, 1995). In addition, these molecules have long been of interest in the study 
of the tooth. Indeed IGF-I has been shown to have autocrine and paracrine effects, both on 
ameloblasts and odontoblasts, during tooth development (Joseph et al., 1996, Gotz et al., 
2006) and can enhance reparative dentinogenesis when applied to injured pulps in rats 
(Lovschall et al., 2001) and rabbits (Haddad et al., 2003). Both IGF-I and IGF-II have 
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previously been shown to be present within the dECM (Finkelman et al., 1990), which is 
consistent with the work presented here. Interestingly, however, IGFBPs have not 
previously been reported as being sequestered within dentine. Notably IGFBP-1 was found 
to be released at very high concentrations by all extraction agents, especially EDTA. While 
IGFBP-2, -3, -4 and -6 were detected by the growth factor array analyses, they were present 
at a much lower intensity; their presence and their precise concentrations were not, 
however, confirmed further with ELISA analysis. Interestingly, the activities of IGFs are 
modulated by the expression of IGFSRs and the binding to IGFBPs, which can act to 
reduce the activity of IGFs or prolong their half-life (Jones and Clemmons, 1995).  
 
Angiogenesis is a key process in wound repair (Gurtner et al., 2008) and it is vital to ensure 
sustained development of the tissue by providing a constant supply of nutrients, 
immunocompetent cells and growth factors to the site of healing. Vascular endothelial 
growth factor (VEGF) and fibroblast growth factor-2 (FGF-2) are considered to be two of 
the most important pro-angiogenic growth factors (Werner and Grose, 2003) necessary for 
wound repair. Indeed, their expression by pulp fibroblasts and odontoblasts is reportedly 
also likely to be key to angiogenic processes in the repair of the pulp (Tran-Hung et al., 
2006). While these growth factors have been shown to have a short half-life (Eppler et al., 
2002), these and other pro-angiogenic growth factors [Platelet derived growth factor-AB 
(PDGF-AB) and placental growth factor (PlGF)], have previously been shown to be 
sequestered in dentine (Roberts-Clark and Smith, 2000). It has been demonstrated, through 
in vitro analyses, that released dECM components have powerful angiogenic activity which 
is likely to enhance capillary microvessel formation during repair of the dental pulp (Zhang 
et al., 2011). More recently, VEGF has been shown to induce differentiation of stem cells 
from human exfoliated deciduous teeth (SHED) cells into endothelial cells via MEK1/ERK 
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signalling (Bento et al., 2013). Analysis of growth factors, in this study, supports previous 
work performed by Roberts-Clark and Smith (2003) and suggests that additional isoforms 
of PDGF such as PDGF-AA and -BB may be present in dECM. VEGF was detected in all 
preparations of dECM extracts and interestingly, significantly more was extracted by white 
and grey MTA than with the other extraction agents.  
 
Innervation of the dental pulp through the neuronal complex, known as the plexus of 
Raschkow, contributes to the survival and function of the tooth in many ways. Neuronal 
complexes emit both autocrine and paracrine signals, in the form of neuropeptides, which 
can be released in response to bacterial components (Brogden et al., 2005, Haug and 
Heyeraas, 2006) in a process known as neurogenic inflammation. Neuropeptide Y (NPY) is 
known to have increased expression in pulp inflammation (El Karim et al., 2006, Awawdeh 
et al., 2002) and more recently, the inflammatory mediators, interleukin-1β and TGF-β1 
have been shown to increase the expression of NPY in human primary pulp fibroblasts, 
suggesting that fibroblasts play a neuro-immunomodulatory role during pulp injury 
(Killough et al., 2010). Neuropeptides have also been shown to regulate the expression of 
angiogenic growth factors in human dental fibroblasts, further demonstrating the interaction 
of these neuronal secreted molecules with other biological systems (El Karim et al., 2009). 
Neuropeptides and neurotrophic factors are also expressed by odontoblasts, which 
developmentally originate from cranial neural crest cells; these neuropeptides and 
neurotrophic factors are thought to contribute to the odontoblast’s role in homeostasis and 
repair of the dentine-pulp complex (Byers et al., 1990, Magloire et al., 2001, Nosrat et al., 
1998). Three families of growth factors exist which have significant neurotrophic effects: 
neurotrophins, glial cell derived neurotrophic factor (GDNF) and neuropoietic cytokines 
(Boyd and Gordon, 2003). The neurotrophin family consists of four members, which 
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include nerve growth factor (NGF), brain derived neurotrophic growth factor (BDNF), 
neurotrophin 3 (NT-3) and neurotrophin 4 (NT-4); these are all expressed with specific 
temporospatial patterns during rodent tooth development (Nosrat et al., 1998). NGF and 
BDNF mRNAs were detected in the developing dental papilla, however, NT-3 and NT-4 
transcription was predominantly epithelial in origin. This expression was strongest during 
early developmental stages when the teeth were not yet innervated. NGF, NT-3 and NT-4 
were shown to be present in all dECM extracts when analysis was performed using the 
cytokine array, however, when levels were evaluated using multiplex ELISA, only NGF, at 
low concentrations, was detected as being present in extracts solubilised by EDTA, white 
MTA and grey MTA. Notably, NGF has previously been shown to induce mineralisation 
and increase expression of DSPP and DMP-1 in vitro in odontoblast lineage cells (Arany et 
al., 2009) and TGF-β1 is known to increase expression and secretion of NGF in a dose-
dependent manner in human pulp cells (Srisawasdi and Pavasant, 2007). These latter data 
suggest that, in the event of pulpal injury, the abundance of TGF-β1 may induce increased 
secretion of NGF (Yongchaitrakul and Pavasant, 2007). The GDNF family consists of four 
members, of which, GDNF was the first to be characterised; this molecule has previously 
been shown to promote differentiation and homeostasis of neurons, together with three 
other trophic factors, namely, neurturin (NTN), persephin (PSP), and artemin (ART) 
(Airaksinen and Saarma, 2002). Analysis of GDNF knockout mice has shown that 
ameloblast and odontoblast differentiation is disrupted, suggesting that GDNF is important 
in tooth cytodifferentiation (de Vicente et al., 2002). Recently, our research group has 
demonstrated in vitro that GDNF may have multi-functionality within the dentine-pulp 
complex, acting as both a survival factor and mitogen during tooth injury and repair (Gale 
et al., 2011). In experiments presented here, GDNF was shown to be extracted from dECM 
by EDTA and all therapeutic pulp capping agents. Following the application of a 
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therapeutic pulp capping agent to a pulp wound, the solubilisation of NGF, GDNF and 
potentially neurotrophins, NT-3 and NT-4, may contribute to pulp healing either directly by 
their effect on pulp cells or indirectly, in terms of mediating immune and inflammatory 
responses, as previously discussed.  
 
The molecular processes involved in recruitment of progenitor cells which contribute to 
reparative dentinogenesis, remain poorly understood (Sloan and Smith, 2007, Sloan and 
Waddington, 2009, Smith and Lesot, 2001). Recently, it has, however, been proposed that 
non-resident progenitor cells that are haematopoietic or pericyte in origin, are the source of 
some of the undifferentiated cells in reparative dentinogenesis (Frozoni et al., 2012, Feng et 
al., 2011). While these are relatively new data, questions have arisen as to how these cells 
are mobilised and / or recruited. Interestingly, in our study, stem cell factor (SCF) was 
found to be present in all dECM preparations, at low intensity, when analysed by the 
cytokine array. Indeed, SCF was detected in grey MTA extracts when analysed using 
multiplex ELISA. While the mechanisms of controlling the redistribution of haematopoietic 
stem cells and progenitor cells, between the bone marrow and blood, in vivo are not fully 
understood, early work showed that injection of mice with SCF results in a profound 
redistribution of primitive haematopoietic cells from the bone marrow into the blood and 
spleen (Fleming et al., 1993, Yan et al., 1994). Enhancing the release of haematopoietic 
stem cells has been used as an adjunctive therapy in patients undergoing chemotherapy and 
/ or radiotherapy. SCF is used individually, or in combination, to mobilise haematopoietic 
stem cells for collection during the process of autologous haematopoietic stem cell 
transplantation (AHSCT), a technique used to enhance the recovery of immune function 
following high dose chemotherapy and / or radiotherapy. Used in combination with G-CSF, 
SCF has been shown to be effective during this process (Herbert et al., 2009, Herbert et al., 
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2010). Theoretically, it may therefore be possible that SCF and other factors, released from 
the dECM by caries and by therapeutic pulp capping agents, initiate the mobilisation and 
homing of circulating stem cells or pericytes which differentiate and contribute to pulpal 
repair. 
 
These analyses have identified a number of new growth factor families in dentine, which 
was already recognised to be a rich reservoir of potent signalling molecules. The ionic 
dissolution products of inorganic materials have been shown to have direct effects in vitro 
on the homeostasis and repair of human tissues (Hoppe et al., 2011). Rather than these 
positive biological effects being as a result of direct contact by the ionic solution 
themselves, it may be more plausible that, these effects are due to the potent growth factors, 
released locally by the dissolution products. The processes involved in wound repair are 
numerous and complex and the relatively “gentle” differential release of growth factors and 
cytokines by therapeutic pulp capping agents, as demonstrated here, may explain how these 
biological events are initiated and orchestrated. 
 
6.5 Biological effects of dECM components released by therapeutic pulp capping 
agents 
 
Following tissue injury, once haemostasis has been achieved and an immune response has 
been initiated, the wound will begin to stabilise to enable the reparative phases of healing to 
begin (Gurtner et al., 2008, Velnar et al., 2009). Specific cues and signals are required to 
recruit progenitor cells to the site of injury to undertake the further processes of 
proliferation and differentiation involved in wound repair. Various growth factors and 
proteins from different sources, including cementum and bone (Ogata et al., 1997) are 
thought to play a role in this overall process, however, as yet these have not been 
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thoroughly characterised. Growth factors known to be present in dECM, including TGF-β1 
(Kwon et al., 2010), fibroblast growth factor (FGF) and epidermal growth factor (EGF) 
(Howard et al., 2010), have also been shown to be effective at inducing pulp cell migration. 
Interestingly, Howard et al. (2010) reported that the structural ECM proteins, laminin, 
fibronectin and collagen type-1, also have the ability to act as chemoattractants to dental 
pulp cells. Other growth factors, such as fibroblast growth factor (FGF), vascular 
endothelial growth factor (VEGF) and platelet derived growth factor (PDGF), used alone or 
in combination with nerve growth factor (NGF) and bone morphogenetic protein-7 (BMP-
7), were shown to be effective in cell homing to initiate re-cellularisation and re-
vascularisation of the pulp chamber in an in vivo ectopic implantation model (Kim et al., 
2010). Recent work by our research group (Smith et al., 2012c) has shown that dentine 
chips, pulp ECM and dECM preparations are effective at inducing pulp cell 
chemoattraction and migration. Notably, when these preparations were degraded by 
enzymatic or acidic digestion to mimic the carious process, these effects were enhanced. 
 
In the experiments presented here, using a transwell plate assay, all preparations of dECM 
components induced migration of RDPCs to the homing agent. EDTA solubilised dECM 
components were previously used by Smith et al. (2012) and similar results were also 
obtained here. For all extracts assessed (EDTA, calcium hydroxide, white MTA and grey 
MTA), migration of RDPCs was significantly greater than control. When data for each 
preparation were combined across all concentrations and the data for the negative control 
were subtracted (negative control is assumed to be passive movement across the membrane 
of the transwell plate), grey MTA extracted dECM components induced over twice as much 
migration of RDPCs, compared with EDTA, and could be considered the most powerful 
chemotactic agent of those tested. White MTA, calcium hydroxide and EDTA extracted 
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dECM components would be ranked, second, third and fourth respectively. Although all 
dECM preparations tested here demonstrated that they were effective at inducing 
chemotaxis of pulp cells in vitro, some appeared more potent than others. As chemotaxis is 
known to be one of the key processes in wound healing, the potency of the chemotactic 
effects of dECM components released by pulp capping agents as shown here, may explain 
at least in part why MTA induces more pulp healing than calcium hydroxide.  
 
Several different growth factors have been shown to increase proliferation of dental pulp 
cells. In an ex vivo culture model, TGF-β1 induced increases in cell numbers in the 
odontoblastic and subodontoblastic layers adjacent to delivery of the growth factor (Melin 
et al., 2000). Exposure of human dental pulp cells (DPCs) to VEGF in vitro increased 
proliferation without inducing differentiation towards an endothelial lineage (D' Alimonte 
et al., 2011) and specific dosages of FGF-2 in ex vivo cultures induced cell numbers to 
increase within the pulp tissue (Ishimatsu et al., 2009, Kikuchi et al., 2007, Kitamura et al., 
2012). In studies presented here using in vitro monolayer cultures, data demonstrated that a 
homogeneous population of an immortalised cell line of odontoblast-like cells (MDPC-23) 
and a heterogeneous population of primary RDPCs, when exposed to different 
concentrations of dECM components containing a rich cocktail of growth factors, 
responded similarly. Low to moderate concentrations of dECM components stimulated cell 
proliferation in a dose-dependent manner, while the highest concentrations decreased cell 
numbers. These data are also consistent with previous reports (Graham et al., 2006, Musson 
et al., 2010, Zhang et al., 2011). As has been demonstrated, the solubilised dECM 
components used here contain numerous biologically active constituents and therefore, the 
cellular responses studied here cannot be attributed to any single protein. Notably, however, 
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it has been shown that TGF-β1, a known constituent of liberated dECM components, can 
alone induce apoptosis in pulp cells at higher concentrations (He et al., 2004). 
 
It has now been demonstrated that dECM components, liberated by the soluble products of 
therapeutic pulp capping agents, induce migration and proliferation in dental pulp cells, two 
key processes in reparative dentinogenesis. The interaction of therapeutic pulp capping 
agents with adjacent dentine has already been suggested for calcium hydroxide (Graham et 
al., 2006). These functional experiments suggest that the solubilisation of bioactive 
molecules from dECM by white MTA and grey MTA may promote events involved in 
reparative dentinogenesis.  
 
6.6 Potential role of hepatocyte growth factor in reparative dentinogenesis 
 
Hepatocyte growth factor (HGF) is considered a multifunctional growth factor and cytokine 
which is involved in a variety of physiological and pathological processes (Trusolino et al., 
2010). The role of HGF / c-Met signalling has been researched intensively in oncogenesis 
and tumor progression leading to the development of drugs which prevent intracellular 
signalling along this pathway (Cecchi et al., 2012). The regulation of its expression in oral 
fibroblasts suggests it may influence local progression of oral squamous carcinoma cells 
invading underlying stroma (Daly et al., 2008). In terms of tissue healing, an in vitro model 
of wound contraction demonstrated increased levels of HGF in oral fibroblasts compared to 
skin fibroblasts, suggesting that HGF contributed to accelerated re-epithelialisation of oral 
wounds compared to skin wounds (Shannon et al., 2006). As discussed in section 1.2.2, 
expression of HGF and c-Met has been implicated as a potential signalling pathway in tooth 
development (Sonnenberg et al., 1993, Kajihara et al., 1999). More recently, primary 
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murine dental papilla cells, exposed to recombinant HGF, demonstrated enhanced 
proliferation and differentiation, with increased expression of the Pax-9 and Msx-1 genes, 
which are central to tooth development (Li et al., 2009).  
 
6.6.1 Presence of HGF and its receptor c-Met in dental tissues 
 
The potential for matrix-bound HGF to be released during clinical treatment is highlighted 
by its solubilisation by EDTA, white MTA and grey MTA. EDTA was a significantly more 
effective extractant of HGF than the MTA varieties; this was likely to be due to its 
powerful demineralising and solubilising actions on the dental hard tissues. This pattern of 
HGF release is consistent with a number of other growth factors analysed here. 
Interestingly, calcium hydroxide and Biodentine® did not solubilise detectable levels of 
HGF from dentine; such differences, in terms of bioactive molecules released from dentine, 
may contribute to differences in biological actions of these materials when applied in vivo. 
The expression of the receptor of HGF and c-Met in isolated rat pulp, as well as in cells of 
primary cultures derived therefrom, was demonstrated here. This informed the use of 
primary RDPC cultures in experiments to assess the effects of HGF as this provides a 
valuable in vitro model for analysis of regenerative events in the dentine-pulp complex 
(Patel et al., 2009). The expression of HGF and c-Met was also confirmed in human pulp 
tissue to ensure that any conclusions drawn from the in vitro analyses were potentially 
translatable to pulp repair in humans. 
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6.6.2 Functional effects of HGF in RDPC cultures 
 
The functional responses of RDPCs to HGF, namely chemotactic activity and 
mineralisation, were clearly demonstrated using the transwell plate assay and alizarin red 
staining. These results were consistent with a previous report showing HGF to be a 
mineralisation-inducing agent in human vascular smooth muscle cells (Liu et al., 2007). 
Notably, HGF was observed to be a powerful chemoattractant in a transwell plate assay 
over a range of concentrations (5-20 ng/mL). These data may also help to further clarify 
which active component(s) are responsible for the stimulatory effects of dECM on pulp cell 
recruitment that have recently been reported (Smith et al., 2012c). Indeed, given that its 
presence in dentine has been demonstrated and that it is known to be released by control 
and therapeutic agents, HGF could be a key contributor to the cell recruitment process 
during dental wound healing. Exploitation of chemotaxis and cell homing processes to 
develop novel treatment modalities, by which to harness the natural reparative mechanism 
of the pulp, or engineer pulp tissue, shows exciting potential (Laird et al., 2008, Mao et al., 
2010). Recently, successful engineering of dental pulp tissue, using chemotaxis-induced 
cell homing, has been reported (Kim et al., 2010). In this published study, the role of 
several cytokines were analysed including FGF, VEGF and PDGF alone or in combination 
with NGF and BMP-7. While the optimum combination of cytokines remains to be 
determined, these data clearly indicated that synergistic signalling interactions may be 
important during the wound repair process. Based on data presented in this thesis, it would 
appear that HGF may also be a good candidate for further investigation in regeneration and 
tissue engineering treatment modalities which require cell homing to be induced. 
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HGF / c-Met signalling has previously been shown to be associated with mineralised tissue 
formation under pathological conditions (Liu et al., 2007, McKinnon et al., 2006), 
highlighting the potential for its involvement in mineralised cell differentiation and 
activation. In this study, we have shown that gene expression changes in RDPCs exposed to 
HGF are indicative of differentiation of these cells towards dentinogenic and osteogenic 
lineages. Runx2 and osterix are core osteogenic transcription factors, which regulate 
expression of numerous mineralisation–associated transcripts including osteocalcin and 
osteopontin (Ducy et al., 1996, Karsenty, 2000). Notably, runx2, osterix, osteocalcin and 
osteopontin were all up-regulated in RDPCs following exposure to HGF. While DMP-1 is 
relatively more abundant in dentine (George et al., 1993), it is also present in bone 
(D'Souza et al., 1997) and Runx2 is involved in the regulation of DMP-1 during both 
osteogenic and dentinogenic events. Thus far, however, the regulatory mechanisms 
involved have been suggested to be different for each cell or tissue type (Fen et al., 2002). 
Expression of DMP-1 on days 7 and 12 was significantly higher in RDPCs for both 
concentrations of HGF applied. These data suggest that HGF, via c-Met binding, activates 
intracellular signalling pathways leading to increased levels of transcriptional signalling for 
regulation of a mineralising cell phenotype. 
 
To further characterise the effect of HGF on repair-associated responses within the dentine-
pulp complex, it was demonstrated that both application of recombinant HGF and induced 
over-expression of HGF using an adenoviral vector system promoted in vitro mineralisation 
in RDPCs. After 8 days culture, there was significantly greater in vitro mineralisation 
detected independent of the HGF delivery approach. These data concur with those reported 
by Li et al. (2009), which showed an increase in levels of the marker of mineralisation, 
alkaline phosphatase, in a developmental pulp cell population exposed to HGF. However, a 
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significantly longer period of culture of 28 days and a single concentration of 10 ng/mL of 
recombinant HGF was required to demonstrate this effect. The same group have also 
indicated that HGF may enhance proliferation and differentiation of primary human pulp 
cells in culture, potentially via the ERK / MAPK signalling pathway (Ye et al., 2006). The 
range of exposure conditions and in vitro mineralisation assays that were applied in the 
present study have not previously been documented nor has the potential tissue location of 
HGF. 
 
While HGF / c-Met signalling is known to play an important role in the repair of many 
tissues, the identification of HGF sequestration within dentine and the demonstration of its 
functional role in pulp cell chemotaxis, differentiation and mineralisation, emphasises its 
potentially important role in signalling repair in the dentine-pulp complex. The release of 
HGF from the dECM by carious demineralisation or therapeutic pulp capping agents may 
therefore play an important role in repair-associated events in vivo. 
 
6.7 Future work 
 
The work presented here offers a detailed analysis of growth factors found within dECM 
and suggests an explanation for the well-recognised healing capacity of calcium silicate 
cements when they are used clinically as pulp capping agents. These studies also provide an 
opportunity and a sound basis for further investigation along many avenues of research, 
which should add to our understanding of dentine-pulp repair.  
 
The hypothesis and suggestion that the interaction of calcium silicate cements with 
surrounding tissue fluids creates an ionic environment that will initiate biological 
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mechanisms of pulp repair requires further investigation. A broader more detailed analysis 
of the release of ions from the hydrated layer of calcium silicate cements is necessary to 
precisely determine the nature of the components released into the surrounding tissue fluid. 
Although there is only limited knowledge of how growth factors and other bioactive 
molecules are bound to dECM, the mechanisms by which calcium silicate cements interact 
with dentine and release these molecules would deepen our understanding. This work has 
focused on the interaction of these materials with the mineralised component of the dentine-
pulp complex, however, it has recently been demonstrated that the ECM of the pulp also 
contains a plethora of bioactive components that participate in events leading to pulp repair 
(Smith et al., 2012). In order to provide a more comprehensive picture of how calcium 
silicate cements interact with the dentine-pulp complex and harness its natural regenerative 
potential, it would be appropriate to investigate the ability of these materials to release pulp 
ECM components and then to determine their subsequent cellular and molecular effects. 
 
The work here has identified numerous growth factors, with previously uncharacterised 
roles in dentine-pulp biology, that are sequestered in dentine. Notably, many have been 
shown to have potent biological effects in other tissues. Indeed, detailed analysis of the 
effects of HGF on primary pulp cells in vitro has now demonstrated that HGF may play an 
important role in the wound repair processes of the dentine-pulp complex. Further analysis 
of these previously uncharacterised growth factors and analysis of their synergistic effects 
with other molecules should identify exciting opportunities for the development of new 
biomimetic treatments and pulp tissue engineering strategies for repair of the injured 
dentine-pulp complex.  
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7.0 CONCLUSION 
 
With reduced rates of edentulism and people now retaining their teeth for longer (Steele et 
al., 2012), there is a real need to develop novel biologically based treatment modalities 
which can protect the pulp, enhance its natural regenerative capacity and enable 
engineering of new tissue if it becomes irreversibly damaged. This can best be achieved by 
developing a thorough understanding of the underlying biological repair processes which 
naturally occur within the dentine-pulp complex. This work aimed to analyse the 
interaction between what is currently considered to be the most successful pulp capping 
agent, MTA, and the dentine-pulp complex, in order to understand how a favourable 
biological response can be induced. 
 
It was shown that grey MTA and white MTA leached multiple different cations from their 
setting and set phases in vitro; these solutions, together with one produced by calcium 
silicate cement, Biodentine®, were able to solubilise dECM components. This has never 
previously been reported. When these materials are used as pulp capping agents, they will 
inevitably interact with dentine at the periphery of the pulp wound and with dentine chips 
(Seltzer and Bender, 1990) that remain on the open pulp surface and in the surrounding 
area. Based on the data presented here, it is possible to postulate that tissue fluid originating 
from the dentinal tubules and the soft tissue of the pulp, hydrates the surface layer of the 
calcium silicate cement releasing ionic dissolution products. These will interact with the 
mineral phase of local dentine by ion exchange and liberate sequestered growth factors and 
bioactive molecules present within it. In turn, these will initiate the events leading to 
reparative dentine formation.  
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Each pulp capping agent tested demonstrated liberation of different proportions of NCPs 
and GAGs in the dECM components obtained. Although dentine is known to be a rich 
source of bioactive molecules, our growth factor analysis demonstrated the presence of a 
number of signalling molecules not previously reported, including SCF, M-CSF, GM-CSF, 
IGFBP-1, GDNF, NGF and HGF. Data from other tissues demonstrate that these molecules 
mediate biological processes required for tissue repair and homeostasis. The repair 
processes in a complex tissue, such as the dentine-pulp, are finely balanced between 
managing the infection, the inflammatory response and the direct tissue healing processes. 
The subtle release of several of the growth factors, now known to be sequestered in dentine, 
by the pulp capping agents tested, may orchestrate this complex process. 
 
The dECM components released by therapeutic pulp capping agents (calcium hydroxide, 
white MTA and grey MTA) were shown to be biologically active and to play a direct role 
in stimulating chemotaxis and proliferation in pulp cells. Both of these processes are key to 
the repair and regeneration of the dental pulp. Higher concentrations of dECM components 
appeared to prevent the proliferation or have a deleterious effect on pulp cells, suggesting 
that the subtle release of these bioactive components may be more beneficial, which may 
explain why these agents are successful in pulp capping.  
 
During this work, a more in-depth analysis of HGF was undertaken as this growth factor 
was shown to be released only by white MTA and grey MTA, which are considered to be 
the most predictable in terms of pulpal reparative responses when used clinically. HGF was 
shown to be a chemotactic agent, capable of inducing differentiation of pulp cells along a 
mineralising lineage, as well as promoting in vitro mineralisation processes in dental pulp 
cell cultures. Both HGF and its receptor c-Met were also detected as being expressed in 
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human pulp cells. These findings indicate the potential role of HGF in mediating pulpal 
reparative responses when released during carious demineralisation or following 
application of pulp capping agents in the clinical situation. 
 
The research presented here suggests a plausible explanation of why MTA and a new 
generation of calcium silicate cements, based on MTA, induce favourable healing responses 
of the dental pulp. This knowledge will provide a sound basis for future work investigating 
molecular processes of pulp repair. It is hoped that such studies will lead to the 
development of new materials and treatment modalities in the future, thus improving the 
predictability of treatment outcomes. 
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APPENDIX I 
 
Sensitivity thresholds for multiplex ELISA 
 
 Limits of Detection 
(pg/mL) 
 Limits of Detection 
(pg/mL) 
 Lower Upper  Lower Upper 
HGF 4.9 8 000 IGF1 9 244.9 400 000 
TGF-β1 1 648 200 000 IGF1-BP1 4.1 8 000 
G-CSF 50.8 40 000 IGF1-SR 564.6 200 000 
GM-CSF 9.5 4 000 IGF2 378.1 200 000 
M-CSF 19.5 8 000 PDGF-AA 5.3 8 000 
SCF 25.6 20 000 VEGF 6.7 40 000 
GDNF 11.6 4 000 FGF 1 166.2 40 000 
NGF 1.3 8 000 BMP4 41.0 200 000 
NT-3 17.8 40 000 BMP7 566 2 400 000 
NT-4 12.1 40 000 EGF 2.2 800 
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Dissolution of bio-active dentine matrix components by
mineral trioxide aggregate
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1. Introduction
Mineral trioxide aggregate (MTA) was developed in the 1990s
initially for use as a root-end filling material due to its ability
to set in the presence of moisture.1 Whilst its chemistry was
based on that of ordinary Portland cement, significant
differences preclude use of the latter as a clinical substitute.2
MTA has been shown capable of inducing mineralised tissue
formation at a variety of oral and dental tissue sites and
subsequently its potential applications within dentistry
have expanded.3 The chemical composition of MTA is a
mixture of oxides with approximately 65% being calcium
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Objectives: To analyze the soluble components of setting and set mineral trioxide aggregate
(MTA), assess the abilities of two varieties ofMTAandCa(OH)2 solutions to solubilise dentine
matrix proteins (DMPs) and determine if these extracts contain signalling molecules
important to pulpal repair and regeneration.
Methods: The metallic ion composition of solutions of white and grey MTA (pH 11.7), 0.02 M
Ca(OH)2 (pH 11.9) and 10% EDTA (pH 7.2) was determined using atomic absorption spectro-
scopy. Extracellular dentine matrix components from powdered human dentine were
extracted using all solutions over 14 days. Extracts were analysed for concentrations of
non-collagenous proteins (NCPs) and glycosaminoglycans (GAGs), and protein profiles were
examined using 1D-polyacrylamide gel electrophoresis (1D-PAGE). ELISAs for TGF-b1 and
adrenomedullin (ADM) were also performed.
Results: Aluminium, calcium, potassium, and sodium ions were detected in both white and
grey MTA solutions. MTA and Ca(OH)2 solutions liberated similar amounts of GAGs and
NCPs although yields were considerably lower than those obtained using the EDTA solution.
1D-PAGE analysis demonstrated differences in protein profiles solubilised from dentine for
all solutions. All extracts contained TGF-b1 and ADM, EDTA solution liberated significantly
greater amounts of TGF-b1, and Ca(OH)2 and grey MTA solutions released more ADM.
Conclusions: These data imply that when placed clinically soluble components of set and
setting MTA may release dentine matrix components that potentially influence cellular
events for dentine repair and regeneration.
# 2007 Elsevier Ltd. All rights reserved.
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a b s t r a c t
Extracellular matrix of dentine contains a rich cocktail of soluble cytokines and growth factors which
mediate wound repair of the dentine–pulp complex. Hepatocyte growth factor (HGF) is a mesenchyme
derived growth factor regulating a broad range of physiological processes including tissue development
and regeneration. In this study, we have investigated the sequestration of HGF in the dentine matrix and
analysed its action as a chemokine in the induction of differentiation and mineral deposition in pulp
derived cells in vitro. Using ELISA, the presence of HGF was demonstrated in solubilised fractions of den-
tine matrix released by the therapeutic pulp repair materials of white and grey mineral trioxide aggre-
gate. HGF was shown to be a chemo-attractant for primary rat dental pulp cells (RDPCs) in transwell
assays highlighting its potential in progenitor cell recruitment during dentine–pulp tissue repair.
Transcription factors Osterix and Runx2, and genes encoding for Osteopontin and Osteocalcin, were
up-regulated in HGF-exposed RDPC cultures compared with controls. Adenoviral-mediated expression
of HGF in RDPCs or exposure to recombinant HGF induced mineral secretion in RDPCs which was signif-
icantly greater than controls. The receptor of HGF, c-Met was also detected within human dental pulp
indicating the potential for HGF released from dentine matrix to contribute to cellular signalling events
following tissue injury. Combined, these data suggest that HGF is important in the repair of the dentine–
pulp complex potentially participating in several aspects of wound healing.
 2012 Elsevier Ltd. All rights reserved.
1. Introduction
Wound healing begins immediately following injury to a tissue
initiating a cascade of events involving resident and migratory cell
populations, extracellullar matrix (ECM) and the action of soluble
mediators [1]. Several soluble signalling molecules have been
implicated in the molecular interactions of the dentine–pulp com-
plex during pulp repair [2], although the underlying mechanisms
are only beginning to be elucidated. Repair of the pulp is a complex
process of cellular events requiring progenitor/stem cell recruit-
ment, involving chemoattraction to the injured pulp site, signalling
of odontoblast-like cell differentiation and subsequent up-
regulation of dentine matrix secretion and mineralisation [3].
While these cellular events are likely to be regulated by a multi-
tude of cytokines and other signalling factors, studies are now
starting to uncover the key molecules involved. Transforming
growth factor-b1 (TGF-b1) has previously been shown to play a
pivotal role in pulp tissue repair, acting as a chemotactic agent
[4] and signaller of cellular differentiation [5]. It may also regulate
activity of terminally differentiated odontoblasts switching be-
tween primary, secondary and tertiary dentinogensis via its action
on the p38-mitogen-protein activated kinase pathway [6]. TGF-b1
is sequestered within dentine matrix together with other cytokines
and growth factors including ﬁbroblast growth factor-2, insulin-
like growth factor-1 and 2, adrenomedullin, vascular endothelial
growth factor and platelet derived growth factor [7–10]. Unlike
bone, dentine demonstrates minimal physiological remodelling
during its lifetime, however, its dissolution can occur pathologi-
cally during caries and much more locally following therapeutic
application of dental materials, such as calcium hydroxide and
mineral trioxide aggregate (MTA) [11,12]. The dissolution process
releases matrix bound growth factors and cytokines, which can
subsequently trigger cellular and tissue repair associated re-
sponses, including tertiary dentinogenesis [2]. The dentine matrix
is complex and harbours a rich cocktail of growth factors many
of which are not yet well characterised and which regulate
dentine–pulp complex homeostasis and repair.
Hepatocyte growth factor (HGF) has previously been demon-
strated to regulate liver regeneration [13,14], but it also exhibits
bioactivity in platelets [15] and plasma [16,17]. HGF is considered
a multifunctional growth factor and cytokine that can act as a
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